Development of impedimetric immunosensors for the detection of a range of antigens of biological or biomedical significance by Garifallou, Goulielmos-Zois
Cranfield University
Goulielmos-Zois Garifallou
Development of impedimetric immunosensors for 
the detection of a range of antigens of biological or 
biomedical significance
Cranfield Health
PhD
Cranfield University
Cranfield Health
PhD
2008
Goulielmos-Zois Garifallou
Development of impedimetric immunosensors for 
the detection of a range of antigens of biological or 
biomedical significance
Professor S. P. J. Higson
© Cranfield University, 2008.  All rights reserved.  
No part of this publication may be reproduced 
without the written permission of the copyright 
holder.
Abstract
This PhD project was funded by the European Union Framework 6 ELISHA 
programme as part of the ELISHA programme. The aim of the research was focused 
towards the development of point-of-care, simple, cost-efficient and reliable 
impedimetric immunosensors for the rapid detection of important antigens such as 
ciprofloxacin and digoxin. Through the cooperation of the 9 involved partners a 
number of protocols have been developed for sensor fabrication and sample testing 
that allow both rapid and reliable detection of a range of antigens. This work 
describes in depth, the use of polymers and cyclic voltammetry for electrode surface 
modification, the use of the avidin-biotin system for antibody immobilisation and 
finally the use of Electrochemical Impedance Spectroscopy for antigen detection. We 
report here the successful development of electrochemical impedimetric carbon based 
immunosensors for the detection of free-form and chelated ciprofloxacin (both in 
laboratory buffer and milk), digoxin and green fluorescent protein. It was observed 
during this work that unavailability of sufficient quantities of the monoclonal 
antibodies could lead to early sensor saturation and hence a less extended antigen 
detection range, while very low quantities of immobilised antibodies could also give 
rise to erroneous results. The immunosensors towards ciprofloxacin detected the 
respective antigen when this was present between 1 ng ml-1 and 10 μg ml-1 in PBS 
buffer and 0.1 ng ml-1 to 10 μg ml-1 when the antigen was added to milk samples. The 
developed digoxin immunosensors could detect digoxin between the concentrations of 
0.1 ng ml-1 and 10 μg ml-1. Lower detection limits where observed for the sensors 
targeting GFP which could detect their respective antigen at concentrations as low as 
100 pg ml-1. The tested concentration range of the latter sensors was extended up to 
100 ng ml-1. 
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Section 1
Introduction Literature Review and 
Experimental Methods
Chapter 1
Context of Research Programme and Rationale 
for this Research
11.1 Aims and Objectives
This PhD research programme focused towards the development of a label-free, 
inexpensive, fast and reliable prototype immunosensor format for point-of-care 
applications. 
The research undertaken in this PhD programme was funded as part of the ELISHA 
contract funded by the European Union 6th Framework ELISHA programme and 
includes Cranfield University alongside 8 other European Union partners as detailed 
below:
1) University of Leeds, UK, as co-ordinator
2) Cranfield University, UK
3) Ecole Centrale de Lyon & Centrale Lyon Innovation, France
4) Technische Universität München , Germany
5) NMRC-Tyndall National Institute, Ireland
6) CSIC- Spanish National Research Council, Spain
7) Uniscan Instruments Ltd, UK
8) University of Grenoble, France, and,
9) Technology Translators Ltd, UK
The specific objectives of this research project within the responsibilities for 
Cranfield University as partner 2 within the project were to:
1) Identify optimal protocols and procedures for reproducible sensor fabrication.
2) Test a range of materials i.e. carbon, gold, platinum for electrode fabrication 
as well as different polymers for use within sensor fabrication.
3) Investigate the effects of different fabrication protocols with regards to sensor 
loading and sensitivity.
4) Extend the range of analytes that had previously been analysed using the same 
approach.
5) Characterise the sensors i.e. detection limits, stability and reusability using 
analytes important to industry as well as within medicine.  
21.2 The ELISHA consortium
The acronym ELISHA stands for “Electronic Immuno-Interfaces and Surface Nano-
biotechnology: A Heterodoxical approach”. The hypothesis upon which this project 
was initiated was a novel concept based on previous breakthroughs in affinity sensing, 
and hence the term ‘heterodoxical’. 
When exposed to their respective antigens and upon AC impedance interrogation, 
antibody loaded polymer based sensors provide a measurable signal that is 
dependant on antigen concentration.
Within and from this research, the European Union aims to ‘promote real 
breakthroughs, based on scientific and technical excellence’ (ELISHA Annex, 2003).
Each of the 9 partners have shown excellence in their respective fields whether it be 
biology, biochemistry, electronics or commercial exploitation of scientific 
discoveries. The academic and industrial partners have collaborated closely to bring 
this project to successful completion. 
The approaches used within ELISHA include multidisciplinary research covering the 
following areas:
 Molecular Electronics: the electronics that will allow ‘sensing’ of the 
Antibody/Antigen interaction occurring at the nano-scale level on the project 
specific electrode surface (due to irreproducibility issues with the project 
specific electrodes, the carbon electrodes depicted in figure 3.4, section 3.4.2 
where alternatively used).
 Molecular Interfaces: the interaction between biological molecules and 
non-biological surfaces.
 Understanding materials phenomena: furthering the understanding of 
multifunctional materials and creating new methods for processing these.
3 Nano-biotechnologies and the general public: the integration of 
nano-biotechnology, new materials and new production technologies in 
modern medicine, the food industry and environmental processes
The primary focus of the consortium was towards the production of nanostructured 
immunosensors that will ultimately form the basis for a commercially viable sensing 
device. This will in turn have a major impact in rapid and reliable analyte detection. 
Main areas of concern are cancer markers, fluoroquinolone antibiotics and prion 
peptides. All targeted substances/molecules have a major impact in the medical and 
food industry as well as in environmental control applications. As a result innovations 
arising towards this scope will promote major strategic and financial benefits.
In order to successfully meet the aims of this project, three main objectives must first 
be met:
1) To gain a deeper understanding and thus provide further knowledge of a newly 
observed signal transduction mechanism occurring in nanostructured 
affinity-based reagent biosensors.
2) To produce model prototypes of electronic and label-free immunosensors and 
through further development of these, proceed to the manufacture of low-cost, 
simple and reliable affinity-based biosensors for medical and environmental 
analyses along with other potentially related purposes, and,
3) The development of electronics specific and dedicated to this project.
The project was structured into 9 workpackages each with a lead project partner as 
shown in table 1.1 below. All other partners contributed to two or more workpackages 
working in conjunction with others within the consortium. 
4Workpackage number and 
description
Responsible partner Other partners involved
1) Affinity reagent 
production and testing
Partner 1 Partner 6
2) Electrochemical 
Transducer production
Partner  5 Partner 2
3) Production of matrix 
precursosrs
Partner 8 Partners 1 & 9
4) Fabrication of nano-
structured immunosensors
Partner 2 Partners 1, 3, 5, 6, 8 & 9
5) Investigations into 
immobilisation strategies 
and matrix construction
Partner 3 Partners 1, 2, 4, 5, 6, 8 & 9
6) Sensor address systems 
and interrogation 
electronics
Partner 7 Partners 1, 2, 3, 6, 8 & 9
7) Signal generation and 
non-specific binding 
optimisation
Partner 1 Partners 2, 3, 4, 6, 8 & 9
8) Evaluation of affinity 
sensor systems including 
signal processing 
Partner 2 Partners 1, 3, 5, 6, 7, & 9
9) Laboratory prototype 
system
Partner 7 Partners 1, 2, 5 & 9
Table 1.1: The ELISHA workpackages and associated partners.
A brief description of each workpackage, as included in the ELISHA technical 
Annex, follows.
Workpackage 1: To produce hapten derivatives for antibody production; to supply 
purified antibodies and recombinant antibody reagents for sensor production; to 
provide modified recombinant antibodies for specific immobilisation protocols 
enabling simple sensor manufacture.
5Workpackage 2: To produce metal (gold and platinum) transducers, using silicon or 
plastics as the substrates, with corresponding mounting connectors; to produce a range 
of metal transducers with different geometries; to produce microelectrode transducers.
Workpackage 3: To produce a range of electropolymerisable monomers or 
electrodepositable materials having specific chemical characteristics to enable 
entrapment or covalent immobilisation of bioactive antibodies and fragments.
Workpackage 4: To identify the correct techniques and conditions to enable 
reproducible manufacture of immunosensors based on the antibodies, recombinant 
antibodies and Fab fragments; to investigate the effect of different fabrication 
protocols on the loading and the sensitivity of the immunosensors produced.
Workpackage 5: To investigate the immobilisation events themselves and develop 
understanding on the chemistry-biochemistry of the immobilisation processes to 
feedback into W4 for effective fabrication; to characterise the nanostructural 
properties that produce the micro and nano-environments required for device 
production; to evaluate different matrices in regards to sensitivity and stability. 
Workpackage 6: To design and evaluate novel interrogation techniques for 
extraction and de-convolution of signals generated from the affinity sensors; to 
develop purpose designed electronics for integration into 1) test bed evaluation rigs 
and 2) laboratory prototype sensor system; to iteratively feed back into W3, W4, W5 
and W7 to optimise and develop sensors, interfaces and electronics for 
immunosensors.
Workpackage 7: To determine the origin of signal generation in the immunosensors 
fabricated and relate this to the matrix used and the method of immobilisation; to 
determine the parameters defining non-specific signal generation and to reduce the 
non-specific effects by a number of experimental means.
Workpackage 8: To characterise and determine the performance characteristics of a 
range of affinity sensors in terms of reproducibility, stability and analytical 
performance; to evaluate a range of prototype sensor systems towards a number of 
6different targets in terms of lower limits of detection, selectivity and possible 
interference effects; to compare analytical performance with standard detection and 
quantification methods, e.g. ELISA.
Workpackage 9: To develop a laboratory prototype system to prove principle using 
the nanostructured affinity sensors developed in the project as the detection method.
It should be noted here, that the Enzyme Biotechnology Group acted as the project 
coordinator and point of contact between the ELISHA consortium and the EU.
7Chapter 2
Introduction and literature review
82.1 Biosensor definition and brief history of biosensor development
A biosensor is defined by the International Union of Pure and Applied Chemistry 
(IUPAC) as:
“A device that uses specific biochemical reactions mediated by isolated enzymes, 
immunosystems, tissues, organelles or whole cells to detect chemical compounds 
usually by electrical, thermal or optical signals”.
A more simple description of a biosensor is given by Kissinger (2005) who states that 
a biosensor is “a device where a biological recognition element is built in (physically
attached or confined) and is the primary selectivity element”.
The biosensor concept was generated when a progenitor device was pioneered by 
Professor L. C. Clark in the format of an oxygen electrode in 1956. This system 
incorporated a biological membrane, permeable only to oxygen, placed over a 
platinum electrode, polarised at -700 mV, which acted as an amperometric electrical 
transducer (Clark L.C., Jnr., 1956). The electrochemical reduction of oxygen at the 
electrode surface generated an amperometric response which allowed for the 
determination of oxygen levels in a tissue sample. Realising the need to expand on the 
number of analytes to be measured and based on his previous experience with the 
oxygen electrode Clark made a landmark address in the New York Academy of 
Sciences Symposium in 1962, where he described how “to make sensors (pH, 
polarographic, potentiometric or conductimetric) more intelligent” by adding 
“enzyme transducers as membrane enclosed sandwiches”. It was then that Clark and 
Lyons demonstrated the use of oxygen electrodes for the determination of glucose 
levels within a sample. This device involved the entrapment of glucose oxidase on the 
sensor by means of a dialysis membrane. The catalytic oxidation reaction between 
glucose oxidase and glucose involved the electrochemical reduction of oxygen, which 
could be directly related to the generated signal. The lowering in the levels of oxygen 
was proportionate to the amount of glucose in the sample as shown by equation 2.1 
(Clark & Lyons, 1962). 
922
Ag/AgCl vsmV-700
2 OHOglucose-D-   tonegluconolac Eq. 2.1
This gave rise to the term ‘enzyme electrodes’ a term which was by some mistakenly 
attributed to Updike and Hicks. They, however, expanded on the experimental detail 
necessary for the development of functional enzyme electrodes targeting glucose 
(Updike and Hicks, 1967). Figure 2.1 depicts a Clark-type electrode.
Figure 2.1: The Clark-type electrode; A) Platinum electrode, B) reference Ag/AgCl-
electrode, C) half-saturated KCl electrolyte, D) Teflon membrane, E)  rubber ring, F) 
the voltage supply and G) the electronic instrument for the measurements of the current 
output is shown.
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The original Clark oxygen electrode design provided the prototype for various 
enzyme electrodes. Nowadays the alternative method of hydrogen peroxide detection 
is more widely used than those sensors employing oxygen concentration 
measurements. Yellow Springs Instruments Company (Ohio) launched their hydrogen 
peroxide amperometric biosensor, based on Clark’s ideas, in 1975 for whole blood
glucose determination. This approach involved the use of a working electrode with 
reversed polarity which could monitor the enzymic production of hydrogen peroxide. 
In 1969, the first potentiometric biosensor was described by Guibault and Montavlo 
(Guibault & Montavlo, 1969).This was a urea sensor deploying an ammonium-
selective liquid membrane electrode with immobilised urease. 
In 1974 the first thermal sensors appeared and were termed thermal enzyme probes
(Cooney et al, 1974) or enzyme thermistors (Mosbach & Danielsson, 1974). The use 
of biosensors for biotechnological and environmental purposes was highlighted by the 
realisation that bacteria could be used as the biological recognition element within 
microbial based electrodes (Divis, 1975). Lubbers & Opitz, (1975) first used the term 
‘optode’ describing a fibre-optics based sensor for the detection of CO2 and O2. These 
workers subsequently immobilised alcohol oxidase at the end of their fibre optics 
oxygen electrode for the detection of alcohol (Voelkl et al., 1980).
Clemens et al., 1976 described the use of an electrochemical biosensor for glucose in 
a glucose-controlled insulin infusion system, employing the use of a bedside artificial 
pancreas. Miles (Elkhart) marketed this system by the name Biostator®. The 
Biostator® is now no longer commercially available although an alternative 
amperometric semi-continuous catheter-based blood glucose analyser was introduced 
by VIA Medical (San Diego). La Roche (Switzerland) additionally, created the 
Lactate Analyser LA640 in 1975. The integrated biosensor in this system employed 
the use of hexacyanoferate as a mediator for electron transfer between lactate 
dehydrogenase and the detecting electrode. While the LA640 was not very 
commercially successful, it provided initiative for the development of mediated 
biosensors and lactate analysers for both clinical applications and the sports industry. 
Schichiri et al., 1982 described the first subcutaneous implantation of a needle-type 
biosensor for glucose which highlighted the possibility of ‘in vivo’ sensor use. Two 
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years later Cass et al., 1984 expanded on the use of ferrocene and its derivatives as 
immobilised mediators for the detection of oxidereductases. These were less 
expensive biosensor components and formed the basis of the Exactech® glucose 
meter, a pen-sized blood glucose monitoring device employing screen printed 
electrodes, launched by MediSense (Cambridge, USA) in 1987. MediSense’s sales 
climbed to $175 million per annum up until the company was acquired by Abbott in 
1996. The world market for biosensors is estimated to reach $6.1 billion by 2012 as 
estimated by Global Industry Analysts, Inc. (www.strategyr.com).Over half of the 
globally produced biosensors are incorporated into glucose meters for diabetes 
patients. The biosensors industry comprises of two types of companies which develop 
either novel biosensor technologies or biosensor-based devices. Some of the 
companies dominating the development of novel biosensor technologies include 
AgaMatrix Inc., Cranfield Health, LifeSensors Inc., M-Biotech and Nova Biomedical. 
Companies dominating the world market for biosensor-based devices include Abbott 
Point Of Care Inc., Affinity Sensors, Neosensors Limited, Siemens Healthcare 
Diagnostics Inc, Animas Corporation, LifeScan Inc., Medtronic Diabetes, and Roche 
Diagnostics Ltd. Boehringer Mannheim and Bayer currently dominate the world 
market for mediated biosensors which are rapidly being employed as more cost 
efficient alternatives to reflective photometry technology in home diagnostics for the 
monitoring of diabetes. It should be noted that the combined sales of Abbot 
Diagnostics, Boehringer Mannheim and Bayer account for 85% of the global 
biosensor market. Figure 2.2 below shows the FreeStyle Lite blood glucose 
monitoring system with an average test response time of 5 s and an average cost 
$16.95 (www.abbottdiabetescare.com). 
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Figure 2.2: The FreeStyle Lite blood glucose monitoring system by Abbot Diagnostics.
The original methodology in biosensor design, as discussed earlier, was to immobilise 
enzymes on the surface of electrochemical sensors assuming that this would enhance 
the ability of a sensor to detect specific analytes. The use of antibodies in sensing 
technology to monitor affinity based reactions was researched from the early 1970’s 
onwards, however, the principle of immunoassays was established in 1959 by Berson 
and Yallow (Berson & Yallow, 1959). Their work developed the widely used 
radioimmunoassay to examine the properties of insulin-binding antibodies in human 
serum, using samples obtained from subjects that had been treated with insulin (van 
der Voort et al., 2005). Since then other immunological techniques have provided a 
range of simplified alternatives in comparison to techniques such as gas liquid 
chromatography and mass spectrophotometry (Grant et al., 2005). The idea to develop 
direct immunosensors by immobilising antibodies on piezoelectric or potentiometric 
transducers had been explored since the early 1970s. The first ‘direct’
immunoelectrode (following the actual binding effect) was reported by Janata J. in 
1975, however, commercially viable immunosensors were introduced following a 
paper published by Liedberg et al., in 1983 employing surface plasmon resonance 
technology to detect bio-affinity reactions. Namely, the BIAcore (Pharmacia, 
Sweeden) launched in 1990, was based on this technology.
Many biosensors are now being developed that can screen a wide range of 
biomolecular interactions. Advances in computing, electronics, polymer science as 
well as the biological sciences are accountable for the range of biosensors that are 
currently used or under development at the time of writing. 
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Many new biosensors can only be used in a laboratory and can be expensive to 
fabricate and operate. Following the need for point-of-care measurements most 
devices are now requiring miniaturisation while their functions are being enhanced or 
expanded for home use. Similarly, one of the principle aims of sensing technology 
and nanotechnology is to develop miniaturised biosensors to facilitate ‘real-time, on 
site’ testing with the required specificity and sensitivity (Kissinger, 2005).
2.2 The factors determining Biosensor design
Many parameters determine the class, sensitivity, selectivity, longetivity and usability 
of biosensors. Of these, three key aspects need to be considered in biosensor design. 
These are 1) the target analyte or process to be measured or monitored respectively, 2) 
the biological recognition element and finally 3) the transducing element. The target 
analyte or process is the determining factor in deciding the design steps of a sensor. 
Which biomolecules or cells have the ability to interact with the desired target must 
also be considered. A target analyte or microorganism can be detected by a number of 
recognition elements such as whole cells, enzymes, antibodies or nucleic acids. 
However, the state of a given sample such as blood, aqueous solution, solid food, 
entails limitations as to which bio-recognition elements can be used. Antibodies 
normally have lower tolerances to stresses than enzymes or whole cells, but can 
provide smaller response times and high selectivity and sensitivity. Microbes can 
screen for a range of analytes but this also entails limited selectivity. The biological 
recognition element must effectively interact with the substrate in order to produce a 
measurable change. 
The signal produced during the biological interactions needs to be considered. The 
changes in mass, temperature, structural changes, changes in the electrical properties 
of the electrode, or the formed complexes determine what class of transducer can be 
used. Optical, calorimetric, electrochemical and other types of transduction methods 
are typically employed according to the nature of the analyte, bio-recognition entity 
and sample state.
A number of other parameters are important in terms of sensor longetivity, selectivity, 
sensitivity and response times. One of the most important factors affecting these key 
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features is the biological recognition entity immobilisation method. Several 
immobilisation methods exist which can be physically or chemically based. In all 
cases it is vital that the immobilisation method does not destroy the biological entity 
or excessively compromise its activity. There are moreover a large number of 
appropriate polymers, biological membranes and filters or gels which can be used 
according to the biological entity of preference and the chosen immobilisation 
method. These substances, whether it be polymers or membranes, require an 
appropriate metal or plastic support platform. A polymer, for example, must allow for 
signal transduction between the biological molecules and the metal electrode in 
electrochemical sensors. Additionally, the signal must not be compromised i.e. 
decrease in signal due to the interfering polymer, in order to fully measure the 
occurring changes on the electrode surface. Non-specific interactions are also affected
by the immobilisation methods used: these can be decreased or eliminated, but at the 
possibility of altering the activity of the recognition entity. The following sections 
provide a brief overview of the different types of substrates that sensing research 
addresses, the various biological recognition elements that can be used and finally the 
transduction methods currently available to scientists. Details regarding various 
immobilisation methods and electrode materials are also provided, however, the 
materials and methods used for immunosensor design are discussed more extensively 
later since they form part of this research project. Figure 2.3 depicts the main 
components of a biosensor.
Figure 2.3: The main components of a biosensor.
Analyte
Biointerface
Transducer
Data Collection and processing
Output
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2.2.1 Biosensor targets
Biosensors were devised as alternatives for expensive and bulky laboratory based 
analyses for use within quantitative analysis of single analytes found in complex 
biological and environmental samples. These analytes range from proteins, pathogens 
or other microorganisms, to the monitoring of biological processes that may be of 
industrial through to medical interest (Davis et al., 1995). 
Biosensors for glucose, lactate, urea, alcohol and a range of other analytes, have all 
been developed (Davis et al., 1995). The most successful sensor within the biosensor 
market globally has, however, been the development of glucose sensors for diabetes. 
The easy to use self-testing glucose strips coupled with pocket-sized amperometric 
meters have dominated the $5 billion/year diabetes monitoring market for the past two 
decades (Newman & Turner, 2005). This project aims to develop similarly successful 
devices as an alternative to many laborious and cumbersome detection methods.
Food and Water analysis
Initial work within the ELISHA project focused towards the development of 
immunosensors for the detection of pesticides and herbicide residues which, if found 
in food may have severe implications for consumer health. Work was also formed 
towards sensors for fluoroquinolones. Fluoroquinolone antibiotics have been widely 
used in animal and human medicine for the treatment of urinary tract infections since 
1980 (Gendrel et al., 2003). Dairy products and meat may contain residues of 
fluoroquinolones which have been shown to have potent unwanted biological effects 
(Hartmann et al., 1999). It is important to note that these compounds, alongside other 
antibiotics, can also give rise to bacterial resistance. Four fluoroquinolones have now 
been banned for use in food products (NBPDP, 2002; Batt et al., 2006). The EU has 
provided clear guidelines and established procedures regarding the monitoring of 
foods for fluoroquinolones, however, with contemporary analytical procedures, these 
standards for food safety cannot yet be successfully reached. 
Pathogenic micro-organisms can give rise to food and water born disease with an 
estimated 40% of the total annual recorded world deaths being due to infections 
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caused by food or water born pathogens (Leonard et al., 2003). Approximately 200 
million people yearly moreover suffer non-fatal infections due to the same pathogenic 
micro-organisms (Leonard et al., 2003). Escherichia coli is naturally found in the 
intestine of mammals and other warm blooded animals and aids the body in vitamin 
synthesis. Some strains of Escherichia coli however, such as the O157:H7 strain, are 
highly pathogenic and can cause acute food poisoning and many more serious 
complications (Alocilja & Radke, 2003). Alongside Escherichia coli, Listeria 
monocytogenes and Salmonella sp. are some of the most commonly encountered
pathogens causing disease and can be found in food samples that have undergone 
insufficient processing or inappropriate storage (Leonard et al., 2003).
Within the food industry continuous and direct monitoring of products is often 
required to determine the freshness and contamination levels (e.g. genetically 
modified products, pesticides, fluoroquinolones and infectious micro-organisms) of 
processed foods. In some cases the monitoring of fermentation processes is also 
required (Mello & Kubota, 2002).
Biosensors offer a promising alternative to cumbersome and often expensive 
procedures that are currently being employed for food or raw materials testing. Such 
procedures may for example include the use of polymerase chain reaction which 
requires experienced personnel and relatively expensive laboratory equipment and 
reagents. Tissue culturing is a traditional and rather simple method for pathogen 
detection, however, the prolonged incubation periods required is the main 
disadvantage of this method.  The common disadvantage of the methods mentioned 
earlier, however, is that they cannot to date be used for fast ‘point-of-care’ 
measurements, as opposed to e.g. handheld devices incorporating biosensors for 
analyte detection. One of the most important limitations of biosensors within the food 
or drink industry is that the biological recognition elements can only retain their 
activity over small temperature and pH ranges. Obviously, during food processing, 
maintaining the conditions of temperature and pH within a limited range can be 
difficult in many, if not all, cases. The simplest example of extreme conditions would, 
for example, be the production of alcohol which can lead to the denaturation of 
biological molecules and so the performance of the sensor. This and other limitations 
however, can possibly be overcome by continuous effort within the various research 
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programmes around the world. The use of bacterial cells and yeast, for example, is a 
promising alternative to many isolated enzymes and antibodies for use in fermentation 
process monitoring.
Disease detection
 Cancer research has received great scientific attention during the past decades. 
The availability of cancer markers, such as PSA allows for the development of 
immunoassays for early detection. It is a known fact that early detection of any 
type of cancer decreases the chances that the disease will be fatal to the 
patient. At the time of writing this report, biosensors targeted towards PSA
have been successfully developed within our group (Barton et al., 2008). 
Prostate cancer is one of the most common cancers suffered by the male 
population accounting for an estimated 11% of all male cancers in the EU and 
9% of cancer deaths amongst European men (Aus et al., 2005).
 The human amyloid disorders, 20 of which have been identified so far, include 
important diseases such as spongiform encephalopathies (in humans these 
include Creutzfeldt-Jakob disease, Gerstmann-Sträussler-Scheinker 
syndrome), Alzheimer’s disease, and type II diabetes (Dumoulin & Dobson, 
2004). Such diseases have been shown to appear sporadically, be inherited or 
are sometimes transmissible (Dumoulin & Dobson, 2004). Most of this class 
of diseases are incurable and lead to premature death. In 2000 4.5 million 
people in the USA were found to be suffering from Alzheimer’s disease.  As 
discussed earlier in this work (section 2.1), over half of the produced 
biosensors globally are incorporated into glucose sensors for diabetes, 
indicating how widespread the disease is worldwide. Prion peptides are the 
suggested cause of transmissible spongiform encephalopathies (Dumoulin & 
Dobson, 2004) and have therefore constituted part of the target analytes within 
the ELISHA consortium. It is suggested that misshaped prion peptides carry 
the disease between individuals and cause brain deterioration. Prion peptides
can be transferred through the air or via touching but infection may also occur 
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via ingestion of infected foodstuffs, through blood transfusion or contaminated 
medical instruments.
 Other diseases ranging from serious and fatal ones to even the simplest and 
non-life threatening ones are currently being diagnosed by ELISA 
immunoassays, PCR and other techniques. Early and reliable detection of
bacterial and viral infections, hereditary diseases or ones that appear 
sporadically is the key for more effective treatment.  Aside from the relatively 
high cost of the required equipment and reagents, the techniques named above, 
also require heavy human input compared to the proposed biosensor format 
described by this work. The aim is to develop an immunosensor that will allow 
rapid screening of multiple samples whether it be for prion peptides, different 
cancer types, fluoroquinolones and a plethora of important targets.
Environmental monitoring
Human activity has since the industrial revolution undoubtedly had a major effect on
the environment over the past few centuries. The disposal of deleterious substances in 
dig sites was common practice in the past decades, however, environmental pollution 
and most importantly water contamination meant that the welfare of both the flora and 
fauna in the surrounding areas could be severely impaired. Currently, many industries 
team up with waste treatment companies that can successfully decontaminate affected 
sites or process industrial waste. The use of fertilisers for agricultural purposes is 
controlled and monitored by tight guidelines allowing for the protection of natural 
forests and lakes. While chemical disposal is controlled, some by-products may still 
escape and cause pollution, therefore bioremediation is of utmost importance. For 
efficient bioremediation however, effective analytical tools are required. 
Measurements need to be taken in the open land or within rivers, the sea or lakes. 
Rapid detection of pollutants means that measures can be taken to prevent further 
damage to the environment. An example of such a biosensor for environmental 
control and bioremediation is the potentiometric microbial electrode which was 
designed to detect organophosphorous pesticides (Purohit, 2003). The European 
Network on Sensors for monitoring water Pollution (SENSPOL) aims to enhance the 
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practical applications of sensors for the rapid detection of environmental pollutants in 
water, such as phosphororganic pesticides and insecticides.
Bio-defence and forensics
Biological Warfare Agents (BWAs) have been used in a number of destructive 
terrorist attacks. Examples include t he Rajneeshee cult in Oregon used Salmonella in 
a number of restaurants in 1984, the Aum Shinrikyo cult in Tokyo used Sarin gas and 
anthrax. The attacks towards the USA on September 11th were also followed by 
anthrax mailed to specific targets around the country (Gooding, 2006). Fast detection 
and characterisation of agents such as these, alongside explosives and illegal drugs, is 
the only approach that can effectively protect civilian lives or warn the police and 
other security agencies of the existence of illegal substances. 
According to Gooding (2006), two types of sensors are required; the ‘detect-to-treat’ 
sensors focusing on rapid identification thus allowing immediate treatment and so 
called ‘detect-to-protect’ sensors, capable of providing an immediate warning when 
exposed to a BWA, thus preventing infection.
Anthrax, for example, is a gram positive bacterium which can be both aerobic and 
spore forming. Spores are used as BWAs due to their high resistance to environmental 
stresses such as temperature or moisture and hence suitability for use as weapons. 
Inhalation of 1,000 to 10,000 spores is required to cause a lethal infection to an 
individual, resulting from the production of endema toxin and lethal toxin by the 
bacterium itself. A detect-to-protect sensor would be based on the detection of anthrax
spores to prevent infection while a detect-to-treat sensor would be focused towards 
rapid detection of the toxins for immediate treatment. 
Baeummer et al., 2004 described a nucleic acid sensor for the detection of BWAs 
based on fluorescence which could detect extremely low amounts of the targeted 
anthrax sequence in 4 hours. Antibody based sensors based on the principles of home 
pregnancy test kits, have also been developed for anthrax, ricin and botulinum toxin. 
In the case of anthrax detection, the detection limits is 1μg ml-1 in solution and 0.25 
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μg from a surface with the detection time ranging from 15 to 20 minutes (Gooding, 
2006).
The use of biosensors for the detection of drug abuse or for the detection of 
explosives has also been described in the literature, especially during the last decade. 
Halamek et al., 2004 report the development of a piezoelectric affinity based sensor 
for cocaine with limits of detection lower than 100 pmol l-1. Smith et al., 2008 have 
assembled a review about the use of biological molecules and whole cells within 
biosensors for the detection of explosives.
It is important at this point to note that the production of a generic immunosensor for 
all the previously discussed applications would be somewhat difficult to accomplish. 
Theoretically, the structure of antibodies allows for millions of recombinations that 
could potentially cover a huge range of different analytes, however, the nature of the 
specimens or the environments in which each analyte may be found in (solid, liquid, 
gas) pose an important limitation. 
2.2.2 The biological recognition entity
Biosensors can be distinguished according to the bio-recognition element used for the 
detection of the desired target. Biosensors can be based on a catalytic process or 
bioaffinity reactions depending upon the biological entity used and the desired target. 
The biological entities used in sensing technology vary from enzymes and antibodies 
to nucleic acids, and whole cells and even cell organelles. The biological recognition 
entity must be specific to the target analyte or biomolecule and plays the most 
important role in terms of specificity, longetivity (e.g. storage) and re-usability. While 
the bio-recognition element is itself a major factor contributing to sensor design and 
characteristics, the immobilisation methods and materials used for sensor fabrication, 
as discussed earlier, impart greatly on sensitivity, selectivity and shelf-life of the final 
sensors (Pejcic & De Marco, 2006).
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Enzyme sensors
Enzyme sensors utilise enzymes immobilised on an electrode surface. Amperometric 
biosensors constitute the largest sub-group and of these glucose oxidase enzyme 
electrodes still represent the most widely used class of sensors to date. 
Ion selective electrodes can be used for a variety of analyses. They are often used in 
potentiometry to detect the catalysed liberation of e.g. hydronium or ammonium ions 
(Pejcic & De Marco, 2006). One of the major problems faced in amperometric 
enzyme based sensors is the non-specific adsorption occurring on the electrode 
surface. Interferents can give rise to erroneous responses. Interferents in blood, for 
example, can include alcohol, drugs or paracetamol. Ascorbate and uric acid, are also 
common types of enzyme based sensors. 
Enzymes often require cofactors in order to display their intended biological activity. 
Cofactors can be thought of as helper molecules that can bind tightly or loosely to the 
enzyme in order to ‘activate’ it. One of the limitations caused by the need for 
cofactors in enzyme sensors is that these molecules need to be continuously 
regenerated if the immobilised enzyme is to retain its biological activity. Figure 2.4 
below depicts the enzymatic reaction taking place in order to convert a substrate into a 
detectable (be the electrode) product.
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Figure 2.4 Working principle of enzymes.
Immunosensors
Immunosensors are based on the affinity reaction between antibodies and their 
respective antigens and are widely used for environmental and medical diagnostics. 
Immunosensors can be sub-divided into direct and indirect types. Indirect 
immunosensors require a label, such as a fluorescent molecule, for detection. A 
number of different labels are commercially available, each with different properties. 
In its simplest form, such an immunosensor would detect an antigen tagged with e.g. a 
fluorescent probe. In this case, the emitted light, which can be measured, will be 
proportionate to the concentration of the captured antigen. Direct immunosensors do 
not require a label; the detection is based on chemical, conformational, mass (or 
other) alterations occurring on the conductive surface upon the antibody/antigen 
binding effect (Van der Voort et al., 2005). The high specificity of antibodies towards 
their antigens affords improved selectivity. Non-specific adsorption can occur in 
immunosensing, however, the sensor fabrication protocols aim to limit such 
interferences or at least account for them. In a similar manner to any biological entity, 
antibodies are sensitive to environmental conditions such as pH and temperature. 
Such conditions may alter their binding efficiency or even destroy them completely.
Antibodies have been successfully immobilised within conducting polymers in 
Substrate Enzyme Substrate enzyme 
complex
Product enzyme 
complex
Product Enzyme
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various works for the development of immunosensors since 1991 (Spencer et al.,
1999; Grant et al., 2003; Tsekenis et al., 2008). More recent advances, including work 
within this research project, have allowed for the site specific immobilisation of 
antibodies on conductive polymer films. 
A major limitation of antibody based sensors is that they suffer from irreversibility. 
Once an antigen has been attached to its antibody it is very difficult if not impossible 
to reverse the reaction without damaging the sensing element. In this PhD project we 
have developed a number of reusable immunosensors, however, once saturation 
occurs, i.e. all the immobilised antibodies hold the target antigen, the sensors cannot 
be used any further.
The use of antibodies for affinity based sensors has been described extensively within 
the literature for the detection of a number of environmental pollutants (Pejcic & De 
Marco, 2006; Garifallou et al., 2007) This project focuses on the development of a 
prototype impedimetric immunosensor target towards a range of analytes using an AC 
impedance interrogation approach. 
Nucleic acid sensors
Nucleic acid sensors are based on the affinity based detection of target sequences via
the use of immobilised complementary DNA or RNA fragments. Detection is based 
on the hybridisation event taking place when a complementary target sequence exists 
within a given sample. During the hybridisation event no new molecules electrons or 
photons are produced. In a similar manner to antibody based sensors, the formation of 
double stranded DNA must be recognised by the alterations in the electrical, chemical 
(or other) properties of the conductive surface (Davis et al., 2005). Electrochemical 
impedance spectroscopy offers huge advantages for this alongside other affinity-based 
detection methods. Fibre optics have also been used in conjunction with DNA based 
sensors, however, electrochemical sensors pose a far more cost effective alternative. 
One of the most important issues in nucleic acid sensor design is the immobilisation 
of the sequences on the sensor surface. Davis et al., 2005 review the successful 
immobilisation of thiol modified DNA strands on gold electrode surfaces, the 
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electrostatic immobilisation of DNA onto cationic surfaces and the use of 
electroconductive polymers such as polypyrrole. 
Hahn et al., 2004 state that no other event since the introduction of PCR has 
influenced the clinical analysis of nucleic acids to such an extent. The detection limits 
facilitated by PCR surpass alternative approaches by far. The development of real 
time PCR has, moreover, provided a highly simplified and reliable approach for the 
quantitation of nucleic acids. Nucleic acid sensors have been developed as possible
alternatives to molecular biology techniques such as PCR for the detection of, for 
example genetically modified constituents or organisms in food products (Deisingh & 
Badrie, 2005). Real-time PCR involves the use of fluorescent molecules called 
quenchers and reporters. The former molecules normally reduce the light emitted by 
the latter when these are attached to the DNA probes; when the reporters are removed 
from the DNA sequence due to the activity of a polymerase molecule they emit 
radiation at the expected wavelength which can be measured by sophisticated 
equipment. In this manner it is possible to follow the DNA amplification process in 
real time. As discussed earlier DNA or RNA sensors have been extensively studied
for their uses in bio-defence applications. To date, very few nucleic acid based 
sensors offer detection limits that can match PCR. It is often seen that a PCR step is 
carried out before use of the sensor within a sample. Another limitation is that to date 
artificial oligonucleotide sequences have largely been used within sensor 
development, and hence, it is not clear how well such devices will perform in real life 
situations since a plethora of newly formed artificial sequences would be required for 
the available range of target DNA sequences (Hahn et al., 2004).
Whole cell or organelle biosensors
These sensors are based on immobilised living cells or tissue such as bacteria, plant 
tissue, or even cell organelles, in order to detect analytes. Biosensors of this type are 
typically used in biotechnology for fermentation processes or for environmental 
monitoring. Guibault reported the first biosensor using mitochondria for the 
measurement of NADH (Guibault, 1976). The main advantages of a sensor of this 
type are the ability to detect a wide range of substances over a significant pH range 
and tolerance to temperature variation as well as generally offering longer shelf-lives. 
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Sensors of this type can easily be regenerated so long as the substances within a 
sample are not lethal to the cell types used (Lei et al., 2006; Mello & Kabuta, 2002). 
Two of the main limitations associated with microbial biosensors are, however, their 
slow response time and decreased selectivity due to the plethora of metabolic 
processes occurring within living cells (Mello & Kabuta, 2002). Molecular biology 
and the DNA manipulation techniques it provided have revolutionised the use of 
living cells in sensing technology. It is possible to genetically ‘tailor’ living cells in 
order to make them more tolerant to specific environmental conditions e.g. pH, 
improve the activity of specific enzymes produced by the cells or clone foreign DNA 
when the requirement for a foreign protein production presents itself. DNA 
manipulation of bacterial cells also affords the introduction of internal reference 
systems which can be useful for establishing baseline responses amongst other things. 
The immobilisation of cells or organelles plays a major role in the longetivity and 
stability of microbial sensors, as it does for enzyme based sensors, immunosensors 
and nucleic acid sensors. The chemical immobilisation approaches include covalent 
binding and cross linking. Covalent binding is based on the direct reaction between 
functional groups of the cell wall and the transducer such as amines or carboxylic
groups. The process requires the use of reaction conditions that can decrease the 
biological activity of the cells or organelles. Cross linking employs the use of reagents 
such as glutaraldehyde to bridge functional groups of the cell membrane of one cell 
with others. This approach may, however, damage the cells. Of the physical 
immobilisation methods adsorption is based on ionic, polar, hydrogen bonding and 
similar interactions that do not damage the cells. Sensor longetivity, however, is not 
guaranteed due to possibl desorption of cells with time. Entrapment is another 
physical immobilisation method that employs the use of dialysis membranes, 
biological polymers or gels (Lei et al., 2006).
Microbial biosensors based on amperometry have been extensively used for the 
measurement of biodegradable organic pollutants in aqueous solutions. Such sensors 
are based on biochemical oxygen demand, measuring the cells’ oxygen requirements 
over a period of a few days. Oxygen consumption (respiration) provides information 
relative to environmental conditions and the stresses under which the microbes live. 
This information in turn gives indications of the chemical presence within a given 
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sample. Potentiometric, conductimetric and optical microbial biosensors have also 
been described in the literature while novel sensors based on barometry (pressure) and 
other detection methods have also been developed (Lei et al., 2006).
2.2.3 The transduction methods
From the mid 1980s, many types of biosensors have been developed for full 
commercialisation; some of these have been based on simple and others on more
complex-biochemical and electrochemical approaches (Davis, 1986). Biosensors are 
more often classified according to the mechanism of transduction and four major 
classes of biosensors include optical, thermal, piezoelectric (mass) and 
electrochemical based sensors. Ion-selective, impedimetric conductimetric, 
potentiometric, amperometric, fluorimetric, luminometric, thermometric biosensors 
and acoustic wave sensors, as well as the more sophisticated fibre optic based 
biosensors, are only some of the examples to indicate and emphasise the scientific 
effort underlying the development of such devices (Davis, 1986; Guan et al., 2004;
Leonard et al., 2003). The following pages provide an insight of the different 
transduction methods used in sensing technology.
2.2.3.1    Optical sensors
As discussed earlier the Lubbers and Opitz (1975) were the first to use the term 
“optode” to describe biosensors employing spectrophotometric techniques. Optical 
biosensors constitute one of the most important classes of sensors for bioanalysis 
mainly due to their high sensitivity, selectivity and rapidity of detection. Sensors of 
this type utilise the light absorbed or emitted as a result of a biochemical reaction. 
Optical fibres are normally used to guide the light waves to a suitable photomultiplier 
(Scheper et al., 1996). Different interactions used in these sytems make use of bio and 
chemiluminescence, UV-vis absorption, reflectance and fluorescence and have been 
successfully used for the detection of pathogenic bacteria, toxins and contaminants. 
The use of surface plasmon resonance and fluorescence based sensors has more 
recently been increased due to the increased sensitivity they offer (Lazcka et al., 
2007). 
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 Bio-luminescence: the bacterial luminescence lux gene has been extensively 
used for real time process monitoring in either a constitutive or inducible 
manner. When the toxicity of a certain compound needs to be determined the 
lux gene can be fused to a constitutive promoter and thus be continually 
expressed. High levels of a toxic compound within the sample will impair or 
kill cell function and thus a measurable difference in luminescence can be 
obtained. In the inducible manner, expression of the lux gene, can be 
‘switched on’ by the target analyte which may be quantitatively analysed by 
alterations in luminescence intensity (Lei et al., 2006).
The exhaustion of nutrients within soil requires monitoring as does the 
contamination of land with a number of industrial pollutants. Bio-
luminescence has been successfully exploited to this end resulting in the 
development of several sensors for soil monitoring (Lei et al., 2006).
 Fluorescence: many fluorescent based detection techniques can be employed 
for the design of biosensors. Fluorescence based sensors incorporate the use of 
a fluorescent compound that can be used to either label the analyte pool or the 
bio-recognition element itself. The difference between fluorescence and 
bioluminescence is that the former requires fluorescent dyes while the latter 
technique uses the naturally occurring light emitting proteins for detection. In 
the case of antibody conjugates, the chosen fluorescent dye is attached to the 
available antibodies. In the presence of, for example, pathogenic organisms,
the antibodies will, normally within 30 minutes, attach themselves to the 
existent pathogens and can be detected via their conjugated fluorophores when 
exposed to the correct wavelength. Upon absorption of light fluorophores of 
this type emit radiation at a lower wavelength to the excitation wavelength. 
This fluorescence radiation can then be monitored and used in conjunction 
with standard techniques such as real-time PCR for the detection of more than 
one type of microorganisms. This technique is, however, frequently both 
extensive in time and extremely expensive due to the requisition of an 
overnight microbial culture as well as the cost of real-time PCR equipment 
(Lazcka et al., 2007). Fluorescence resonance energy transfer (FRET) sensors 
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employ the use of two different types of fluorophores, one of which acts as a 
donor and the other acting as a receptor. The formation of the antibody/antigen 
complex causes structural changes to the antibody. Such structural changes
reduce the distance between the donor and receptor fluorophores thus 
irradiating at known wavelengths. This technique has been shown to reach 
detection limits of 2 μg/ml in food samples (Lazcka et al., 2007).
 Surface plasmon resonance: surface plasmon resonance (SPR) sensors detect 
changes in the refractive index caused structural alterations i.e. the formation 
of antigen/antibody complex upon binding, on the surface of a thin metal 
platform. A thin gold layer is applied on a glass plate which is subsequently 
irradiated by a p-polarised light from a laser via a hemispherical prism. The 
reflectivity is measured as a function of the angle of incidence and the 
resulting curve shows a peak that is called the SPR minimum Adsoprtion 
phenomena as well as antibody-antigen interaction kinetics may be measured 
using SPR, however, the technique requires specialised personnel and 
equipment. This technique has been successfully utilised for the detection of 
pathogenic bacteria via the antibody/antigen reaction method (Lazcka et al.,
2007).
2.2.3.2    Thermal biosensors
Thermal or calorimetric biosensors can utilise absorption or evolution of heat during 
enzyme/substrate interactions or the temperature variations within an enzyme-
containing solution upon addition of the target analyte (Meadows, 1996). The changes 
in temperature are detected using a thermistor or transistor and normally involve the 
use of a control biosensor or control system where no target substance is added. 
Thermistors are essentially ceramic semiconductors with very high negative 
temperature resistance coefficient.  Sintering mixtures of manganese, iron, cobalt, 
nickel and uranium oxides are used to fabricate thermistors of this type which reflect 
any temperature changes as changes in resistance (Ramanathan & Danielson, 2001). 
During a biochemical reaction, the total heat absorbed or evolved, is proportional to 
the molar enthalpy and to the number of produced molecules. Total heat is also 
29
dependent on the heat capacity of the system and generally the heat capacity of 
organic solvents is two to three times lower than that of aqueous solvents. For this 
reason the use of organic solvents affords higher sensitivity to calorimetric 
measurements. Thermal sensors have been successfully used for the determination of 
cholesterol concentration in blood serum; the reactions of oxidation and 
decomposition produce heat that can be easily detected. Various thermal sensors have 
also been extensively used by the food and biotechnology industries (Meadows, 1996; 
Ramanathan & Danielson, 2001).
2.2.3.3    Piezoelectric biosensors
Mass or piezoelectric biosensors employ the use of a quartz crystal which displays an 
altered vibrational frequency when substances are adsorbed onto its surface. Due to 
the nature of the effects being detected such devices are also called acoustic wave 
sensors. The applied pressure deforms the crystal lattice forming a dipole moment in 
its molecular structure. While many types of crystals exhibit this piezoelectric effect, 
quartz crystals have been found to possess many favourable electrical and chemical 
alongside mechanical properties (Meadows, 1996; Bunde et al., 1998). 
Non-specific adsorption has been a major issue with this type of sensors and they 
have consequently been mostly used for gas phase analyses. Such devices have, 
however, displayed extremely low detection limits reaching femtogram levels for
drug vapours for forensic applications. AT-cut shear mode quartz crystals have been 
successfully used for viscometric purposes and interfacial processes. 
One of the variants of this type of sensing systems is the mass-amplified quartz crystal 
microbalance immunoassay. This technique incorporates the use of sol particles 
ranging in diameter preferably from 5-100 nm. The technique involves the use of 
antibodies to capture analytes at the crystal surface. Sol particles are antibody 
modified and can thus bind to the immobilised analyte molecules causing a vastly 
altered vibrational frequency (Bunde et al., 1998).
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While successfully employed within the sensing industry and medical diagnostics, the 
above mentioned transduction methods generally require trained personnel and the 
use of expensive or complex equipment. The following section focuses on 
electrochemical biosensors, which are rather simple to use but extremely effective and 
do not generally require complex instrumentation for measurements to be carried out.
2.2.3.4    Electrochemical biosensors
Electrochemical biosensors have received the major share of the attention in biosensor 
development (Turner et al., 1986). Electrochemical biosensors employ a biological 
recognition element and a transducer that converts the occurring biological reactions 
to an electrical signal (Wang, 2006). The detection methods may be amperometric 
(current), potentiometric (potential) or impedimetric (impedance) in nature; other 
methods are available, however the three mentioned above predominate. Some of the 
overwhelming advantages of electrochemical sensing technology are the low cost of 
equipment, simplicity of use, rapidity of result acquisition and the ability to work with 
turbid samples. Sensitivity i.e. how the minimum quantity of target analyte that can be 
detected in a sample, is probably the most important aspect to consider in regards with 
a sensing device. As Wang (2006) report, the sensitivity of currently available 
electrical bioassays allows them to rival the most advanced optical devices. These 
characteristics frequently make them favourable for use in medical diagnostics, 
environmental and industrial monitoring and defence purposes (Lazcka et al., 2007).
Surface structure and reactivity are two of the main areas of concern for the 
development of successful electrochemical sensors. Materials science is extremely 
important for sensor design. The electrodes as well as the covering layers (recognition 
element) are required to have unique properties providing selectivity and sensitivity. 
These aspects are discussed extensively later, however since this project is based on 
the use of electrochemical immunosensors, a review of the detection methods is 
provided below.
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Amperometric biosensors
The first biosensor, as described in section 2.1, was amperometric in nature. 
Amperometric biosensors exploit the exchange of electrons between the analyte or 
biomolecule of interest and the sensing electrode. Upon application of a polarising 
potential, the electroactive chemical or biological species is oxidised or reduced; these 
reaction result in an electric current, which can be monitored. This current can be 
related to the concentration of the analyte (Mello & Kubota, 2002; Wang, 2006). Such 
amperometric biosensors - those selectively detecting the presence of electroactive 
species- are collectively called ‘first generation’ biosensors. ‘Second generation 
biosensors’ or ‘mediated biosensors’ are those employing mediator molecules such as 
ferrocene carboxylic acid or ferri-ferrocyanide. These compounds are small in size 
and can mediate the exchange of electrons between the analyte and the sensing 
electrode in a reversible manner. There are also a number of amperometric sensors 
that belong to a third generation. Third generation biosensors employ direct electron 
transfer to and from the electrode to the enzyme and finally to the target analyte. In 
such examples the electrons themselves act as secondary substrates for the occurring 
enzymatic reactions and result in the production of a catalytic current, making this a 
catalytic process in nature (Mello & Kubota, 2002).
The main disadvantage of amperometric biosensors lies in their selectivity which is 
limited by the redox potential of the present electro-active species, hence the 
measured current may be the result of the oxidation and reduction of more than one 
species within a given sample (Mello & Kubota, 2002). In order to reduce or 
eliminate such interferences it is possible to use permselective membranes and other 
types of “molecular filters” that allow passage towards the electrode surface to 
specific analytes but prohibit passage to others.
Amperometric biosensors used for glucose detection have attracted great interest due 
to the increase of diabetes within the population of developed countries. Glucose 
oxidase has been extensively used, due to its robustness, for the development of novel 
fabrication techniques and materials testing. Previous reports have described glucose 
sensors with response times of 33 s and sensitivity as low as 3.05 μA/ mM glucose
(Hervás Pérez et al., 2006). Some of the self-testing kits discussed earlier (section 
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2.2.1) have response times between 5-10 s and only require 0.5-10 µl fingerstick 
blood samples. Other amperometric sensors have been developed for pesticide 
detection using cholinesterases, lysine detection using lysine oxidase and sulphite ions 
using sulphite oxidase. Further work to develop prototypes with higher sensitivity and 
lower response times is ongoing and amperometry continues to play a major role 
within biosensor research (Hervás Pérez et al., 2006).
Potentiometric biosensors
The first ever potentiometry based sensor was described by Guilbault and Montalvo in 
1969. The sensor was directed towards the detection of urea using the enzyme urease, 
which was immobilised in an ammonium-selective liquid membrane (Guilbault & 
Montalvo,1969). 
Potentiometric biosensors are the least common within the electrochemical sensor 
class (Lazcka et al., 2007). Such sensors employ the use of a membrane (e.g.
inorganic crystal, glass, plasticised polymer) or alternatively a surface sensitive to the 
target species. The sensor produces a potential that is proportional to the logarithms of 
the concentration of the target molecule. Essentially, potentiometric devices can 
detect alterations in pH and the concentration of ions within a solution using an ion-
selective electrode, and hence the term ion-selective electrodes (ISEs) is often used 
for potentiometric devices (Mello & Kubota, 2002; Pejcic & de Marco, 2006). Since 
potentiometric biosensors measure the changes in concentration (or activity) of ions in 
a solution it is expected that they yield Nernstian responses upon changes in the ionic 
strength of the solution. Consequently, a decade change in the concentration of the 
measured ions corresponds to a potential change of 59.1 mV at room temperature. 
Extensive research in this field has shown that the membrane properties must not vary 
as a result of sample concentration changes, for the responses to be Nernstian (Bakker 
& Meyerhoff, 2000). The main advantage of potentiometric biosensors is that they 
can be used for a broad range of concentrations. Their simplicity, low cost of 
production, availability for continuous monitoring, stability and long lifetimes have 
contributed in making them a popular analytical sensor class (Pejcic & de Marco, 
2006; Lazcka et al., 2007). Equation 2.2 shows the principle of the penicillin 
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biosensor based on the breaking down of the internal penicillin structure by the 
enzyme penicillinase.
  Hacidpenicillicpenicillin asepenicillin Eq. 2.2
The use of transistors that can amplify the generated signal is common in 
potentiometry and such devices are collectively called ISFETs (ion-selective field 
effect transistors). In this case the biological reactions are detected using a 
semiconductor’s field-effect. In ISFETs, the generated electric field creates regions of 
excess charge in a semiconductor substrate that can increase or decrease the local 
conductivity. ISFETs provide the possibility for miniaturisation in potentiometric 
sensor design, however, they constitute a concept which brings with it certain 
disadvantages. Some of these disadvantages include the incompatibility with various 
immobilisation methods due mainly to ISFET fabrication technology, poor detection 
limits, poor reproducibility and device instability (Lazcka et al., 2007). Figure 2.5 
below depicts the principle of ISFET’s.
Figure 2.5 Schematic representation of an ISFET. 
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A p-type silicon substrate with source and drain diffusions is separated by a channel 
covered with SiO2 as insulator and a metal gate. The polarity and magnitude of the 
gate voltage difference (VG) that is applied between the substrate and the gate are 
such that a n-type inversion layer is formed between the drain and source diffusions. 
The effective electrical resistance of the surface inversion layer and the voltage 
difference (VD) between source and drain determine the magnitude of the drain 
current (ID). 
One of the major limitations of potentiometric devices is the leaching of membrane 
components into the sample. However, attempts to minimise leaching have introduced 
the use of electroactive ingredients within polymeric membranes. Clinical blood 
analysers have employed this technique successfully (Pejcic & de Marco, 2006).
Conductimetric sensors
Conductance is the direct opposite of resistance i.e. the ability of a material to pass 
electrons. Conductimetric biosensors are based on alterations of the conductivity of a 
medium or substrate resulting from biochemical reactions. Enzyme based 
conductimetric sensors rely on the increase of conductivity upon substrate binding. 
Whole cell based conductimetric sensors have also been reported in which the present 
microorganisms metabolise uncharged substrates to intermediates e.g. carbohydrates 
to lactic acid. The occurring bioprocesses cause a change in ionic species. The 
quantifiable amount of charged intermediates is proportional to the growth rates of the 
existing microorganisms. Since conductimetric measurements monitor changes in the 
medium they do not show high specificity and can have poor signal to noise ratio, 
however, they are extremely sensitive (Lei et al., 2006; Mello & Kubota, 2002).
Impedimetric sensors
Impedance is very similar to resistance as they both regard the opposition to the flow 
of electrical current. However, impedance is actually the resistance of a component at 
a given frequency. Impedance can only exist when there is AC current or fluctuating 
DC current. Electrochemical Impedance Spectroscopy (EIS) is slightly more complex 
than most other electrochemical based transducing approaches. This approach 
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involves the application on the electrode, of small amplitude alternating excitation 
potential over a range of frequencies, using the resulting current to calculate the 
impedance of the system. The current and potential possess a phase difference that 
depends on the nature of the examined system. The angle by which the sine curve of 
the voltage lags or leads the sine curve of the current is called the phase angle (ф).The 
amplitude of the produced current and voltage and the phase angle between them 
determine the impedance of the system. Impedance is currently used for the detection 
of food pathogens, bacteria and sanitation microbiology and was accepted as a first 
action method by the Association of Official Analytical Chemists (AOAC). 
Impedance is a non-destructive and low cost technique based on changes of the 
conductance and capacitance of an electrochemical system. Any process that can 
affect the conductivity of an electrochemical transducer can be monitored by EIS. The 
applications of impedance in industry and research range from testing of batteries and 
semi-conductors to thin film technology and corrosion monitoring (Mello & Kubota, 
2002; Pejcic & de Marco, 2006). 
An immense amount of impedance studies have been carried out especially within 
polymer science and the development of metal coatings to monitor electrochemical 
properties and corrosion respectively. EIS has more recently been used for the 
development of impedimetric sensors. The use of impedance for protein 
immobilisation and antibody/antigen interactions was a breakthrough in sensing 
science, proving that impedance could potentially be used for direct monitoring of 
affinity based biosensors (Mirsky et al., 1997). Essentially EIS can be used for each 
of the biosensor assembly stages as well as to monitor changes during analyte 
addition at different concentrations (Fernandez-Sanchez et al., 2005). Numerous 
groups report the use of impedance for monitoring of antibody and DNA based 
sensors from the late 1990s onwards. Sargent & Sadik, 1999 report the use of 
antibody doped polypyrrole for the fabrication of sensors and subsequent EIS 
measurements upon antigen additions. Farace et al., 2002 highlight the use of 
reagentless biosensing using EIS while Davis et al., 2005 report the development of 
DNA based impedimetric biosensors. More recently work within our group involved 
the use of EIS for the detection of ciprofloxacin at various concentrations (Garifallou
et al., 2007). Since the use of EIS represents the focus of this PhD project, specifics of 
this technique will be discussed in detail later.
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2.3 European Union Interest in Sensing Technology
This project combines the fields of advanced nanotechnologies and biotechnology in 
order to provide ‘state of the art’ low-cost and reliable solutions for the detection of a 
wide range of diseases as well as food and environmental pollutants. Within and from 
this research, the European Union aims to ‘promote real breakthroughs, based on 
scientific and technical excellence’ (ELISHA Annex, 2003).
The ultimate goal of the co-operating partners is to further enhance knowledge of 
mechanisms that can be employed towards the development of fast, reliable and cost 
effective biosensor prototypes. This will in turn have a major impact in rapid and 
reliable disease detection. Main areas of concern are cancer markers, fluoroquinolone 
antibiotics and prion peptides.
All targeted substances/molecules have a major impact in the medical and food 
industry as well as in environmental control and care. As a result innovations arising 
towards this scope will promote major strategic and financial benefits
2.4 Nanobiotechnology and Biosensors
Nanotechnology aims to improve biosensor sensitivity and performance by the use of 
nano-materials in the fundamental design of the device. Nano-materials have 
promoted the introduction of several novel signal transduction technologies to be used 
for sensing, whilst allowing the development of portable devices for real-time in vivo
and point of care measurements. Nano-materials are typically defined as those whose 
dimensions vary from 1 to 100 nm and are affected by the quantum size effect and 
surface effects, thus displaying a unique set of desirable physical and chemical 
properties for sensing technology (Jianrong et al., 2004).
Of the numerous nanomaterials available, nanoparticles have been most extensively 
described. Functional nanoparticles, electronic, magnetic, optical or possessing other 
properties, can be bound to biological molecules to aid the detection and amplification 
the produced signals. In acoustic wave sensors and specifically the widely used mass-
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amplified quartz crystal microbalance, antibody modified sol particles have been 
successfully employed for detection of analytes. The sol particles cause a vast change 
to the vibrational frequency of the quartz crystal due to their large mass. In this 
technique, analytes are first bound on the electrode surface by immobilised antibodies 
and a subsequent binding occurs upon addition of modified sol particles.
Gold nanoparticles have been used for fluorescence based detection in optical sensors. 
This method involves the attachment of thiol and a fluorophore at the respective ends 
of oligonucleotides which are subsequently bound to gold nanoparticles and form arch 
like structures. Upon hybridisation with the target sequences, conformational changes 
restored fluorescence to the quenched fluorophore. Single base detections have been 
reported by Maxwell et al., 2002 using this method.
Magnetic biosensors are based on magnetic nanoparticles that can be prepared in 
single domain, superparamagnetic or other forms and bound to biorecognition 
molecules in order to separate or enrich the target analytes. Safarik & Safarikova, 
(1999) describe the use of magnetic field gradients to separate and manipulate 
magnetically labelled cells. Figure 2.6 depicts the different biomolecules that can be 
attached on the surface of nanoparticles for use in various sensing applications. 
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Figure 2.6: Schematic representation of a nanoparticle and the various biomolecules 
that can be attached to its surface for use in sensing technology.
Electrochemistry based sensing is another field employing nanoparticles for improved 
sensor performance. It should be noted that metal nanoparticles do not compromise 
the bio-functionality of any recognition molecules they may be attached to. Cai et al., 
2001 describe the use of gold nanoparticles in a DNA sensor format to enhance the 
amount of nucleic acid immobilised onto the electrode surface thus lowering the 
detection limit. Affinity assays can also be performed by monitoring the 
electrochemical signals of biomolecule bound metal nanoparticles. Numerous 
scientific reports describe other approaches employing nanoparticles for 
electrochemistry based approaches and there is great potential for industrial and 
medical applications. Miniaturisation of the sensing apparatus and high sensitivity are 
the main benefits of nanoparticle use within sensing technology. Carbon and gold 
nanotubes, nanowires and nanofibres have also received increased attention over the 
past decade for their potential applications within the sensing industry.
Drugs, DNA, siRNA, aptamers, peptides/proteins,
antibodies, PEG, folic acid, etc.
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2.5 Antibodies and their use in Sensing Technology
As discussed earlier the immunoassay concept was introduced by Berson and Yallow, 
(1959), while the idea of immunosensors was introduced by Jamata et al., (1975). 
Immunoassay development continues to be a vibrant area of research due to the many 
advantages offered by the use of antibodies in antigen detection, namely high 
specificity and sensitivity. 
Antibodies are molecules produced by the immune system as a response to the 
presence of antigens. Antibodies bind their target analytes hence stopping infection of 
the host organism. The structure of antibody molecules, shown for IgG1 in figure 2.7,
is extremely important to their binding capacity (Killard et al., 1995).  
Figure 2.7: Basic structure of the human IgG1 antibody (Killard et al., 1995).
Structurally, each antibody or antibody class is unique, however, a typical example is 
that of the immunglobin G subclass (IgG). Four polypeptide chains constitute one 
L Chain
Carbohydrate
CDR’s
H Chain
-S-S- bonds
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IgG1 molecule, two heavy (H) and two light (L) chains composed of 450 and 212 
amino acid residues respectively. Disulfide bonds (-S-S-) exist that link the H chains 
with each, the same bonds also link each H chain with a L chain. The L and H chains 
are divided into constant and variable domains based on the variability of the amino 
acid sequences found within each chain. The L chains consist of one constant (VL) 
and one variable domain (VL) while the heave chains consist of three constant (CH1, 
CH2, CH3) and one variable domain (VH). Two of these domains on both the L and H 
chains posses intrachain disulphide bonds which contribute to their globular structure. 
The VL and VH domains associate with each other as do the CL and CH1 domains, 
while CH2 regions pair with each other as do the CH3 regions. An additional domain
exists between CH1 and CH2 that offers flexibility to the two antibody arms and is 
called the hinge region. VH and VL, are the regions most important for the 
determination of the binding of proteins. Variability in the amino acid sequence of 
these regions results in different antibody molecules with altered binding abilities. 
More specifically VH and VL each contain three hypervariable regions named 
‘complementarity determining regions’ (CDRs) that essentially form the binding site 
for the antigen. Thus changes in these regions result in the formation of different 
antibody molecules with different specificity and affinity for analytes, without 
altering the basic antibody structure. This system affords an estimated 108 different 
specificities, and hence, a vast number of antibodies targeting specific molecules 
(Killard et al., 1995).
B lymphocytes are the cells responsible for antibody production in the animal body. 
During an immune response these cells produce different epitopes i.e. antibody 
molecules that each target different sites on the antigen surface. This immune 
response is not reproducible as different antibodies may be formed if subsequent 
immunisations occur with the same antigen. This population of antibodies is termed 
polyclonal but is of no great use to sensing technology, thus techniques have been 
developed to produce monoclonal antibodies with known specificities and affinities 
(Killard et al., 1995). As for the population of polyclonal antibodies, monoclonal ones 
are similarly produced by B lymphocytes, which however, have a short in vitro life 
span. This limitation can be overcome by the fusion of B lymphocytes producing the 
desired antibody with tumorigenic myeloma cells offering the former ‘immortality’. 
Animals are normally used for the production of monoclonal antibodies mostly mice, 
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goats and rabbits. The procedure involves infection of the animal with the antigen to 
force the animal’s organism into producing the desired monoclonal. As Killard et al.,
(1995) report, in the case of mice, the spleen of the infected animal is removed and 
the antibody producing B lymphocytes (splenocites) harvested. These are subsequently 
fused to non-antibody producing myeloma cells by means of polyethelene glycol. 
Upon cell division chromosome mixing can possibly result in the development of 
‘immortal’ antibody producing hybrids. The remaining unfused splenocytes die due to 
their limited life span after a short while and incubation in HAT medium 
(hypoxanthine, aminopterin and thymidine) is used to prevent growth of myeloma 
cells. What remains is a population of fused cells which are allowed to grow in 
different wells and are periodically checked for antibody production by means of an 
appropriate immunoassay. Some of these wells contain hybrids deriving from a single 
parent cell and produce a single type of antibody, a monoclonal.  Different procedures 
can subsequently be used for large scale production either via culture flasks and 
bioreactors or by injecting the hybrids to mice which develop hybridoma tumours.
A crucial part in antibody research has been played by antibody engineering and 
molecular biology. Some monoclonal antibodies present a great example of 
engineered molecules with increased affinity and specificity for their target antigen. 
The next step of such technologies is the expression of antibody fragments that can be 
fused with reporter genes (Killard et al., 1995). 
Many antibodies are commercially available at the industrial level. It is important 
however to note that the use of the desired antibody must be teamed with the choice 
of an appropriate transducer for the derived immunosensor to be successful. 
Immunosensors are known for their ease of use, low detection limits and high 
selectivity. There are two main parameters to consider while aiming developing a fit 
for use sensor: 
a) the intrinsic specificity of  the biological material; in complex samples 
specificity may be compromised,
b) the ability of a transducer to detect the binding process and produce a readable 
signal, normally of electrical nature (Killard et al., 1995). 
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The transduced signal whether it be electrochemical, based on fibre-optics or derived 
in any other form is frequently proportional to the concentration of analyte in the 
tested sample (Miller & Anderson, 1989). The need for in vivo measurements in order 
to e.g. monitor the metabolism and/or drug intake for patients in clinical units, 
necessitates the development of devices that can remain stable for a prolonged period 
of time within an organism (Miller & Anderson, 1989). The main problem for in vivo
use of immunosensors is the stability of the antibody over a period of time. Biological 
functionality may be lost or compromised due to environmental factors i.e. blood 
constituents or simply due to the antibody’s limited life. Matrix interferences (such as 
chemical and physical interferences from the range of constituents in e.g. blood) and 
drift problems must be addressed before immunosensor implantation is feasible and 
reliable (Luppa et al., 2001). The reversibility of the binding reaction is another 
problem requiring a solution before real-time in vivo monitoring is realised. In its own 
nature, the antibody/antigen reaction is a non-reversible process. However, 
regeneration of the immunosensor surface may be possible. One proposed solution is 
the application of a highly concentrated antigenic solution with weak affinity for the 
antibody of interest but it should be noted that surrogate antigens are not always 
available. Another solution is to engineer antibodies or antibody fragments with high 
tolerance to chemical treatments that can help dissociate the complex on the sensor 
surface without compromising biorecognition functionality. Jung et al., (1999) report 
the use of phage display for selection of high stability antibody fragments. Phage 
display involves the insertion of DNA fragments (e.g. those responsible for producing 
the antibody of interest) into phage DNA which is then used to transfect bacterial 
cells, normally Escherichia coli. The inserted DNA regions ensure the expression of 
the antibody fragments on the coating protein of the phage particles. The phage are 
allowed to replicate and the ones displaying antibodies or antibody fragments that 
may be useful can be retained by the use of wells with immobilised target DNA or
proteins. Such libraries are nowadays successfully used for the production of a  
plethora of antibody fragments for use in immunoassays.
Despite the overwhelming amount of scientific literature describing successful 
immunosensor prototypes, their use in medical diagnostics, while not negligible, is 
not widespread. Problems arising during immunosensor development, range from the 
immobilisation method to antibody orientation on the transducing surface. The 
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immobilisation method and fabrication reagents may compromise antibody 
functionality.
2.6 Polymers in Sensing
Traditionally the use of polymers in sensing technology was primarily focused 
towards the entrapment, by different methods, of biorecongition elements on the 
electrode surface. The advantages in polymer science, however, have produced 
materials that apart from bioelement immobilisation can also play a major role in the 
electrical and chemical properties of the sensor. Some polymers can offer 
permselectivity while others can act as mediators for the occurring enzymatic 
reactions (Davis et al., 1995). According to Adhikari & Majumdar, (2004), polymers 
have played a major role in the development of state-of-the-art biosensors over the 
past three decades. Whether in conducting or non-conducting forms, polymers possess
chemical and physical properties that provide great versatility in terms of sensor 
fabrication; different substances can be chemically manipulated in various ways, so as 
to obtain different characteristics and behaviour (Adhikari & Majumdar, 2004). 
Electrode coating by polymers is a commonly used technique. Polymeric coatings can 
insulate an electrode or enhance its electroconductivity and also prevent degradation 
of the electrode surface or the active molecules trapped on the sensor. The properties 
of conventional gold, carbon and platinum electrodes have previously been enhanced 
by polymer deposition (Gerard et al., 2002). Alternatively the chosen polymer may 
play a role in the sensing mechanisms involved (Adhikari & Majumdar, 2004).
The most attractive polymers for use within sensing technology are those that can be 
electropolymerised or electrodeposited. Electropolymerisation can be carried out 
galavanostatically, potentiostatically or by potential cycling. These methods are 
detailed and discussed later as they are used extensively in this research programme. 
Where biomolecule entrapment is concerned the electrodeposition process involves 
the electrochemical oxidation of a chosen monomer via the use of an electrolyte that 
contains the desired biomolecule to form a thin membrane, a polymer film, on the 
electrode surface. Immobilisation of biomolecules on a polymer film requires 
different procedures, however, the polymer electrodeposition on the electrode surface 
is similar in both cases. The advantages of electrodeposition are that the 
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polymerisation reactions can be performed at room temperature and can be entirely 
controlled e.g. via allowing greater control over the thickness of the polymer film and 
greater reproducibility (Gerard et al., 2002; Yuqing et al., 2004). Film thickness is 
important when considering signal transduction i.e. a very thick polymer film may 
become a limiting factor as to how much charge reaches the electrode surface. 
Another advantage of depositing polymers via electropolymerisation is that this 
approach is not limited by the surface area or geometry of the electrode and can thus 
be applied to electrodes with more complex geometries (Yuqing et al., 2004). With 
regards to polyaniline, electrodeposition and especially potential cycling leads to the 
formation of a highly homogenous film. Details relating to the electrochemical 
deposition of o-phenylenediamine and polyaniline (the two polymers used in this 
project) are included in the results section of this work.
Older technologies required entrapment of enzymes within the polymer film, thus a 
mixture of monomer and enzyme were used to coat the sensor via electrodeposition. It 
is nowadays common practice to directly immobilise enzymes and other biomolecules 
onto a deposited polymer film. Novel biocompatible polymers have offered the 
possibility of these new immobilisation procedures alongside enhanced properties 
making them favourable for use in biosensing. 
2.6.1 Conducting polymers
Conducting polymers were introduced in the 1970s as novel organic materials with 
electrical and optical properties very similar to those of metals and semiconductors. 
Guimard et al., (2007) report that polypyrrole was known since the 1960s. However,
very little was understood regarding its electroconductive properties. The existence of 
a conductive polymer was realised in 1977 when researchers noticed a 10 million fold 
increase in the conductivity of iodine doped polyacetylene. Polyacetylene, while 
extensively studied is a non-cyclic polyene sensitive to air and is difficult to study or 
work with due to its inherent instability. Polyheterocycles, one of which is 
polyaniline, started being produced in the 1980s and emerged as polymers with high 
stability, ease of processing and great conductivity. A vast range of conducting 
polymers with diverse chemical structures is currently available each offering 
different favourable characteristics. Many of the monomers used are compatible with 
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aqueous solutions at neutral pH which allows their use with biological components 
such as in biosensors. Additionally, the polymerisation conditions define the chemical 
and electrical properties of the formed polymer film offering more flexibility in the 
choice of an appropriate material (Bartlett & Birkin, 1993). Conducting polymers 
enhance the sensitivity, versatility and reaction kinetics of biosensors used in the 
diagnostics and medical industries (Gerard et al., 2002). They can efficiently transfer 
electrical charge derived from a biological/chemical reaction and are frequently 
biocompatible in neutral aqueous solutions (Gerard et al., 2002). For this reason they 
can be used for biomolecule immobilisation or entrapment for biosensor fabrication 
(Adhikari & Majumdar, 2004; Gerard et al., 2002). The most extensively used 
monomers for biomolecule entrapment within a polymer film have been polyporrole 
and its derivatives. Such substances can be polymerised under mildly oxidative 
conditions rendering them favourable for use with bioelements. Other popular 
monomers, however, require specific non-biocompatible conditions to form a 
conducting polymer film. Aniline for example requires acidic conditions to form a 
highly conductive polymer (Wallace et al., 1999). For this reason such monomers 
have not been extensively used for entrapment purposes as the potential for
biomolecule denaturation is a possibility. Currently used immobilisation methods, 
however, surpass this limitation. Biomolecules nowadays are frequently immobilised 
on the surface of the polymer film rather than within it, thus, the electrodeposition 
conditions do not affect any of the biological molecules involved in e.g. sensor 
fabrication.
Conducting polymers owe their unusual but very favourable properties such as 
conductivity and high electron affinity to the π-electron backbone of their molecular 
structure (Gerard et al., 2002; Saxena & Malhotra, 2003). Some of the most widely 
used conducting polymers include polyaniline (used in this project), polyazulene and 
polythiophene and have also found use as electrode materials for rechargeable 
batteries; polyaniline, for example, is being as an anti-static coating material by 
Hitachi-Maxell for a 4Mb floppy-disk (Gerard et al., 2002). Figure 2.8 depicts the 
chemical structure of aniline.
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Figure 2.8: The chemical structure of aniline. Aniline consists of a phenyl group 
attached to an amino group.
2.6.2 Non-conducting polymers
While conducting polymers have offered great benefits to the continuous research for 
higher quality biosensors, they also have some disadvantages. One of these 
disadvantages is that conducting polymers can be affected by other components that 
are present in a sample and this can give rise to erroneous readings (Guerrieri et al.,
1998). Guerrieri et al., 1998 also report that significant advancements have been 
achieved using non-conducting polymers. 
As would be expected, electrodeposition of a non-conducting polymer film onto any 
electrode surface is a self-limiting process (Law & Higson, 2005), thus non-
conducting polymer films are often very thin contrary to conducting polymer films. 
The insulating nature of non-conducting polymer electrodeposition, results in films 
that may range from 10 to 100 nm in thickness and are virtually defect free. The 
thickness of any polymer film can affect sensor magnitude of response as well as 
response times (Myler at al., 1997). This allows for rapid diffusion of substrates and 
products to and from the biorecognition element thus offering faster result acquisition. 
Alongside rapidity, non-conducting polymer films also offer permselectivity by 
preventing interfering species from reaching the electrode surface and contaminating 
it, thus improving sensor selectivity (Yuqing et al., 2004). Non-conducting polymers 
have also been shown to provide great reproducibility (Guerrieri et al., 1998; Yuqing 
et al., 2004). Yuqing et al., (2004) report the use of poly 1,3-diaminobenzene in order 
to eliminate interference from ascorbate, urea and other oxidisable species. As 
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Guerrieri et al., (1998) report, rapid and interference free amperometric biosensors 
have been developed for glucose and lactate using non-conducting polymers. Some of 
the most important non-conducting polymers include derivatives of phenol and those 
of the phenylenediamines e.g. o-phenylenediamine the structure of which is shown in 
figure 2.9 (Yuqing et al., 2004). Phenylenediamines in particular provide thin dense 
films and are inert to reactive chemical species such as O2H2 and have thus been of 
particular interest for their O2 and O2H2 selectivity. Myler et al., (1997) describe the 
development of enzyme electrodes for the detection of glucose in whole blood, based 
on ultra thin o-phenylenediamine composite membranes (Figure 2.10). According to 
the authors, the resulting sensors displayed increased biocompatibility and excellent 
diffusion limiting properties while the determinations from this work showed close 
correlation to hospital laboratory analysis. Yuqing et al., (2004) report the attempt to 
develop an implantable glucose biosensor using phenylenediamines. The described 
sensors functioned extremely well in buffer, urine, plasma and serum, they did not,
however, perform as well in blood samples (Daly et al., 2000). As the authors state, 
the electrodes tested in whole blood showed decreased reproducibility and in some 
occasions reduced detectable signal as well as high background signal, which is 
expected due to the number of constituents (some of which may interfere with the 
sensing process) present in blood.   
Figure 2.9: The chemical structure of o-phenylenediamine.
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Figure 2.10 Electron micrograph of an o-phenylenediamine insulated electrode (Barton 
et al., 2004).
2.6.3 Non conducting polymers and their use in this research project.
The use of non-conducting polymers within this research programme is far more 
specific however. Here it is aimed to produce impedimetric microelectrodes by the 
use of both conducting and non-conducting polymers, namely poly-o-
phenylenediamine and polyaniline. The process is described by Barton et al., (2004)
and involves the insulation of gold-coated glass slides with the non-conductive poly-
o-phenylenediamine followed by sonication of those modified electrodes to produce 
cavities on the polymer surface. Immediately afterwards aniline is electrodeposited on 
the surface of the electrode forming mushroom-like formations that rise from the 
sonication cavities. Otherwise, aniline can first be electrodeposited onto the bare gold 
electrodes followed by deposition of o-phenylenediamine and subsequent 
sonochemical ablation. 
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2.7 Electrochemistry and electrochemical methods
Electrochemistry is the science that studies and explains the relationship between 
chemical and/or biological changes and electrical potentials or currents. It is a 
powerful analytical tool and closely associated with this project since the use of 
electrochemistry is important for both sensor fabrication and analysis of results 
collected from the final biosensor formats.
In 1793, Alessandro Volta discovered that by placing two metals on opposite sides of
a wet tissue one could produce electricity (Lower, 1994). Only a few years onwards 
Nicholson and Carlisle indicated that water can be decomposed to its basic elements, 
hydrogen and oxygen by the application of electricity; this is called electrolysis. 
Following this important discovery it was realised that all atoms are electrified, metals 
being electropositive alongside hydrogen and all the non-metals being 
electronegative. Over one century after this theory was proposed Michael Faraday 
proved that the quantity of a product of electrolysis depends on the amount of applied 
electric charge passed (Lower, 1994). This can be summarised by equation 2.3 below. 









z
M
F
Q
m Eq. 2.3
Where:
m is the mass of the substance altered at an electrode 
Q is the total electric charge passed through the substance 
F = 96 485 C mol-1 is the Faraday constant 
M is the molar mass of the substance 
z is the valence number of ions of the substance (electrons transferred per ion)
There is an abundance of literature regarding electrochemistry and the different 
phenomena this science studies, thus very few concepts will now be briefly described. 
The concepts of mass transport and the electrical double layer are considered in the 
following pages, alongside voltammetry and AC impedance, two of the techniques 
used extensively within this PhD research project.
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2.7.1 Mass Transport
For a species in a solution to sufficiently undergo redox reactions, the working 
electrode must constantly be provided with fresh reactants. This introduces the 
concept of mass transport, i.e. how the species in a solution reach and leave an
electrode surface.
There are three modes of mass transport: Migration, Convection and Diffusion. 
Migration arises from the movement of ions in the solution in the presence of an 
electric field. For movement of ions towards an electrode, the electrode in question 
must be polarised. Since migration effects are difficult to measure it is desirable to 
introduce in the solution an electrolyte such as KCl which suppresses migration 
effects while increasing conductivity of the solution (Monk, 2001).
Convection involves the physical movement of the solution. It occurs by physically 
moving the solution; this may occur via stirring, agitation or even movement due to 
localised changes that occur due to heating of the solution. 
Diffusion occurs due to the continual consumption of reactant in the solution to 
produce the product. This causes changes in the concentration of species throughout 
the solution while entropy forces naturally attempt to minimise the changes of the 
concentration gradient. Fick’s Laws describe the effects of diffusion in a solution 
with an electroactive species. Fick’s first law states that the diffusive flux moves from 
regions of high concentration to regions of lower concentration with a magnitude that 
is proportional to the concentration gradient. Fick’s second law states that the time 
rate of concentration change is related to the second derivative of the concentration 
gradient through the diffusion coefficient. Diffusion will always exist in a solution 
containing electrolytes even if migration or convection are not present (Monk, 2001).
2.7.2 The electrical double layer
Whether it be under potentiostatic control or equilibrium, the molecules and ions in a 
solution always interact with the electrode surface. The region where these 
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interactions take place is called the Electrical Double Layer. The events taking place 
in this region are non-faradaic, i.e. no exchange of electrons occurs. Ions and other 
particles constantly adsorb and desorb from the electrode surface. When the cell is in 
equilibrium, adsorption and desorption occur at the same rates. When an electrode is 
polarised this equilibrium is disturbed (Monk, 2001). 
Various models have been created to explain these interactions; two of the earliest are 
schematically represented and discussed, while the newer models involve numerical 
modelling to better approach those interactions. 
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The Helmholtz model (1850s)
Helmholtz assumed that any excess charges on the metal surface of an electrode 
immersed in solution are neutralised by a layer of ions with opposite charge present in 
the solution itself. This redistribution of charges which is caused by electrostatic 
forces renders the electrode surface neutral. In essence, the interface between the 
solution and the electrode surface acts like a capacitor storing charge and there is a 
potential drop that is proportional to the distance from the electrode. As the Helmholtz 
model suggests, the electrical double layer is an electrically neutral interface. This is 
described in the schematic of figure 2.11.
Figure 2.11: The Helmholtz Model
(http://www.cheng.cam.ac.uk/research/groups/electrochem/teaching.html).
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The Stern Model (1924)
The Stern model takes into account the fact that ions are capable of movement within 
the solution while also accounting for diffusion and adsorption effects, as discussed 
earlier. Finally according to the Stern Model the attracted ions can be adsorbed onto 
the electrode surface while diffusion drives other attracted ions closer to this area. 
This region is called the diffuse layer (as shown in figure 2.12).
Figure 2.12: The Stern Model
(http://www.cheng.cam.ac.uk/research/groups/electrochem/teaching.html).
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2.7.3 Voltammetry
Voltammetry is a technique widely used in electroanalytical chemistry, that allows the 
study of potential-current relationships in electrochemical cells. In voltammetry the 
varying potential results in differences in the current thus providing information about 
the analyte of interest. The measurements involve a polarised working electrode and 
the method of polarisation determines the type of voltammetric technique being 
employed. Importantly it is the difference between the potentials of two electrodes 
that can be measured rather than the absolute potential of one electrode. For this 
reason it often is required that a reference electrode is present for voltammetric 
experiments alongside a working electrode and a counter electrode. The reason for 
using this three electrode system will now be discussed.
The potential difference (E) observed between a reference and a working electrode 
will be equal to the sum of potential drops of two interfaces, namely the working 
electrode-solution and reference electrode-solution interfaces, as shown be equation 
2.4 below.
   refsiRsmE   Eq. 2.4
R is resistance of the solution and iR is the voltage drop in the solution due to current 
passing through the two electrodes.
The potential drop of the reference electrode-solution interface is fixed when small 
currents pass through the two electrodes e.g. in the case of microelectrodes and iR is 
negligible, hence any changes in the potential are reflected by (φm - φs) and no 
counter electrode is required. The use of larger currents however, e.g. when large 
electrodes are used, means that a) iR ceases to be negligible and b) the chemical 
composition of the reference electrode may be altered so the potential drop of the 
reference electrode-solution no longer retains a fixed value. For this reason a counter 
electrode is introduced in the system.The power source for any voltammetric 
experiments is a potentiostat.
55
A wide range of voltammetric techniques exist many of which are based on linear 
sweep voltammetry. Linear sweep voltammetry measures the current at a working 
electrode when the potential between the working and reference electrodes is swept in 
a linear manner over time. Cyclic sweep voltammetry is an extension of linear sweep 
voltammetry. In this method, when the potential reaches a pre-defined value, the 
potential scan is reversed and the same potential range is scanned in the opposite 
direction. Cyclic voltammetry has been extensively used within this PhD research 
program for electrode testing and polymer deposition.
Cyclic Voltammetry
Cyclic voltammetry is best suited method for the fast acquisition of kinetic and 
thermodynamic processes such as, for example information relating to electron 
transfer reactions within an electrochemical cell. It is often the first step in 
electrochemistry to determine analyte redox potentials in a laboratory environment.
It is now important to introduce the Nernst equation which is used to predict the 
relations between voltage and concentration of reactants at non standard conditions. 1 
molar solute concentrations, gas pressures of 1 atmosphere and typically a 
temperature of 25oC are defined as standard conditions. At such conditions, the 
potential of an electrochemical cell can be calculated from the standard electrode 
potentials. The Nernst equation, shown below (Eq. 2.5), is used to calculate the 
equilibrium electromotive force (reduction potential) of an electrochemical cell by 
taking into account the standard electrode potential and the activities of the 
electroactive species within the cell.
][
][
ln0
R
O
nF
RT
EE  Eq.2.5
E0 is the standard electrode potential.
R is the universal gas constant (8.314510 J K-1 mol-1).
T is the absolute temperature.
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O and R are the concentrations of the reacting species. The Nernst equation ideally 
uses the activity coefficients of these components however at low concentrations 
these coefficients can be replaced by concentrations instead.
F is the Faraday constant.
n is the number of electrons transferred in the cell reaction or half cell reaction.
At room temperature, the constant RT/F can be replaced by 25.679 mV.
Under ideal conditions, when the reaction in the solution is reversible the peak 
separation will be 59 mV. A voltammogram from a cyclic sweep is depicted in figure 
2.13 below.
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Figure 2.13: A typical Cyclic Voltammogram; Au working electrode using 
Ferrocenecarboxylic acid in PBS at a scan rate of 50 mV s-1.
In cyclic voltammetry and for any typical redox reaction, species O will be reduced to 
species R during the cathodic scan until a reduction peak is created where no further 
conversion occurs. At this point species R will have formed a diffusion layer around 
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the electrode inhibiting species O to reach the electrode surface. This results in loss of 
equilibrium and the subsequent decrease in passing current. When the predetermined 
potential limit of the cathodic scan is reached, a reverse scan is initiated during which 
species R is oxidised to species O. The availability of species R due to the previously 
formed diffusion layer causes a current increase while at higher potentials the 
conversion rate from species R to species O increases. When all of species R within 
the diffusion layer has been oxidised, a current decrease is observed. In the above 
figure, ferrocenecarboxylic acid acts as a redox couple. When the reaction is 
completely reversible the two peaks that reflect the oxidation (forward peak) and 
reduction (reverse peak) of the species will have the same peak current height.
In an ideal environment the difference between the two peaks in such a reaction 
should be 59mV. This can be seen by the Nernst equation when this is expressed in 
base 10 logarithms rather than natural logarithms.
][
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log
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EE     Eq. 2.6
Cyclic voltammetry may be used to test the reactivity of species in a solution while in 
this research project it is also mainly used for electrodeposition of polymers on the 
electrode surface to fabricate biosensors (Barton et al., 2004). Additionally cyclic 
voltammetry may be used for antibody entrapment within a polymer film for use in 
biosensors (John et al., 1991; Sadik & Wallace, 1993).
2.7.4 AC Impedance
Impedance (Z) of a given circuit quantifies the opposition to a sinusoidal alternating 
current. During impedimetric analysis a perturbing voltage is applied across an 
electochemical cell, over a frequency range, thus minimal changes occur in the 
concentration of the solution while a current is still generated. An AC impedance 
voltage is applied in a cyclic sinusoidal manner due to which the current alternates. 
The current that is generated from this system is frequency (ω) dependent and will be 
out of phase by a time factor (θ). Two components of impedance are measured; the 
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real component (resistive) is indicated by Z’ and the imaginary component 
(capacitive) Z” (Monk, 2001). An impedimetric approach may be modelled by a 
system made of resistors and capacitors.
In any impedimetric process the applied oscillating sinusoidal potential will be:
tEE sin     Eq. 2.7
Where ω is the angular frequency equal to 2πf where f is in Hertz.
E is the instantaneous value.
ΔE is the maximum amplitude.
The applied potential described in equation 2.7 can be represented on a polar diagram 
as the rotating vector E, as depicted in figure 2.14.
Figure 2.14: Representation of sinusoidal potential in the complex plane.
This applied potential causes a current flow determined by the equation
)sin(   tii   Eq. 2.8
hence the resulting current will be of different phase (lagging or leading) and 
amplitude to the applied voltage. However, it will in most cases retain the same 
frequency and be of sinusoidal nature.
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Upon application of a voltage E, the response of the elements within a simple circuit, 
can be determined by Ohm’s law, when only simple resistance exists.
R
E
i    Eq. 2.9
In a polar diagram the rotating vectors, potential (E) and current (i), of a circuit with 
pure resistance, are separated by the phase angle φ. In this case, however, the phase 
angle is zero. This is shown in figure 2.15.
Figure 2.15: Representation of current and potential in the complex plane.
Earlier within this work, the electrical double layer was introduced. Within this region 
ions of the constituents within a cell can be accumulated or depleted. This ability of 
the system to store charge introduces the concept of capacitance. In simple terms 
capacitance is the measure of stored electric charge upon the application of a potential 
and is determined by the equation:
E
q
C    Eq. 2.10
q is the stored charge among the capacitor elements
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E is the applied potential
For a capacitive system, the relationship between current and potential can be given 
by the following equation, derived from equations 2.7 and 2.9:
tECi  cos Eq. 2.11
Where capacitance is concerned, 1/ωC can be replaced by Xc (capacitance reactance) 
resulting in the equation below:
)2/sin(   t
X
E
i
C
Eq. 2.12
This equation is similar to Ohm’s law for resistive systems but with R replaced by Xc
and a current that leads the voltage in terms of phase, since the phase angle is π/2. The 
introduction of j = ( 1 ) is now necessary, which describes the sinusoidal response 
of a system. Then equation 2.7 becomes
ijXE C Eq. 2.13
In a phasor notation, E is the sum of every voltage drop across the different elements,  
within a system of resistors and capacitors connected in series.
iZEjXRiEEE CCR  )( Eq. 2.14
Where Z is the impedance. The current is no more in phase or 90o out of phase with 
the voltage. Then the phase angle is determined by the following equation:
RCR
X C

1
tan  Eq.2.15
Total impedance can be further analysed into two more components the real and 
imaginery component symbolized by Z’ and Z’’ respectively, Z’ being the resistive 
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and Z’’ being the capacitive component. Figure 2.16 describes the relationship 
between the real and imaginery components and the total impedance of a system.
Figure 2.16: Representation of Total impedance Z and the real (Z’) and imaginery (Z’’) 
components.
For series circuits the overall impedance is the vector sum of the reactance of the 
separate components. The overall impedance for parallel combinations is the 
reciprocal of the sum of the reciprocal impedances of each of the components. 1/Z
being the reciprocal impedance is defined as the admittance Y, which is used to 
describe impedance combinations. 
Some general considerations regarding impedance measurements need to be taken 
into account for AC impedance to be successfully used in diagnostics. Normally, a 
large frequency range must be used. The system that will be interrogated i.e. electrode 
material, polymers used, bioelements used determine which impedance spectra will be 
covered during the interrogation. Within this project the chosen frequency range is 
between 1 Hz and 10000 Hz. Additionally, electrochemical processes are by nature 
non-linear while the most developed impedance theories are linear. In order to 
overcome this limitation, the exciting signal must be kept small enough to allow for 
an approximation to linearity, generally this means that a peak-to-peak current of 10 
mV should ideally be used. One more important aspect to consider is electrode 
positioning. The working and counter electrodes must be symmetrically arranged to 
allow uniformity in current distribution, while the reference electrode should have as 
low resistance as is physically possible.
R(Z’)
-jXC (Z’’)
φ
Ζ
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Electrode impedance is normally described by equivalent electrical circuits the, 
simplest of which is the Randles circuit as shown in figure 2.17. 
Figure 2.17: The Randles circuit.
RE is the electrolyte resistance between the working and reference electrodes.
Cdl is the double layer capacitance.
Rct is the charge transfer resistance.
Zw is the Warburg impedance reflecting the effect of mass transport of the 
electroactive species on the system.
Zf is is the combination of Rct and Zw
The last two elements can normally be combined (Zf) to reflect Faradaic impedance 
caused by the charge transfer process between the working electrode and the 
electrolyte. For diffusion limited processes Zw is dominant while for charge transfer 
controlled processes Zf equals Rct. Impedance data is normally displayed in a Nyquist 
plot where the Z’’ component is plotted against the Z’ component. A typical Nyquist 
plot, based on a Randles circuit, could be presented as in figure 2.18 below 
(Fernandez-Sanchez et al., 2005).
RE
Cdl
Rct Zw
Zf
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Figure 2.18: Typical Nyquist plot based on a Randles equivalent circuit.
At high frequencies the solution resistance does not allow for any electrolysis to occur 
while as the frequency is lowered the faradaic (charge transfer) component of the 
working electrode impedance gives the semicircular shape. At the lowest end of the 
frequency range the process becomes diffusion limited due to the changes in ion 
localisation within the solution, driven by the perturbing potential. At this point the 
component with the major contribution is the imaginary or capacitive component.
AC Impedance allows the detection of minor changes on the surface of the electrode 
in question by detecting changes to the opposition of flowing current. The technique 
is non destructive since the perturbation used is near zero current thus not affecting 
any kinetic information on the surface of interest. Impedance techniques are 
nowadays extensively used for corrosion studies on polymer coated or metal 
transducers. The technique can relay information regarding the biological or chemical 
processes that cause sensor degradation. Lazcka et al., (2007) report the use of EIS for 
determination of total biomass in a sample while extensive examples of DNA and 
antibody modified electrochemical impedance based biosensors are described in the 
scientific literature (Davis et al., 2005). One of the main advantages of EIS over 
potentiometry and amperometry is that the technique does not require any type of 
label. Expensive labels or those harmful to human health such as radioisotopes can be 
Z’’
RE Rct
ω
Charge transfer-limited process
ωmax= 1/RctCdl
Diffusion-
limited 
process
π/4
Z’
65
avoided using this powerful tool for chemical analysis. Additionally the technique 
offers rapidity and simplicity. However, Lazcka et al., (2007) further report that the 
detection limits of EIS are still poor. Additionally, the understanding of the 
phenomena occurring on EIS of immunosensors, and the subsequent creation of a 
measurable signal, is not as of yet well studied and understood. Furthermore, 
electrode size and separation distance may play a role in the detection limits achieved, 
however, this aspect has not yet been examined either.
Extensive work within the sensing industry included the use of EIS for sensor 
development.  A large number of studies incorporated EIS to gain an understanding of 
the biomelecular interactions of conductive and semi conductive surfaces. Enzyme 
and whole cell based sensors have also been characterised by EIS, while its use for 
cell culture monitoring has also been reported (Pejcic & de Marco, 2006). Finally, EIS 
has been used to provide details concerning the immobilisation of biomolecules on the 
sensor surface by determining the changes in impedance of modified electrodes. In 
this project minor changes on the sensing surface occur when antigen is attached to an 
antibody covered electrode, hence the system functions as a biosensor. Several groups 
have reported successful detection of various types of antigens or other molecules by 
the use of AC Impedance (Farace et al., 2002; Ouerghi et al., 2002). Davis et al.,
(2005) have reported the use of impedimetric DNA sensors for differentiation among 
different species of fish. Impedimetric experiments allow the experimentalist to 
monitor such changes and effectively make the detection of disease, pollutants, 
chemicals in various samples, feasible.
Figures 2.19 and 2.20 contain representative Nyquist (Z’ vs Z”) and Bode (total 
impedance vs frequency) plots. These were obtained from data acquired during this 
research project. It can be seen that increasing concentrations of polyclonal 
(non-specific) IgG result in changes of impedance whether it be the faradaic or 
capacitive components or total impedance. These figures are further discussed in the 
Results and Discussion section.
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Figure 2.19: Z' v Z'' - Nyquist plot; Impedance responses of polyclonal IgG loaded 
carbon based sensors upon exposure to various antigen concentrations (in PBS).
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Figure 2.20: A typical Bode plot, total impedance vs log10 frequency; total impedance 
responses of polyclonal IgG loaded carbon based sensors upon exposure to various 
antigen concentrations (in PBS).
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2.8 Antibody Immobilisation
In any biosensing device, the main component affecting specificity is the biological 
sensing moiety. The immobilisation method used in each case depends upon the type 
of the biorecogniton element and the transducer to be used. Bioelement 
immobilisation is of pivotal importance to sensor fabrication because it affects 
parameters such as the sensor detection limits, sensitivity, reusability as well as 
reliability. Some of the most widely used methods include encapsulation, cross 
linking, adsorption, covalent bonding and entrapment (Mello & Kubota, 2002). 
Reports from the early 1990s (John et al., 1991; Cooper & Hall., 1992; Sadik & 
Wallace., 1993) suggest that physical entrapment was then viewed as the preferred 
method for biomolecule immobilisation resulting in successful sensing devices for a 
variety of target substances. This immobilisation method normally involves the 
addition of both antibody and monomer to be used in an aqueous solution protocol 
followed by an electropolymerisation protocol. In this manner the antibody molecules 
are entrapped within the polymer structure thus imparting it with molecular 
recognition. The polymer of choice may simply provide support for biomolecule 
immobilisation or subsequently be involved in the occurring reactions i.e. as a 
mediator. While this method and newer improved variations are supported by a large 
number of researchers, others support that possible antibody leakage, long term 
instability and poor reproducibility are three of its drawbacks and choose alternative 
immobilisation approaches (Korri-Youssoufi et al., 2001). Nevertheless, as it has 
already been stated in this work, conducting polymers offered favourable 
biocompatibility allowing for a range of different approaches to be developed based 
on the characteristics of available polymer substrates. Alongside physical entrapment, 
passive adsorption, electrochemical micro-assembly and other techniques, most of 
which in essence involved dipping of electrodes into antibody containing solutions, 
have been developed (Bender & Sadik, 1998).
Adsorption on the active surface of the sensor is possibly the simplest method for 
antibody immobilisation as the only requirement is that the polymeric or metal 
support surface to be incubated in a solution in the presence of the biorecognition 
element (Bilitewski, 2006). Adsorption is based on van der Waals forces between the 
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biorecogntion molecules and the supporting surface. The method often includes the 
use of an analyte permeable membrane, covering the transducer, on which the 
antibodies or enzymes are adsorbed (Mello & Kubota, 2002). However, as Lazcka et 
al., (2007) report, adsorption may also occur on an unmodified electrode surface such 
as gold. The method while fast and extremely simple suffers irreproducibility issues 
since the biomolecule antibody attachment is random and the orientation of the 
binding sites is not even minimally controlled. It is thus possible that the antibody 
binding site becomes inaccessible to the antigen and hence this could compromise 
sensor sensitivity. Additionally, desorption of the attached biomolecules may occur 
upon changes to pH, ionic strength or temperature (Anzai et al., 1993; Mello & 
Kubota, 2002).
Covalent immobilisation is also a very commonly used method for protein attachment 
on a membrane matrix or even an unmodified electrode surface. This method is based 
on the interactions between terminal functional groups (normally from the amino acid 
side chain and non important for catalytic activity) and reactive groups on the support 
surface. Carbodiimide or succinimide derivatives are used for the activation of such 
functional groups which can then readily react with aldehyde, epoxide, carboxylic or 
amino groups. Chemical treatment of the support surface whether it be polymer based 
or an unmodified substrate, is required for the generation of functional groups. Upon 
deposition of the protein solution on the support surface, only a small incubation 
period at room temperature is required (Bilitewski, 2006; Mello & Kubota, 2002). 
Similarly to physical adsorption described earlier, this method suffers from random 
orientation; additionally, the chemical pretreatment may lead to slight distortions on 
the protein structures, thus rendering a large amount of molecules inactive. 
A more recent alternative to all of the above immobilisation methods is the use of 
bioaffinity binding which offers, above all else, oriented immobilisation of the 
biorecognition molecules. This method is based on the biochemical properties of the 
chosen recognition entities as they utilise biochemical affinity reactions. Bilitewski, 
(2006) describes three techniques, namely, immobilisation via protein A or protein G, 
immobilisation via biotin-binding proteins or immobilisation of recombinant proteins 
via tags. Of the three methods mentioned, the one incorporating the use of biotin 
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binding properties will be now discussed, as it has been chosen for antibody 
immobilisation within this research project.
Anzai et al., (1993) have reported the use of the avidin-biotin system for biomolecule 
immobilisation on conducting polymers. Avidin is a glycoprotein with a molecular 
weight of 68 kDa and a very high affinity constant for biotin binding (Ka= 10
15 M-1).  
Each avidin molecule has four biotin binding sites (Anzai et al., 1998). Biotin is a 
vitamin with a molecular weight of 244 Da, found in every living cell with the highest 
concentrations being found in the liver, kidney and pancreas. Many proteins bind to 
biotin, while biotinylated antibodies have successfully been prepared (Dakshinamurti 
et al., 1986). Due to the strong interactions between biotin and avidin, this is a very 
useful system for exploitation in protein immobilisation on sensors. Bilitewski, (2006) 
indicates that the biotin-avidin system was found to be more efficient than direct 
chemical or physicochemical immobilisation procedures. The same author reports that 
sensors fabricated using the avidin-streptavidin system can be regenerated by 
denaturation of streptavidin at very harsh conditions and subsequent reloading of the 
sensing surface with fresh proteins. Several groups have reported the fabrication of 
successful amperometric and impedimetric biosensors using the avidin-biotin 
complex (Ouerghi et al., 2002; Ding et al., 2005), and hence the use of this system is 
also preferred in this project. In this research project neutravidin is used rather than 
avidin. Neutravidin is a deglycosylated form of avidin with a near neutral isoelectric 
point of 6.3; it has many key characteristics that give provide low non-specific 
binding which is very important when it comes to sensitive immunological 
measurements. Figure 2.21 describes the immunosensor format when the biotin/avidin 
system is used. The protocol for sensor fabrication can be found in Materials and 
Methods chapter.
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Biological receptor (MAb)
Biotin
Avidin (tetrameric protein)
Biotinylated polymer
Transducer
Figure 2.21: Covalent attachment of bioreceptor to a biotinylated polymer modified 
with a tetrameric protein (ELISHA 2nd year report).
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2.9 Sonication and Microelectrodes
Sonication is a process that involves the use of sound waves to lyse whole cells, speed 
up biological interactions and more recently create cavities on different surfaces (Law 
et al., 2003). This latter procedure can only be carried out in liquids e.g. in a water 
bath and involves the creation of bubbles that rapidly collapse onto target surfaces.
The use of sonication in this research programme is limited to the fabrication of 
microelectrodes. Law & Higson, (2005) report the use of a custom made sonic bath in 
which electrodes covered by the insulating polymer poly-o-phenylenediamine were 
immersed and sonicated in order to produce cavities on the polymer surface. These 
cavities provide passage to the electrode surface through very small openings that can 
act as microelectrodes. To further enhance the conductivity of the cavities aniline can 
be electrodeposited forming mushroom like formations that rise form the sonication 
cavities (Barton et al., 2004; Myler et al., 2004). Barton et al., (2004) report the use of 
this technique for the production of microelectrode arrays on the surface of planar 
electrodes. It is suggested by the authors that one microelectrode would give a limited 
response due to size limitations while an array would provide a similar if not greater 
response to a normal sized electrode (due to the cumulative signal production of the 
existing microelectrodes) as well as offering stir independence. 
As discussed in section 2.7.1, diffusion is one mode of mass transport to and from the 
electrode in an electrolyte solution. While a solution is unstirred diffusion control is 
normally the prevalent mode of mass transport; if this same solution was to be stirred 
then the diffusional gradients in the solution would change (Higson, 2003). A planar 
normal sized electrode can be affected by this and provide inaccurate data. However, 
microelectrodes are small enough to experience hemispherical solute diffusional 
profiles (Barton et al., 2004). Any molecule can move towards or away from the 
electrode in a 180o two dimensional arc much like the shape of a hemisphere thus 
rendering it stir-independent (Higson, 2003). Additionally ready made 
microelectrodes (P10 described in the Materials and Methods section) have already 
been prepared for this project without the use of sonication and are described in the 
Materials and Methods section.
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The custom made sonic tank (Ultrawave Ltd., Cardiff, UK) contains sonic transducers 
that induce the formation of cavitational bubbles. Figure 2.22 shows the energy 
distribution within the old sonic tank; ‘hot’ spots (nodes) and ‘weak’ spots (anti-
nodes) are clearly visible. For this reason rotating the sensors during the sonochemical 
ablation step was necessary when using this tank. The new tank as can be seen in 
figure 2.23 contains 108 transducers as opposed to 12 in the previous design. The 
increased number of transducers allows for a better distribution of the ultrasound 
energy within the bath area and so homogeneity for the final sensors.
S o n o lu m i n e s c e n c e
ta n k  p r o f i l i n g  w it h  
n o  b a f f l i n g
S o n o lu m i n e s c e n c e ta n k  
p r o f i l i n g  w i th  th e  a d d i t io n  
o f  b a f f l i n g  i n  th e  ta n k  to  
d is r u p t  s ta n d in g  w a v e s
Figure 2.22: The first custom made sonic bath and Sonoluminescence Profiling of the 
tank (ELISHA 2nd year report).
Figure 2.23: The new sonic bath (ELISHA 2nd year report).
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Chapter 3
Materials and Methods
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3.1 Buffers and Solutions
Sodium di-hydrogen orthophosphate (AnalaR), di-sodium hydrogen orthophosphate 
and sodium chloride (AnalaR) were obtained from BDH (Poole, Dorset, UK) and 
used for the preparation of 10X Phosphate Buffered Saline (PBS) at pH 7.4 stock 
solution using 0.13 mM  NaH2PO4, 0.528 mM Na2HPO4 and 0.51 mM NaCl. 1mM or 
5 mM ferrocenecarboxylic acid from Sigma-Aldrich (Gillingham, Dorset, UK) was 
diluted in PBS for cyclic voltammetry. 
5 mM o-phenylenediamine (Acros organics, Geel, Belgium) was dissolved in PBS for 
electrode polymerisation. 1 dm3 of aniline buffer was prepared using 0.5 M KCL 
(Fisher Scientific UK Ltd, Loughborough, UK)and 0.3 M HCL (AnalaR, Poole, 
Dorset, UK) at pH 1 to for 0.2 M aniline (Sigma-Aldrich, Gillingham, Dorset, 
UK)solutions. 
All buffers were prepared with H2O obtained from a Purelab UHQ Deioniser (Elga,
High Wycombe, UK).
3.2 Antibody/antigen preparation and biotinylation
Anti-Prostate specific antigen and prostate specific antigen were purchased from 
Europa Bioproducts Ltd (Cambridge, UK). Ciprofloxacin polyclonal antiserum (As
171) was provided by AMRg and was raised against 1-(3-mercaptopropyl)-6-fluoro-
7-(piperanicyl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid coupled to HCH. The 
preparation of the immunogen and of the antibodies will be described elsewhere
(Pinacho et al., 2007). Polyclonal IgG from rabbit, goat, murine and human whole 
serum were purchased from Sigma-Aldrich (Gillingham, Dorset, UK). Digoxin and 
anti-digoxin where purchased from Sigma-Aldrich (Gillingham, Dorset, UK). GFP
was purchased from Millipore/Upstate (Hampshire, UK) and monoclonal anti-GFP 
was purchased from  Sigma-Aldrich (Gillingham, Dorset, UK).
The biotynilation kit BK101 and Biotin 3-sulfo-N-hydroxysuccinimide ester sodium 
salt (water soluble biotin) were purchased from Sigma-Aldrich (Gillingham, Dorset, 
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UK). Immunopure NeutrAvidin protein was purchased from Perbio Sciences UK Ltd 
(Nothumberland, UK). Bovine serum albumin was obtained from Sigma-Aldrich 
(Gillingham, Dorset, UK). For antibody biotynilation the procedure outlined in the 
BK101 kit was followed (See section 2.8 for details). Biotinylated antibodies and their 
respective antigens were kept in aliquots of 200 μl at a concentration of 1 mg ml-1.
When lower antibody concentrations could only be obtained, these were concentrated. 
Concentration and purification of antibodies is described later in this chapter.
3.3 Equipment
For any process involving voltammetric procedures a potentiometer supplied by 
Sycopel Scientific (Tyne & Wear, UK) was used. The GillCac impedance kit (ACM 
Instruments, UK) was used for all impedimetric measurements. The custom made 
sonication tank  was built by Ultrawave Ltd (Cardiff, UK).
3.4 Electrodes
3.4.1 Project specific electrodes
Project specific electrodes, designed and fabricated by Tyndall National Institute 
(Ireland), were given the labels of P3, P4, P5 and P10 (microarray-type) type 
electrodes, schematics of which are shown in figures 3.1, 3.2 and 3.3.
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Figure 3.1: P3 and P4 electrodes.
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Figure 3.2: P5 electrodes.
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Substrate
Delivery
Silicon/silicon oxide -suggest 800-1000nm SiO then
adhesive layer - 50 nm Ti
electrode layer -100 -150 nm Au
surface passivated with SiN except for contact 
pad and microarray electrodes
7 wafer run 
2 
P10 microarray  electrode    PAM 24/01/05
2  mm
3 mm
15 mm
9 mm long 
and 20 m
wide track

2.54 mm
0.5  mm
0.5 mm
2 mm
gold microelectrode
array covered by SiN
passivation (only a few 
electrodes shown)
patterned
chrome 
adhesion 
layer
SiN 
passivated
background
20 m
between 
centres
10 m
diameter
‘micro-
electrodes’
Figure 3.3: P10 electrodes.
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3.4.2 In-house carbon electrodes
The screen printed carbon electrodes designed by Microarray Ltd., Manchester, UK 
and fabricated by Parlex Corp. Ltd., Isle of Wight, UK, where mainly used for the 
impedimetric work carried out within this PhD research project.
Figure 3.4: Typical in-house screen-printed carbon electrodes (Parlex Corp Ltd, Isle of 
Wight, UK). Surface area of working electrode is 0.2178cm2.
Ag/AgCl Ink 
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Carbon Ink 
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Area Masked 
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81
3.5 Cyclic Voltammetry
3.5.1 FCA tests and polymer deposition
Ferrocenecarboxylic acid (FCA) tests were normally performed by cyclic sweeps 
between -0.2 V and +0.6 V unless otherwise stated. o-phenylenediamine was 
electrodeposited by 100 cyclic sweeps between 0 V and +0.9 V (vs Ag/AgCl) initially 
and between 0 V and +0.8 V in later work. Aniline was electrodeposited by 20 (or 
until the voltammograms matched for each electrode) cyclic sweeps between -0.2 V 
and +0.8 V (vs Ag/AgCl) and by finally running a linear sweep from -0.2 V to +0.8 V 
(vs Ag/AgCl). This ensured conversion of aniline to its emeraldine form (green).
3.6 Sonication
A custom made sonic tank with internal dimensions of 750 x 750 x 600mm 
andworking volume 750 x 750 x 500 mm (Ultrawave Ltd., Cardiff, UK). 
Sonochemical ablation of polymer coated electrodes was performed using a number 
of different parameters. The energy at which the sonication tank operates (total output 
25 kW) determines the intensity of sonochemical ablation applied on the sensors. 
Normally the energy level was between 50 % and 100% and time of ablation did not 
exceed 60 seconds. The electrode sheets were fixed in the middle of the tank and 
sonicated for the chosen time.
3.7 Sensor fabrication
30 μl volume of biotin-sulfo-NHS (Sigma-Aldrich, Gillingham, Dorset, UK ) at 10 
mg ml-1 was placed on the polymer coated working electrode surface for 24 hours. 
After 24 hours, the sensors were rinsed with deionised water and 30 μl of neutravidin 
at 10 μg ml-1 placed on the working electrode for 1 hour. After rinsing biotinylated 
antibody was added at a concentration of 1 mg/ml. Finally, non-specific interactions 
were blocked by 10-6 M bovine serum albumin; the sensors were then left in PBS 
buffer overnight prior to use.
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3.8 AC impedance
Antigen solutions for ac impedance were prepared by diluting the required 
concentration of antigen in 30ml of PBS pH 7.4 unless otherwise stated. The sensors 
were first interrogated without antigen addition. Following this each sensor was 
exposed to the required antigen concentration for 30 minutes, rinsed well with 
deionised water and then subjected to impedance interrogation.
Impedance parameters:
Previous work within our group established the optimum test settings for the type of 
work carried out towards sensor development. A frequency range from 10000Hz to 
1Hz (5mV a.c.) was used and 100 readings were taken per test. As discussed in 
section 5.2 the faradaic charge transfer process dominates the impedance of the 
system at the lower frequency range between 1 Hz and 1.5 Hz, for this reason the 
impedance values obtained at 1 Hz where further used to construct calibration curves. 
The working electrode surface area (for carbon sensors) was 0.2178cm2. Potassium 
hexacyanoferrate and potassium ferricyanide were purchased from Sigma-Aldrich 
(Gillingham, Dorset, UK) to prepare a 10 mM ferri/ferrocyanide ratio 1:1 in PBS pH 
7.4 buffer to be used as a redox couple for impedimetric measurements.
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3.9 Antibody purification and concentration
When monoclonal antibodies where provided in whole antiserum, these were purified 
using a 5 ml protein G-column (Pharmacia). The process involved the collection of 
two eluents the first of which samples contained unwanted substances while the 
second contained the polyclonal or monoclonal IgG sample to be further used for 
sensor fabrication. The IgG fraction was eluted using glicine buffer (pH 2.7) and 
dialyzed overnight. Samples were then aliquoted and stored at -20 °C or subjected to 
biotinylation. This work was carried out by partner 1, University of Leeds.
Figure 3.5: Absorbance trace recorded at 280 nm from a sample of rabbit sera following 
IgG separation, showing both absorbance peaks of sera albumen, and IgG fraction. 
For antibody concentration, a Centriprep centrifugal filter unit fitted with an Ultracel 
YM-30 membrane containing glycerol, to prevent drying, was used. This procedure 
also ensured the removal of sodium azide from the antibody solution. The unit was 
purchased by Millipore, Hertfordshire, UK. The procedure involved three subsequent 
centrifugations in a cold room (4ºC), each for 20 minutes at 30,000 rpm.
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Section 2
Results and discussion
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Introduction
One of the aims of this research project is to develop fast and reliable immunosensors 
targeting a range of analytes including, for example, fluoroquinolone antibiotics, 
digoxin and prostate specific antigen. The experimental procedures include polymer 
deposition on gold and carbon electrodes, antibody immobilisation on transducer 
surfaces and impedimetric interrogation of the fabricated sensors.
A set of experimental procedures were undertaken in order to fabricate and 
subsequently interrogate impedimetric immunosensors using different 
antibody/antigen pairs. Several conditions affect the development of appropriate, fast 
and reliable immunosensors, including the polymer used, the electrodeposition 
conditions, antibody attachment to the polymer and ultimately the interrogation 
method and parameters. The conditions of polymer electrodeposition and electrode 
interrogation using voltammetry were extensively evaluated in order to obtain the 
optimum set of parameters for highly reproducible and reliable sensors.
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Chapter 4
Characterisation of gold and platinum 
electrodes and electrochemical methods
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Introduction
One of the first objectives was to apply protocols previously developed by our group 
to the newly acquired sensors specific to ELISHA. Initially our work involved the 
electrodeposition of o-phenylenediamine and aniline on electrodes provided by the 
Tyndell National Institute (Ireland), and subsequent sonochemical ablation for the 
planar gold electrodes. The electrodeposition conditions had previously been used 
with success by our group on different carbon electrode formats (Law et al., 2000; 
Barton et al., 2004). The choice of electrodeposition by means of cyclic voltammetry 
was made so that the oxidation and reduction peaks indicating the deposition of each 
polymer layer would be clearly seen and hence the process could be followed. The 
objective was therefore to determine whether these predetermined conditions could be 
successfully applied to gold and platinum planar electrodes and microelectrodes as 
described in the materials and methods chapter. 
4.2 O-phenylenediamine electrodeposition
The insulating nature of o-phenylenediamine (Law & Higson, 2005) is clearly seen in 
figure 4.1 which displays cycles 1, 5 and 100 of a one hundred cycle sequence of 
voltammetric deposition of o-phenylenediamine between 0 mV and 900 mV. In order 
to confirm the electroconductivity of each gold electrode, potential sweeps were also 
performed before and after polymerisation, in the presence of 1mM 
ferrocenecarboxylic acid (FCA). Cyclic voltammetry with added FCA was performed 
using different potential sweeps, however, it was finally decided to set the potential 
limits to -0.2 and + 0.6 V in order to minimise the compromising of results due to the 
double layer charging effects. FCA has a Nernstian (reversible) behaviour. As 
expected in typical cyclic voltammograms an anodic peak is seen at oxidising 
potentials when the reduced FCA is converted to ferrocinium ion species (Fernandez 
& Carrero, 2005). When the potential sweep is reversed ferricinium is converted to 
FCA thus causing a cathodic peak of similar magnitude to the previously observed 
anodic peak. 
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Figure 4.1: O-phenylenediamine electrodeposition (-0.2 to 0.9 V) on a P4 Au electrode 
showing cycles 1, 5 and 100.
As clearly seen in figure 4.1, the predetermined o-phenylenedimaine electrodeposition 
conditions were successfully used for gold planar electrodes, which had previously 
been tested for their electroconductivity by being imposed to cyclic voltammetric 
sweeps. As expected during the first electrodeposition cycle, a large peak was 
observed with the current reaching the range of 90 μA. Subsequent cycles cause the 
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electrode surface to become less conductive until at 100 cycles of polymerisation a 
baseline current is achieved as a result of electrode insulation. As Pritchard et al., 
(2004) report, the resulting insulating film has an approximate thickness of 50 nm. 
Additionally, it should be noted that o-phenylenediamine films are colourless when at 
a reduced form but red when oxidised (Martinusz et al., 1994). Martinusz et al., 
(1994) have made some important observations regarding the electrochemical 
polymerisation of o-phenylenediamine. The authors suggest that o-
phenynelenediamine polymerisation is not autocatalytic and occurs at low potentials 
during the reverse cyclic voltammetry scan. Additionally, film formation can be 
explained by two electron transfer processes which include the redox reaction of 1, 4-
diazine groups, followed by a protonation-deprotonation reaction and possibly a 
dimerisation reaction.
Figure 4.2 depicts near perfect insulation that was achieved using the discussed 
o-phenylenediamine electrodeposition conditions.
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Figure 4.2: Cyclic voltammetric interrogation (-0.2 to 0.6 V) of a P4 Au electrode before 
electrodeposition and after electrodeposition of o-phenylenediamine (O-PD) (100 cycles).
90
The peak separation for the unmodified electrode does not resemble the expected 59 
mV value obtained for an ideal diffusion controlled reaction, but rather a larger peak 
separation of 87 mV. The effects of electrode fabrication, solution constituents and 
environmental conditions do indeed affect the kinetics of the occurring 
electrochemical reactions, however, this observation in conjunction with others gave 
rise to subsequent investigations that will be discussed in the following sections.
4.3 Aniline electrodeposition 
In three electrode cells (working-counter-Reference), similar to the ones being used in 
our work, monomers of the chosen conductive polymers undergo reactions that 
eventually cause them to become insoluble and precipitate on the electrode surface. 
As Gardner and Bartlett, (1995) report the movement of counter-ion into and out of 
the polymer film results in visible current peaks during cyclic voltammetric sweeps. It 
is readily understood within the literature that the shape of the resulting 
voltammograms and peak currents will be determined by the individual monomer 
used and the electrode surface (gold, platinum, carbon).
In this work, 0.2 M poly-aniline pH 1 was deposited onto P4 electrode surfaces by 25 
continuous potential sweeps between -0.2 V and +0.8 V. Previous works have 
indicated that optimal conditions for polyanaliline deposition include a potential 
between -0.2 V and 0.7 to 1.2 V along with acidic solution pH. HCl is very often used 
for the successful electropolymerisation of aniline (Genies et al., 1989). The buffer 
recipe used to dissolve aniline is described in Materials and Methods, section 3.1 and 
ensured electroconductivity of the final polymer as polyaniline is not 
electroconductive if prepared at neutral or basic pH (Pritchard et al., 2004). The pH 
range used varied from pH 3.7 down to pH 1 and it was found that electroconductive 
aniline was best when obtained at pH 1. The oxidised form of a polyaniline film has a 
blue-green colour and is normally referred to as emeraldine. It should be noted that 
the surface area of the deposited film increases as a power of the volume.  Genies et 
al., 1989 have extensively reviewed the properties of aniline and the effects of 
different deposition methods on the properties of the resulting film. It should initially 
be noted that the observed peaks during cyclic voltammetric work vary greatly 
depending upon the electrode material used e.g. gold, carbon or platinum. The 
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reaction rate of electrodeposition has been shown to be proportional to the 
temperature between 0oC and 60oC and thus environmental conditions along with 
solution temperature can also affect the deposition process hence the shape of the 
voltammograms.
There has within the literature been some debate between different research groups as 
to the number of electrons required for aniline polymerisation. It is generally accepted 
that two electrons are required along with a number of supplementary electrons 
necessary for polymer oxidation, however, the mechanism of polymerisation has not 
yet been fully understood. Acidic conditions are required for PANI deposition. 
However, the rate of deposition depends on the concentration of anions and not the 
pH. It has been suggested that aniline oxidation is catalysed by the fully oxidised form 
of polyaniline, pernigraniline, and that the reaction is self catalysing. An intermediate 
was shown to arise through aniline oxidation, p-aminophenylamine (PADPA), which 
has attracted extensive research itself for the possibility of novel polymer discovery.
Polymerisation of the aniline polymer gives rise to five distinct oxidation states. 
Given the generic structure depicted in figure 4.3 these five oxidation states can be 
analysed.
Figure 4.3: Generic structure of polyaniline.
With x equal to half the degree of polymerisation:
1) Leucoemeraldine n=1, m=0 is the fully reduced state and is easily oxidised.
2) Pernigraniline with n=0 and m=1 (imine groups instead of amine) is the fully 
oxididised state but can be easily degraded.
3) Emeraldine with n=m=0.5 is either neutral or partially reduced or oxidised and 
is the most stable form.
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Figures 4.4 and 4.5 display the voltammograms obtained from electrochemical 
deposition of aniline on P4 Au electrodes. Figure 4.4 depicts electrodeposition of 
aniline under non-conductive conditions (buffer pH 3.7), while figure 4.5 depicts the 
electrodeposition of the polymer under strongly acidic conditions (buffer pH 1).
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Figure 4.4: Electrochemical deposition (-0.2 V to 0.8 V) of aniline on a P3 Au electrode
under non-conductive conditions (pH 2.8).
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Figure 4.5: Cycles 1, 5 and 100 of aniline pH 1 electrodeposition on P4 electrodes under 
conductive conditions (pH 1).
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It can be seen that with every deposition cycle, the peak current observed increases
(figure 4.5). This is due to the increase of the conductive surface area from 
accumulation of polyaniline layers on the electrode surface with each potential sweep. 
It should be noted here that gold and most metals are superior conductors to any of the 
known conductive polymers. While initially the conductivity of coated electrodes is 
seen to increase, it must be understood that a high number of consecutive potential 
sweeps (e.g. 100) will become a limiting factor and the cumulative conductivity 
through the polymer will start decreasing. This can be explained as the polymer film 
becomes thicker with each sweep. In agreement with results obtained by Sasaki et al., 
(1986), our observations from aniline electrodeposition on P3 electrodes indicate an 
initial peak which is non reversible. This peak that occurs only in the first cyclic 
sweep corresponds to the diffusion limited oxidation of the monomer and partial 
deposition. 
Cyclic sweeps using an FCA doped solution of PBS buffer (pH 7.4) was used to 
investigate the electroconductivity of each P4 electrode after polyaniline deposition. 
Figure 4.6 compares the voltammograms before and following polymerisation with 
both 200 mM aniline (25 cycles) and 5 mM o-phenylenediamine (100 cycles).
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Figure 4.6: 1 mM FCA before deposition and after deposition of aniline and 
o-phenylenediamine, potential sweep between -0.2 and +0.6 V.
As intended and expected, the polyaniline modified electrode displays the highest 
current peaks in comparison to the bare electrode and the o-phenylenediamine coated 
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electrode. Having made these observations, we verified that the polymer deposition 
protocols previously developed with our group could be successfully applied to work 
involved in the ELISHA project.
4.4 Sonochemical ablation
Sonochemical ablation of the polymer coated electrodes was performed following the 
electrodeposition of the insulating polydiaminobenzene film. Either single electrodes 
or electrode coated sheets (depending on the nature of the experiment) where 
immersed in the sonication tank, which was filled with water, and fixed at a set 
location. The procedure has been previously described by our group (Barton et al., 
2004). It was observed that o-phenylenediamine results in a defect-free film of 
approximately 30-40 nm in thickness using the described electrodeposition 
conditions.  An extensive set of different parameters with regards to sonication power 
level, time of ablation and electrode positioning within the tank, were tested in order 
to determine the optimum conditions for microelectrode array construction. 
The sonochemical ablation of polymer coated electrodes for the formation of 
microelectrodes has previously been described by a number of papers within our 
group (Myler et al., 2004; Barton et al., 2004, Grant et al., 2005). As it is suggested 
by Barton et al., (2004) ultrasound passing through water (or another solvent) creates 
thermal agitation alongside localised hotspots, resulting in the creation of superheated 
vapour bubbles. At standard temperature conditions (25oC) these bubbles can be 
cooled by the solvent and implode into high velocity microjets, rendering them 
capable of shattering a range of solids. This mechanism was exploited in this work 
towards the creation of microelectrode arrays on a diaminobenzene coated electrode. 
Upon implosion, the bubbles cause cavities on the deposited film surface thus 
exposing the underlying conductive surface. Cavity distribution is random due to the 
fact that sonochemical ablation is a chaotic process. The resulting pores range in 
diameter from a few hundred nm to 3 μm. The smaller cavities are thought to act as 
nucleation sites for the creation of more bubbles thus aiding their own expansion as 
more microjets can reach the polymer surface (Barton et al., 2004). 
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It should be noted that the largest cavities of a 3 μm diameter no longer act as 
nucleation sites. It is also noted that some pores may initially form close to each other 
and upon further expansion unite forming a ‘dumb-bell cavity’ as depicted in figure 
4.7. Due to the presence of two different sizes of electrodes on the surface, these are 
called bi-modal. Barton et al., (2004) report that sigmoidal voltammograms were 
observed upon cyclic sweep testing, however, the diffusion layer effects present a 
major interfering factor. Diffusion layer charging effects are typically much smaller in 
the case of microelectrode arrays over normal size electrodes, however, it is suggested 
that the large pore density on the electrode surface may cumulatively give rise to 
diffusion layer charging. Barton et al., (2004) continue by describing the 
electrochemical deposition of GOx doped aniline for the formation of mushroom-like 
protrusions on the electrode surface and subsequent amperometric and impedimetric 
analysis to determine sensor responses to a range of glucose concentrations. 
Figure 4.7: Formation of cavities following sonochemical ablation of o-
phenylenediamine covered sensors.
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Figure 4.8 below depicts the voltammetric responses of bare, insulated and finally 
sonochemically ablated gold electrodes, as described by Barton et al., (2004).
Figure 4.8: Cyclic voltammetry testing for a bare, an insulating polymer coated and a 
sonochemically ablated electrode.
The same microelectrode array fabrication procedures were followed in our work, 
however reproducibility issues indicated the necessity for further testing of the project 
specific electrodes provided by Tyndall National Institute (Ireland). Having evaluated
a set of different conditions, it was found that usage of very high acoustic power 
stripped off the insulating polymer and damaged the Au surface; a similar effect was 
also seen to occur if the time allowed for sonochemical ablation was too great. After 
some empirical experiments it was decided to use 50% power (maximum operational 
frequency of 20 kW) for times between 15 seconds and 60 seconds. In order to test 
the formation of sonication cavities, the electrodes were subsequently subjected to 
cyclic voltammetry using 1 mM FCA as described in previous experimentation within 
the project. Figure 4.9 displays the results obtained following sonochemical ablation 
of polymer coated electrodes.
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Figure 4.9: Cyclic voltammetric sweeps of sonochemically ablated electrodes by 
rotation, at 50% power for 30 seconds in FCA.
While electrode 1 (figure 4.9) displays almost perfect microelectrode behaviour
(almost sigmoidal shape of the voltammogram), the rest electrodes seem to have 
become insulated. Some reasons that may result in irreproducibility are discussed 
here. As already mentioned sonochemical ablation does not allow for perfectly even 
distribution of energy i.e. the cavitation bubbles are not distributed evenly within the 
bath area. Additionally, the project specific electrodes are very small in size and this 
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minimises the averaging effect afforded by the use of larger electrodes. As discussed 
earlier high power or sonochemical ablation for an extended time may damage the 
polymer and the electrode surface, however, since one electrode was not damaged it 
was realised that the problem might be associated with the electrode fabrication 
process.
4.5 FCA tests on non-modified electrodes
In order to examine whether there was a fault in the electrode fabrication process, a 
set of voltammetric tests was performed on all types of project specific electrodes 
(including platinum) to ensure that there was reproducibility among electrodes when 
the conductive surfaces were not coated. The behaviour of each electrode was to be 
tested in solutions containing 1 mM ferrocenecarboxylic acid (FCA). It should be 
noted that those tests were performed at various scan rates (10 mV s-1, 25 mV s-1 and 
50 mV s-1). The scan rate affects the shape of a resulting voltammogram due to the 
presence of the diffusion layer. At a slow scan rate the diffusion layer grows by a 
substantial amount thus the flux of electrons reaching the electrode surface is limited 
hence the passing current observed on a given voltammogram will be low. At 
increasing scan rates, the measurements are recorded faster, thus the observed current 
will be higher. Alternative scan rates were used in this work in order to extensively 
analyse the reproducibility in the voltammetric measurements among the project 
specific microelectrodes. The chosen potential range was from -200 mV to 600 mV. 
Where the format used was that of dual electrodes (e.g. P4 and P5), the second 
electrode was connected as a counter. A typical voltammetric sweep is depicted in 
figure 4.10.
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Figure 4.10: Cyclic sweep between -0.2 and 0.6 V for a bare P4 electrode in FCA at 50 
mV s-1.
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The voltammogram in figure 4.10 displays a cyclic sweep of 1 mM FCA between the 
potential range of -0.2 V and 0.6 V at a scan rate of 50 mV/s. The two expected peaks 
occur during the anodic scan at 274 mV with an observed current of 5.82 μA and for 
the cathodic scan at 148 mV with an observed current of 4 μA. The distance between 
the peaks is 126 mV, more than double of the 59 mV typically expected peak 
separation distance. Additionally, while well defined, the peaks were not similar in 
magnitude to each other suggesting either the existence of a non completely reversible 
redox reaction or a disturbance during the scans. In order to sufficiently test the 
reason for this, the potential range for the cyclic sweep was increased between -1 V 
and 1 V as seen in figure 4.11.
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Figure 4.11: Cyclic sweep between -1 V and 1 V for a bare P4 gold electrode in plain 
PBS at 50 mV s-1.
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Fresh solutions were prepared while the electrodes were only interrogated by 
voltammetric scans in plain PBS buffer. The absence of a redox couple allowed 
measurements to be made purely on the characteristics of the electrode itself. The 
voltammogram in figure 4.11 displays one cycle of a cyclic sweep on a bare gold 
electrode (P3 and P4) between -1000 mV and 1000 mV. The cathodic peak occurs at 
375 mV with an observed current of 3.09 μA. The appearance of a reduction peak 
under these conditions leads to the conclusion that a pollutant may be present in either
the solution used or the electrode materials that interferes with the normal 
oxidation/reduction behaviour of FCA. The P3 and P4 electrodes were subsequently 
sent to the manufacturer for testing and re-evaluation while our work continued with 
voltammetric testing of gold and platinum P5 and P10 electrodes. These findings were 
then compared to the screen-printed carbon three electrode system described by Law 
& Higson (2005). As expected due to the absence of analyte, the normal oxidation-
reduction peaks were not observed while the extra reduction peak was still present 
when using the P4 electrodes. 
In subsequent experiments, the scan rate of voltammetric sweeps was varied between 
10 mV s-1, 25 mV s-1 and 50 mV s-1. The scan rate affects the shape of a resulting 
voltammogram due to the presence of the diffusion layer. At a slow scan rate, the 
diffusion layer grows by a substantial amount, hence the current observed within a 
given voltammogram will be low. At increasing scan rates, the measurements are 
recorded faster, thus the observed current will be higher. Alternative scan rates were 
used in this work in order to extensively analyse the reproducibility in the 
voltammetric measurements among the project specific microelectrodes. The chosen 
potential range was from -200 mV to 600 mV. Two characteristic voltammogram of 
the obtained results can be seen in figure 4.12.
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Figure 4.12: Cyclic sweeps between -0.2 V and 0.6 V in 1mM FCA for P10 Au electrodes 
at different scan rates. E1: 50 mV/s, E2 25 mV/s and E3 10 mV/s.
It was found that all gold electrodes (P3, P4, P5 and P10) displayed highly 
irreproducible behaviour from one another. Irreproducibility was found for the 
platinum electrodes; however, it was not as high as that found for the gold electrodes. 
P5 (intedigitated) and P10 (microarrays) should be expected to behave like 
microelectrodes due to their design. While typical microelectrode voltammograms 
were obtained for some gold and most platinum electrodes, the irreproducibility of 
these voltammograms still was very significant. Cyclic voltammetry is typically not as 
sensitive a technique as ac impedance. It was expected that small differences between 
electrodes during cyclic voltammetry would be extremely pronounced if impedimetric 
experiments were to take place. Figures 4.13 and 4.14 display cyclic voltammograms 
E3
E2
E1
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from P5 gold and platinum electrodes respectively, in 1 mM FCA at a scan rate of 10 
mV s-1. 
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Figure 4.13: Cyclic sweeps between -0.2 V and 0.6 V in 1 mM FCA for 4 different P5 Au 
electrodes at 10mV s-1.
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Figure 4.14: Cyclic sweeps between -0.2 V and 0.6 V in 1 mM FCA for 4 different P5 Pt 
electrodes at 10mV s-1.
4.6 Screen printed carbon electrodes
Due to the unexpected and irreproducible behaviour of the gold and platinum 
electrodes, it was decided to select alternative designs of electrodes for subsequent 
impedimetric sensor fabrication. Within our group two sensor formats have been 
extensively used and characterised as described by Barton et al., (2004) and Law & 
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Higson (2005). The screen printed carbon sensors described by Barton et al., (2004) 
were chosen in this context for all subsequent work within this project. The authors 
report that the reproducibility of the sensors after extensive trails was found to be 5% 
variability. Figure 4.15 depicts the electrodeposition of aniline on a planar carbon 
electrode of this type.
No peaks appear during the first cyclic sweep while current peaks start to appear 
between -200 and +350 mV vs Ag/AgCl, indicating the reduction/oxidation of surface 
bound polyaniline. The first of these peaks appears at 212 mV vs Ag/AgCl with a 
current reaching 110 μA, while the second peak appears at -39 mV and reaches 103 
μA. As already discussed, conductivity increases from each subsequent scan due to 
the increasing thickness of polyaniline on the electrode surface. 
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Figure 4.15: Polyaniline electrodeposition (-0.2 to 0.8 V) on a screen printed carbon 
electrode 1, 10 and 20 cycles shown.
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4.7 AC impedance
Impedimetric experiments using the project specific electrodes were carried out to 
confirm the findings being achieved via cyclic voltammetry. Impedance changes are 
measured in ohms (Ω). While performing impedimetric experiments on bare 
electrodes, great discrepancies were observed among them with impedance values 
displaying differences as high as 700 Ω from one electrode to the other. The changes 
in percentage impedance response from baseline that occur due to antibody binding 
are normally low (results shown in the following chapters). It is clear in this context 
that using different sensors (replicates) would result in differences rising due to sensor 
irreproducibility, rather than antigen-antibody binding and thus any results using these 
electrode templates could not be considered to be valid. For this reason the project 
specific electrodes were not used further during this research programme but instead 
in-house carbon screen printed electrodes (Microarray Ltd, Manchester, UK) were 
used in addition to a commercial screen-printed carbon three electrode format (WE-
REF-CE).
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Chapter 5
Development of immunosensors for the 
detection of Ciprofloxacin
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5.1 Development of immunosensors for the detection of Ciprofloxacin using 
non-highly concentrated and non-purified antigen
Introduction
Ciprofloxacin belongs to a group of antibiotics known as the fluoroquinolones as 
stated earlier. Due to problems arising from antibiotic resistance, the EU has 
established guidelines regarding the use of such substances by humans and for 
animals (Bishai, 2002; Bogialli et al., 2008). AC impedance analysis is a promising 
tool for the detection of anti-fluoroquinolones in food products (Mello & Kubota 
2002). 
Quinolones are a group of antibiotics with great antibacterial activity and broad 
spectrum of action but are also associated with the emergence of bacterial resistance 
and some adverse biological effects that in some cases have been severe (Blondeau, 
2004). Nalidixic acid, the first quinolone to be described, was produced by the 
modification of a compound isolated during the production of chloroquinolone in 
1962 (Pinachoa et al., 2008). Quinolones onstitute a relatively new class of antibiotics 
and are synthesised from a 3-quinolone carboxylic acid. They have a broad 
antibacterial spectrum against both gram negative and gram positive bacteria. Their 
mode of action is based on the inhibition of DNA gyrase and DNA topoisomerase, 
both of which are involved in DNA replication, recombination, decatenation and 
repair. Some quinolones, such as danofloxacin and enrofloxacin were specifically 
developed for the treatment of enteric and respiratory infections in cattle (Bogialli et 
al., 2008). Due to limited activity and early development of bacterial resistance to 
quinolones a new group of antibiotics was developed by the addition of a fluorine in 
carbon six position (C6) to the initial quinolone structure. Fluoroquinolones have been 
seen to have excellent tissue penetration as well as strong interactions with outer 
membrane protein.
The first fluoroquinolone to be approved for clinical medicine was ciprofloxacin in 
the mid 1980s. In general quinolones can be classified into three generations. The first 
generation includes nalidixic acid and oxolimic acid alongside others, which have 
been found to have limited activity against E. coli and other gram negative bacteria. 
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Additionally, they display poor oral bioavailability and limited distribution into 
systemic tissues. The second generation fluoroquinolones includes ciprofloxacin and 
danofloxacin. These compounds, developed in the 1980s, displayed increased activity 
against gram negative Enterobacteriaceae as well as some activity against gram 
positive bacteria such as P. aeruginosa. They further displayed improved oral 
bioavailablility. The third generation quinolones displayed similar activity to second 
generation drugs but showed enchanced antibactiral activity against gram positive 
bacteria. They also displayed better oral bioavailability alongside lower toxicity and 
longer serum half-life (Martinez et al., 2006; Ball, 2000).
A continuous effort for the development of novel fluoroquinolones has resulted in the 
discovery of many new compounds some of which complete their clinical trials in 
2010. This initiative for novel antibiotic development results mainly from the rapid 
emergence of bacterial resistance. Specifically in the case of fluoroquinolones, with 
concentration dependant antibacterial activity, emergence of bacterial resistance is 
mostly associated with suboptimal dosing.
Falagas et al., (2007), examine literature reports regarding the dosage to humans of 
various fluoroquinolone antibiotics. They aim to determine, in their review, the 
effectivity and safety of low versus high daily dosages. Safety is an important matter 
in the case of any drug. Fluroquinolones display somewhat high toxicity with adverse 
effects that range from moderate to extremely severe. Phototoxicity for example, 
results from the additional fluorine in lonefloxacin and chlorine in clinafloxacin. 
Adverse effects in the central nervous system have been associated with the 
unsubstituted 7-piperazine derivatives. More severe reactions include haemolytic 
ureamic syndrome associated with temafloxacin and unpredictable hepatic reactions 
resulting from the use of trovafloxacin. Trovafloxacin has been withdrawn from the 
market and banned from use for this very reason.
Ciprofloxacin has a broad spectrum of activity against particularly gram negative and 
some gram positive bacteria. It has been extensively used for the treatment of urinary 
and respiratory tract infections for decades, however, there have been reports of 
failure when used for the treatment of pneumonococal infections. Ball, 2000 reports 
that gemifloxacin appears to be the most effective compound for use against S. 
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pneumoniae infections also showing the least potent adverse biological reactions. 
Hartmann et al., (1999) studied the concentration of ciprofloxacin in hospital 
wastewaters using high performance liquid chromatography (HPLC) and made 
correlations with DNA damaging effects. The levels of detected ciprofloxacin ranged 
from 0.7 ng- 124.5 ng ml-1 and genotoxicity was observed from levels as low as 5.2 
ng ml-1. The therapeutic range of ciprofloxacin lies between 0.57-2.3 μg ml-1 in serum 
and 1.26-4.03 μg ml-1 in tissue (Licitra et al., 1987). 
The importance of fluoroquinolones in the medical industry and the potent biological 
effects of some of these drugs on human health and environmental welfare have made 
it a necessity to develop methods for their fast detection and reliable determination of 
their concentration in e.g. in food products. Torriero et al., (2006) describe a 
horseradish peroxidise sensor for the detection of ciprofloxacin based on the 
inhibition of catechol oxidation, however, exisiting piperazine compounds may 
interfere with the detection process. 
In this chapter, the development of an impedimetric biosensor for ciprofloxacin is 
described. Screen printed carbon electrodes where coated with polyaniline and 
subsequently loaded with biotynilation reagent. By the exploitation of biotin-
neutraviding interactions, biotynilated antibodies were attached to the modified sensor 
surface and the resulting sensor interrogated through an impedance protocol after 
exposure to various concentrations of ciprofloxacin in PBS buffer 7.4, 10 mM 
Ferri/ferocyanide. Control sensors were also fabricated containing polyclonal IgG 
antibodies to account for non-specific interactions. Work on the development of 
ciprofloxacin sensors was undertaken with the collaboration of Mr. G. Tsekenis. 
Figure 5.1 below depicts the structure of ciprofloxacin.
Figure 5.1: Structure of ciprofloxacin.
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Results and discussion
The procedures described in chapter 3 were followed in this work for the fabrication 
of ciprofloxacin immunosensors using screen printed carbon electrodes. For this set of 
experiments the polyclonal IgG on each sensor surface was kept at a concentration of 
1 mg ml-1. The biotynilation procedure resulted in a significant loss of anti-
ciprofloxacin antibody thus the obtained concentration was 0.25 mg/ml. Additionally, 
no further purification or concentration steps were performed for this initial phase of 
sensor development. The consequences of this are discussed along with the 
interpretation and analysis of data. As supported by Tully et al., (2007), the 
polyclonal IgG response is expected to be much lower than the specific antibody 
responses, since a polyclonal immune response contains a plethora of antibodies 
targeted to various antigens, while the monoclonal antibodies target only one specific 
antigen.
Additional investigations were carried out to determine the optimum impedance 
conditions with regards to solution use and impedance parameters. During this work, 
the cell offset was set to -0.4 V, 0 V and +0.4 V and two different solutions were used 
for impedimetric measurements; a PBS buffer pH 7.4, and a 10 mM ferri/ferrocyanide 
PBS solution. Data interpretation indicated that the greatest result resolution was 
achieved at an offset of + 0.4 V and would be the best choice of offset potential for 
subsequent work. It was also observed that the presence of a redox couple for 
impedimetric measurements limits the imaginary component of impedance, while in 
plain PBS buffer, the Z” component normally dominates impedance. Previous work 
within our group (Grant et al., 2005) indicated that the Z’ component of impedance is 
far more reproducible for data interpretation. For this reason 10 mM ferri/ferrocyanide 
enriched PBS buffer (pH 7.4) was used in all subsequent work to a) minimise the 
capacitive effects, and, b) to enhance the resolution of results based on charge transfer 
effects, however, some experimentation using plain PBS buffer has also been 
undertaken for comparison of results.
The chosen concentration range (1-1000 ng ml-1) covered four orders of magnitude, 
thus providing basic information regarding sensor characteristics such as reusability 
(how many times the sensor can be reused for measurements) and detection (What is 
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the lowest and highest concentrations the sensor can effectively detect and quantify) 
limits. The chosen range was to be further extended in subsequent work. 
Unfortunately, as we will discuss in chapter 6, early sensor saturation resulted in non-
reliable measurements for the specific antibody loaded sensors. As reported by 
Defega & Kwak, (2008), while working with DNA based sensors, an equilibrium 
state is observed where no more hybridisation occurs. Similarly, saturation of 
antibody loaded sensors means that no more specific binding can occur on the sensor 
surface. 
Figure 5.2 is the Nyquist plot for the specific anti-fluoroquinolone antibody to varying 
concentrations of ciprofloxacin in PBS pH 7.4 in the presence of 10 mM 
ferri/ferrocyanide. It should be noted that impedance increases as the frequency 
decreases, with maximum impedance values being obtained at 1 Hz. An initial 
observation of this figure suggests sensor saturation upon addition of antigen at 1 µg 
ml-1. This can be deduced by a small drop in faradaic impedance from 500 ng ml-1 to 
1 µg ml-1. Another interesting observation is that the capacitive impedance at 20 ng 
ml-1 was higher than that observed for 50 ng ml-1. Aside from these two occasions for 
both the faradaic and imaginary component, impedance generally is seen to increase 
upon exposure to higher antigen concentrations as shown in figure 5.2. This increase 
is, however, relatively small, a fact which in combination with non-specific antibody 
responses indicates that these measurements could be not be relied upon. Upon 
saturation, any further changes in impedance are assumed to be caused due to non-
specific binding (antigen loosely absorbed on the sensor surface) and can thus, as 
already stated, be erroneous (Garifallou et al., 2007).
115
0
10000
20000
30000
40000
50000
60000
70000
80000
0 20000 40000 60000 80000 100000
Z' ( ohm.cm-1)
Z
'' 
(o
h
m
.c
m
-1
) 
 1
1
Baseline
1ng
5ng
10ng
20ng
50ng
500ng
1ug
Figure 5.2: Z'’ v Z', Nyquist plot. Impedance responses of anti-ciprofloxacin loaded 
carbon based sensors upon exposure to a range of ciprofloxacin concentrations (in PBS,
10 mM ferri/ferrocyanide).
As already stated, the polyclonal IgG concentration on the sensors was higher than the 
concentration of anti-ciprofloxacin. It was thus assumed that the ciprofloxacin sensors 
were becoming saturated due to a low antibody concentration on the surface. Sensor 
saturation renders the production of a calibration curve impossible not only due to non 
reliable measurements being made but also due to the variations among the 
interrogated sensors, which inevitably lead to increased standard errors. It was 
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assumed that after concentration and purification of the specific antibody, the
responses would become greater due to larger quantities of antigen being immobilised 
at the sensor surface. The concentration of anti-ciprofloxacin was increased from 0.25 
mg ml-1 to 1 mg ml-1. The following impedance plots provide details about the 
responses of IgG loaded sensors and a further insight into the differences between 
plain PBS buffer and a 10 mM ferri/ferocyanide solution for impedance interrogation.
Figures 5.3 and 5.4 depict the Nyquist plots (faradaic vs capacitive impedance 
components) for polyclonal IgG response to varying concentrations of ciprofloxacin, 
using ferri/ferocyanide (figure 5.3) and in plain PBS (figure 5.4). In the presence of a 
redox couple it can be seen that both the Z’ (real) and Z” (imaginary) components 
increase with increasing antigen concentrations (figure 5.2). Changes in the Z’ 
component of impedance indicate the occurrence of a charge-transfer mechanism on 
the electrode surface upon exposure to antigen, as suggested by Tully et al., (2007). 
Increased amounts of antigen result in an increase of both the capacitive and faradaic 
components. Contrary to observations for the specific sensors, the non specific loaded 
electrodes, do not show signs of saturation. The production of calibration curves for 
both specific and non specific response was required for direct comparison, and an 
explanation of how these calibration curves where produced is provided within this 
section.
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Figure 5.3: Z'’ v Z' - Nyquist plot. Impedance responses of polyclonal IgG loaded 
carbon based sensors upon exposure to various ciprofloxacin concentrations (in PBS, 10 
mM ferri/ferrocyanide).
As seen in figure 5.4, below, the use of plain PBS buffer results in an increase of the 
capacitive component of impedance upon antigen exposure while the faradaic 
component is seen to decrease with increasing concentrations. It is important to note 
that the presence of a redox couple such as ferri/ferrocyanide facilitates charge 
transfer and decreases the capacitive charging effects occurring on the electrode 
surface. As discussed earlier in this chapter, it is the faradaic events that are of interest 
in this work, thus, further work using plain PBS buffer were not undertaken.
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Figure 5.4: Z'’ v Z' - Nyquist plot. Impedance responses of polyclonal IgG loaded 
carbon based sensors upon exposure to various ciprofloxacin concentrations (in PBS).
The high impedance values obtained at 1 Hz (as discussed in section 3.8) allowed the 
creation of two calibration curves (figures 5.5 and 5.6 for specific and non-specific 
response respectively) for the range of concentrations that was investigated. The Z’ 
component values at 1 HZ upon antigen addition can be compared to the baseline 
response at 1 Hz thus showing the percentage increase in Z’ from baseline at various 
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concentrations.  This procedure is followed for both specific and non-specific sensor 
responses and subsequently the non-specific response is subtracted from the specific 
response. In this manner, any non-specific interactions that may be occurring on the 
monoclonal antibody loaded sensors can be accounted for. 
The above results were further analysed in order to produce percentage impedance 
change plots for both IgG and anti-cirpofloxacin sensors. The equations used for this 
analysis are shown below, where,
% Impedance change=   100*/ '0''0 ZZZ        Eq. 5.1
Z’0 is the baseline faradaic component of impedance at 1 Hz and Z
’ is the sample 
faradaic component of impedance at 1 Hz. 
As we will see later in this chapter, impedance may fall or rise with increasing antigen 
concentrations, and this depends on the antigen/antibody pair being used; this 
phenomenon will be discussed later. For this reason any values obtained by equation 
5.1 above are converted to absolute values for use in the calibration curve plots.
The standard errors (for three replicate sensors) are individually calculated for 
non-specific and specific responses using the standard deviation equation. However, 
in order to obtain standard errors for corrected calibration curves, a different approach 
is required. In these plots the values used for the ‘corrected impedance’ curve are the 
result of subtraction of non-specific responses from their respective specific responses 
as follows, where,
(% specific change at 1 ng ml-1)- (% non-specific response at 1ng ml-1)
=% corrected change       Eq. 5.2
For the calculation of standard errors for specific plots:
=SQRT [(STDev for specific change at 1ng ml-1)2+
( STDev for non-specific change at 1ng ml-1)2]       Eq. 5.3
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Figures 5.5 and 5.6 depict the change in impedance from baseline upon the addition of 
ciprofloxacin concentrations ranging from 1-1000 ng. A near linear correlation 
(R2=0.97) was found to exist between change in impedance and log10 ciprofloxacin 
concentration. It is obvious that the IgG response was much greater (6.57% change at 
1000 ng) than the specific response while the accounted errors where also much 
lower. A maximum 4.6% impedance change form baseline was observed, however, 
the extremely high standard errors clearly indicate that these results are not reliable. 
An additional trend can be seen in figure 5.5. A usual calibration curve would contain 
a linear phase within its curve, which reaches a plateau towards the higher end of 
concentrations, representing sensor saturation. Such behaviour was seen in subsequent 
work that was undertaken following this initial set of impedimetric experiments. In 
this case the IgG sensors were not saturated thus no plateau is visible. It is clear from 
these calibration profiles, that the fabricated immunosensors would not meet the 
requirements for use as a practical sensing device. 
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Figure 5.5: Calibration curve of per cent (%) impedance response against log10
ciprofloxacin concentrations (1 ng ml-1-1000 ng ml-1) for IgG doped polyaniline coated 
carbon electrodes at 1Hz (in 10 mM ferri/ferrocyanide).
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Figure 5.6: Calibration curve of per cent (%) impedance response against log10
ciprofloxacin concentrations (1 ng ml-1-1000 ng ml-1) for anti-ciprofloxacin doped 
polyaniline coated carbon electrodes at 1Hz (in 10 mM ferri/ferrocyanide).
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Figure 5.7 represents the corrected calibration curve which resulted following 
subtraction of the non-specific response from the specific response.
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Figure 5.7: Corrected calibration curve of per cent (%) impedance response against 
log10ciprofloxacin concentrations (1 ng ml
-1-1000 ng ml-1) for anti-ciprofloxacin doped 
polyaniline coated carbon electrodes at 1Hz (in 10 mM ferri/ferrocyanide).
Figure 5.8 below includes a typical Bode plot obtained for polyclonal IgG sensors at
various antigen concentrations in 10 mM ferri/ferrocyanide. 
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Figure 5.8: Bode plot- Z vs frequency. Total impedance response for polyaniline doped 
with IgG (non specific antibody) after exposure to various concentrations of 
ciprofloxacin (in 10 mM ferri/ferrocyanide).
Figure 5.9 is a variation of figure 5.8 focusing in the frequency range between 10Hz 
and 1Hz and a smaller spectrum of impedance values to allow for better resolution.
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Figure 5.9: Bode plot-total impedance vs frequency. Total impedance response for 
polyaniline doped with IgG (non specific antibody) after exposure to various 
concentrations of ciprofloxacin (in 10 mM ferri/ferrocyanide). Range of frequencies 
from 1Hz to 10Hz. 
Conclusions
One of the most important matters to consider by this set of experiments is that in 
general increasing antigen concentrations caused an increase in impedance. The 
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Nyquist plots (figures 5.3 and 5.4) show near semicircle curves corresponding to the 
occurring charge transfer mechanism. In this case the semicircle diameter increases 
upon material binding on the sensor surface, whether this material be antigen binding 
to antibody or target DNA being hybridised to the immobilised complementary 
sequence (Trully et al., 2007; Defega & Kwak, 2008). Partners within the ELISHA 
consortium (Ionesku et al., 2007) also report increasing impedance upon exposure to 
higher antigen concentrations, which this far, is in accordance with our results. 
Further work indicated that whether an impedance increase or decrease is observed 
(with exposure to various antigen concentrations) is determined by the nature of the 
antigen/antibody combination as well as any possible purification and concentration 
procedures. This subject will be covered within the following section.
Another important issue within these initial investigations have been the observations 
of rather large error bars arising from irreproducibility amongst replicate sensors 
during ac impedance testing. The procedures described within this work have been 
heavily manual from electrode coating with polymers to antigen addition for 
impedance testing in the final stages of each experiment. Naturally, extreme care has 
been taken to minimise possible human errors, however, further automation would 
ensure that his important factor were minimised even more. It should be noted here 
that human error was not the contributing factor for the observed error bars. Work 
carried out later (as shown in the following sections) indicated that using set 
concentrations of antibody for sensor immobilisation was vital for reproducibility 
among replicate sensors. Sensor saturation upon antigen addition was thought to be 
resulting in these large error bars and it was thus decided to try using antibody 
concentration post biotinylation of 1 mg ml-1. As will be seen, later within this 
chapter, when antibodies are used at this concentration, sensor saturation does not 
occur early during testing, and hence more extended ranges of antigen concentrations 
can be used.
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5.2 Development of immunosensors for the detection of Ciprofloxacin using 
purified and concentrated anti-Ciprofloxacin
Introduction
The experimental procedure described in section 5.1 was repeated using purified and 
concentrated anti-ciprofloxacin. The concentration of immobilised polyclonal and 
monoclonal antibodies on the sensor surface was 1 mg ml-1. Figures 5.10 and 5.11 are 
the average Nyquist and Bode plots from three replicate sensors with immobilised 
anti-fluoroquinolone when exposed to different concentrations of the antigen. 
Baseline impedance of these newly fabricated sensors, containing purified 
monoclonal antibody, was dramatically lower than the previously described sensors 
containing non-purified anti-fluoroquinolone. It is important here to note that while 
impedance was previously found to increase upon exposure to increasing 
concentrations of antigen; in this instance the obtained results indicated impedance 
decrease with increasing antigen concentrations.
Previous work within this group showed that the binding event for different 
antigen/antibody pairs may increase or decrease the impedance of the systems. It is 
argued here that this is the result of two competing processes; non-specific adsorption 
(non-purified antibody) leads to increases in impedance-especially in regards with the 
capacitive component of the system (Z”). Specific antigen/antibody binding in the 
case of ciprofloxacin leads to a lowering of impedance. Other work within our group 
has indicated that not all specific binding leads to impedance increase (Tsekenis et al.,
2008). Impedimetric interrogation of electrodes containing anti-myelin basic protein 
antibody displayed increases in impedance with increasing antigen concentrations. 
Impedance responses heavily depend upon the very nature of the antibody/antigen 
complex of choice. Myelin basic protein is a mixture of materials varying in 
molecular weights from 14-24 kDa. It is likely that this specific protein is insulating 
in nature thus causing impedance increase upon binding contrary to ciprofloxacin 
binding which causes impedance to decrease. We believe that all antibody/antigen 
pairs lead to impedance decrease, however, the larger antigens appear to have a 
competing insulating effect on the sensor, which in some instances, may be the 
dominant factor in impedance change.
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Upon the antibody/antigen binding event H2 bonds are formed which stabilise this 
interaction while the binding specificity between the two biomolecules is affected by 
some weak interactions such as van der Waals and electrostatic forces alongside 
hydrophobic interactions. Such events may also cause variation of impedimetric 
responses among different antibody antigen pairs. While the reasons underlying these 
two events cannot as yet be answered with certainty, this give may rise to new 
projects when this project has been completed and a prototype sensing device has 
been fully developed.
It should be noted that while the observed impedance changes may be positive or 
negative, the percentage impedance change from baseline values is always reported as 
absolute values allowing for comparison of different sets of sensors.
Results and Discussion
Figures 5.10 and 5.11 contain the Nyquist and Bode plots obtained for anti-
ciprofloxacin doped sensors upon exposure to ciprofloxacin and following impedance 
interrogation. A steady decrease is obvious in the real component of impedance with 
increasing antigen concentrations indicating that the binding event enhances charge 
transfer rather than hindering it. As seen by the Nyquist plot (figure 5.10), there is a 9 
kΩ (Z’ component) difference between the baseline response and the response at 
antigen concentration of 10 μg ml-1 at 1 Hz (real component). Impedance changes are 
higher in the lower range of concentrations but decreases, however, at much higher 
antigen concentrations, indicating sensor saturation. Degefa & Kwak, (2008), report 
that their DNA based sensors reached ‘hybridisation equilibrium’ after 1 hour and 
resulting in a plateau value for any further impedance measurements, which is in 
accordance with the data obtained here. As discussed in section 5.1 the Z’ component 
was found to be far more reliable, as evidenced by the magnitutde of error bars, than 
the Z’’ and this is obvious in the present work. The observed impedance changes 
suggest that the real component of impedance is the main contributor to total 
impedance and hence the values obtained at 1 Hz will be further used for the 
production of a calibration curve. While there is a constant increase of the real 
component of impedance, the imaginery component reaches its maximum value at a 
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midrange frequency (normally below 100 Hz) and then displays a drop with a 
minimum value at 1 Hz. As suggested by Barton et al., (2009) this type of impedance 
spectrum indicates a surface-modified electrode system for which the electron transfer 
is slow and impedance is controlled by the interfacial electron transfer. 
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Figure 5.10: Z'’ v Z' - Nyquist plot. Impedance responses of anti-ciprofloxacin loaded 
carbon based sensors upon exposure to various ciprofloxacin concentrations 1ng ml-1 to 
10µg ml-1 (in PBS, 10 mM ferri/ferrocyanide).
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A Bode plot was also recorded depicting the total impedance change against log10 of 
the frequency range. Observation of the bode plot in figure 5.11 indicates the presence 
of faradaic charge transfer (Zf) in the range of frequencies between1 Hz- 1.5 Hz while 
the double layer capacitance (Cdl) dominates impedance above 1.5 Hz and up to 1 
kHz. The electrolyte resistance (Re) dominates the interrogation above 1 kHz. 
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Figure 5.11: Bode plot. Impedance responses of anti-ciprofloxacin loaded carbon based 
sensors upon exposure to various ciprofloxacin concentrations (in PBS, 10 mM 
ferri/ferrocyanide).
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Figures 5.12, 5.13 and 5.14 respectively depict the percent impedance change from 
baseline for specific and non specific sensors and finally a calibration profile for the 
newly fabricated anti-ciprofloxacin biosensors.  It can be seen that the specific 
responses were much greater than non–specific responses and also displayed little 
variation among the 3 replicate sensors. As depicted in figure 5.14 there was a 57% 
increase in impedance from baseline at the highest antigen concentration of 10ug ml-1.
It is further apparent that the specific sensors started saturating towards the higher end 
of concentrations thus a plateau is becoming visible towards higher concentrations in 
this plot. The highest response observed for non-specific sensors was approximately 
8% change from baseline while higher variation was also observed among the three 
non-specific replicates. 
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Figure 5.12: Calibration curve of per cent (%) impedance response against log10
ciprofloxacin concentrations (1 ng ml-1 to 10000 ng ml-1) for anti-ciprofloxacin doped
polyaniline coated carbon electrodes at 1Hz (in 10 mM ferri/ferrocyanide).
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Figure 5.13: Calibration curve of per cent (%) impedance response against log10
ciprofloxacin concentrations (1 ng ml-1 to 10000 ng ml-1) for polyclonal IgG doped 
polyaniline coated carbon electrodes at 1Hz (in 10 mM ferri/ferrocyanide).
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As depicted in figure 5.14 the responses between 1-100 ng ml-1 show a constant 
increase in impedance change while a plateau is reached upon subsequent 
measurements at higher antigen concentrations. 
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Figure 5.14: Corrected calibration curve of per cent (%) impedance response against 
log10 ciprofloxacin concentrations (1 ng ml
-1 to 10000 ng ml-1) for anti-ciprofloxacin 
doped polyaniline coated carbon electrodes at 1Hz (in 10 mM ferri/ferrocyanide).
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The Pearson correlation coefficient, R2=0.94, demonstrated a near linear correlation 
for the log10 concentration range from 1 to 100 ng ml
-1 (Figure 5.15) after subtraction 
of the non-specific response which constituted a minor percentage of the impedance 
changes recorded.
R2 = 0.9417
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Figure 5.15: Corrected calibration curve of per cent (%) impedance response against 
log10 ciprofloxacin concentration for anti-ciprofloxacin doped polyaniline coated carbon 
electrodes at 1Hz (in 10 mM ferri/ferrocyanide). 1-100 ng ml-1 concentration range.
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Conclusions
The development of an immunosensor targeted towards ciprofloxacin detection was 
described here. The observed impedance changes indicated that the sensor has an 
approximate detection limit of 1 ng ml-1 and can detect various concentrations of 
ciprofloxacin up to 10ug ml-1. Sensor responses to antigen exposure were found to be 
concentration dependant with a linear correlation at least over the lower concentration 
range between 1-100ng ml-1. It should be noted that the same three replicates were 
interrogated for each of the antigen concentrations appearing in the figures discussed. 
We have not to date attempted to refresh the sensors by removing the bound antigen 
via chemical or other procedures. 
It is possible that if the binding reaction could be reversed, the linear correlation range 
for impedance response and antigen concentration could be extended further to higher 
concentrations. Nevertheless, the analysed data indicate the fabrication of a successful 
sensor for the detection of ciprofloxacin in PBS, 10 mM ferri/ferocyanide solution 
that may form the basis for a commercial device. Published work from impedance 
interrogation of ciprofloxacin sensors using PBS buffer can be found in appendix I 
(Garifallou et al., 2007).
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5.3 Development of immunosensors for Ciprofloxacin detection in milk
Introduction
In the previous section (section 5.2) the development of a biosensor for ciprofloxacin 
detection in PBS, 10 mM ferri/ferocyanide solution was described. Practical uses of 
the sensor e.g. in real samples such as milk and food products, had not at the time 
been investigated by our group. For the device developed to be of any practical value 
further investigations were required using this time a consumable food product. It was 
therefore decided to attempt to detect ciprofloxacin at various concentrations in milk. 
The maximum allowed concentration of ciprofloxacin or enrofloxacin in milk 
products has been limited to no more than 100 ng ml-1 by the European Union. 
Other groups have reported the use of liquid chromatography based methods for the 
detection of fluoroquinolones in milk (Hassouan et al., 2007; Rodriguez-Diaz et al., 
2006). In both works the authors report that the developed immunoassays have a 
detection limit of 3 ng ml-1. The assay described by Rodriguez-Diaz et al., (2006)
employed the use of luminescence detection with liquid chromatography, and it was 
reported to provide a linear range between 8ng and 3.5 μg ml-1. ELISA based assays 
for fluoroquinolone detection in milk have also been reported but their detection 
limits are in the range of several ng ml-1 (Bucknall et al., 2006; Duan & Yuan, 2001). 
Cao & Mirsky, (2008) described a DNA sensor coupled with a surface plasmon 
resonance technique that was reported to detect between 3-20 ug ml-1 enrofloxacin in 
milk. Ionescu et al., (2007) described a polypyrrole based sensor coupled with an AC 
impedimetric capable of detecting as low as 10 pg ml-1 ciprofloxacin in milk. In this 
work the lower limit for interrogations was 0.1 ng ml-1. We have previously showed 
that our sensors can detect ciprofloxacin in PBS at concentrations of 1 ng ml-1 and 
hence we subsequently decided to attempt the detection of lower concentrations. 
Results and discussion
As can be observed in figures 5.16 and 5.17, the Nyquist and Bode plots respectively, 
a steady increase in impedance was shown with exposure to increasing antigen 
concentrations. The Nyquist plot presented in figure 5.16 displays the Z’ and Z’’ 
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components of impedance and in agreement with previous observations, Z’ is the 
main contributor to total impedance, and so further analysis will be undertaken using 
the real component rather than the imaginery component. The difference in 
impedance between baseline response and response for 10μg ml-1 ciprofloxacin is 
approximately 30 kΩ (Z’), indicating a rather high response hence adequate antigen 
detection. Interestingly, the increase in impedance was not in line with previously 
obtained data for ciprofloxacin in PBS pH 7.4, 10 mM ferri/ferocyanide solutions as 
described in section 5.2, where we discussed the possible reasons for impedance 
decrease with increasing antigen concentrations. The possible reasons for this are 
discussed later within this section. 
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Figure 5.16 Z’’ vs Z’ Nyquist plot. Impedance responses of anti-ciprofloxacin loaded 
carbon based sensors upon exposure to various ciprofloxacin concentrations 0.1ng ml-1
to 10000 ng ml-1 (in milk).
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Figure 5.17: Total impedance vs frequency, Bode plot. impedance responses of anti-
ciprofloxacin loaded carbon based sensors upon exposure to various ciprofloxacin
concentrations (in milk).
Figure 5.18 displays the calibration curve for anti-ciprofloxacin loaded sensors at 1 
Hz. As can be easily observed there was a 39% change in impedance from baseline 
upon exposure to 10 μg ml-1 ciprofloxacin. 
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Figure 5.18 Calibration curve of per cent (%) impedance response against log10
ciprofloxacin concentrations (0.1ng ml-1 to 10000 ng ml-1) for anti-ciprofloxacin doped 
polyaniline coated carbon electrodes at 1Hz (in milk).
Initially during this work, a set of polyclonal IgG sensors were fabricated to be used 
as controls similarly to previous work in this project. However, it was evident that the 
non-specific response in this case was not significantly lower than the specific 
response reaching a value 28% change to baseline upon exposure to the highest 
antigen concentration. Figure 5.19 depicts the calibration curve obtained for 
polyclonal IgG coated sensors. Milk is a complex matrix of various constituents 
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including proteins, salts and a plethora of other components. It is thus understood that 
polyclonal IgG is most likely to bind a large amount of these constituents, resulting in 
high impedance responses upon AC impedance interrogation. Interestingly, the IgG 
loaded sensors displayed impedance decrease upon exposure to milk. Milk is expected 
to contain a range of antigens that can be detected by antibodies present in the IgG 
mixture, and therefore, the high response observed for these control sensors was 
attributed to the nature of the matrix. Considering the complexity of milk as a sample, 
it is hard to make any conclusions regarding the reactions taking place on the 
polyclonal sensor surface and the obtained results from AC impedance interrogation 
at this stage. For this reason an alternative anti-PSA (since PSA is not found in milk) 
monoclonal antibody was chosen for the fabrication of new control sensors. As 
discussed in the materials and methods section, BSA was used to minimise all non-
specific binding, as a result the observed responses for the polyclonal sensors were 
indeed caused by the polyclonal antibodies binding a range of antigens found in milk. 
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Figure 5.19: Calibration curve of per cent (%) impedance response against 
log10ciprofloxacin concentrations (0.1ng ml
-1 to 10000 ng ml-1) for polyclonal IgG doped 
polyaniline coated carbon electrodes at 1Hz (in milk).
Figure 5.20 depicts the calibration curve obtained for anti-PSA based sensors when 
these were exposed to the chosen range of ciprofloxacin concentrations in milk. As 
expected, the non-specific responses obtained were a minimal fraction of the specific 
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responses reaching 11% change from baseline at 10 μg ml-1 ciprofloxacin. As 
previously, these were subtracted from their respective specific responses in order to 
produce a corrected calibration curve accounting for any non-specific interactions. 
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Figure 5.20: Calibration curve of per cent (%) impedance response against log10
ciprofloxacin concentrations (0.1ng ml-1 to 10000 ng ml-1) for anti-PSA doped polyaniline 
coated carbon electrodes at 1Hz (in milk).
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Figure 5.21 represents the corrected calibration curve obtained upon AC impedance 
interrogation for the chosen range of antigen concentrations. As previously, these 
values are those obtained from the real component of impedance at 1 Hz. 
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Figure 5.21: Corrected calibration curve of per cent (%) impedance response against 
log10 ciprofloxacin concentrations (0.1ng ml
-1 to 10000 ng ml-1) for anti-ciprofloxacin 
doped polyaniline coated carbon electrodes at 1Hz (in milk).
Figure 5.22 displays the corrected calibration curve for the range between 0.1-100 ng 
ml-1 ciprofloxacin concentrations. In accordance with previous work, there is a linear 
correlation between impedance increase and log10 antigen concentration in the lower 
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range of concentrations and up to 100 ng ml-1 (R2=0.95), whereas higher 
concentrations tend towards a plateau indicating sensor saturation.
R2 = 0.9545
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Figure 5.22: Corrected calibration curve of per cent (%) impedance response against 
log10 ciprofloxacin concentrations (0.1ng ml
-1 to 10000 ng ml-1) for anti-ciprofloxacin 
doped polyaniline coated carbon electrodes at 1Hz (in milk). 1-100 ng ml-1 concentration 
range.
The matter of increasing impedance upon exposure to antigen has been discussed 
earlier in this work in regards with non-specific adsorption and also the nature of 
some large molecular weight antigens. Ciprofloxacin is known to form chelation 
complexes with the calcium ions present in milk. These complexes give rise to 
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increasing impedance upon binding rather than decrease which has previously been 
described for ciprofloxacin samples in PBS buffer and a redox couple. Whether it is 
the chemical properties of chelation complexes or their size that causes increase in 
impedance is at this stage unknown.
Conclusions
Ciprofloxacin and other fluoroquinolone antibiotics are reported to form calcium 
chelate complexes in the presence of calcium ions. These complexes consist of two 
ciprofloxacin units attached to one calcium ion (Katz & Willner, 2003; Upadhyay et 
al., 2006). It was previously observed within our group that DNA based sensors give 
rise to such variations in impedance behaviour. Adsorption of complimentary DNA 
on the sensor surface led to impedance decrease while adsorption of non-
complimentary strands led to impedance increase (Davis et al., 2004; Davis et al., 
2007). It is, nevertheless, obvious that the fabricated immunosensors can detect 
ciprofloxacin in milk and PBS buffer and hence it is evident that the detection of both 
free and chelated ciprofloxacin is achievable. The obtained results also indicate that 
our sensors can differentiate between the free and complexed form of ciprofloxacin by 
means of impedance decrease or increase, respectively, upon exposure to antigen. The 
development of successful immunosensor for the detection of ciprofloxacin has been 
described. The fabricated sensors where to found to have detection limits between 0.1 
ng and 10 μg ml-1 upon interrogation by an AC impedance protocol.
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Chapter 6
Development of immunosensors for the 
detection of digoxin
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Introduction
Digitalis or as it is more widely known, Digoxin, is a plant extract from Digitalis 
lanata (Hollman, 1996). Digoxin is a purified cardiac glycoside used for the treatment 
of congestive heart failure and cardiac arythmia. It is often used for conditons such as 
atrial fibrillation, atrial flutter and also heart failure that cannot be controlled by any 
other medication. Therapeutic preparations based on Digoxin include Lanoxin, 
Digitek and Lanoxicaps.
The mode of action of digoxin is based on effects on both the heart directly and the 
parasynthetic nervous system. Any effects on the parasynthetic system are due to the 
regulation of plasma norepinephrine. The drug can block the antrioventricular node 
causing a reduced conduction velocity thus essentially decreasing electrical pulses 
followed by decreases in heart rate; therefore it is invaluable for conditions like 
arythmia (Chun & Chodosh, 2006; Dawson & Buckley, 2007). Its direct cardiac effect 
is the increase of the force of contraction via inhibition of the Na+/K+ ATPase 
dependant pump (sodium-potassium pump).This is a transmembrane protein that 
helps to maintain resting potential, mediates transport and regulates cellular volume. 
Digoxin can bind to the extracellularly located a-subunit of this protein on myocyte 
(heart) cells and compete with K+ ions. This binding effect results in the increase of 
Na+ ions in the cellular environment which leads to an increase in Ca2+ ions. The 
reason for this is that the activity of the Na+/Ca2+ pump is slowed down by increased 
levels of Na+. Eventually, these events lead to an increase in phases 4 and 0 of the 
cardiac action potential, which controls the function of the electrical conditions 
system in the heart. These effects alongside the parasynthetic nervous system effects 
lead to a decrease in heart rate. The increased amounts of Ca2+ are stored in the 
sarcoplasmic reticulum and released by each action potential resulting in increased 
contractivity of the heart (Goldstein et al., 2006; Chun and Chodosh, 2006). 
The adverse effects of digoxin are concentration dependant and normally occur when 
the serum concentration of the drug exceeds 0.8 ng ml-1. The therapeutic range of 
digoxin has been referred as between 0.8-2 ng ml-1 (Wang & Song, 2005), so adverse 
effects are inevitable in most cases. Several reports indicate that heart failure patients 
being treated with high concentrations show higher all-cause mortality rates than 
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patients being administered the drug at lower concentrations (Wang & Song, 2005). It 
is widely known, however, that anything surpassing 2 ng ml-1 leads to toxicity.  
Patients with low K+ levels often suffer adverse effects since, as discussed earlier in 
this section, digoxin competes with K+ for binding to Na+/K+ transmembrane protein.  
Some of these unwanted consequences of digoxin use include nausea, vomiting, 
diarrhea and other disturbances that can occur due to use of medication. Less frequent 
but more severe adverse effects include acute psychosis, delirium, amnesia and many 
more. Goldstein et al., (2006) report that Na+/K+ ATPase activity may be involved in 
the etiology of mental disorders. Consequently any medication that can affect the 
transmembrane protein function, such as digoxin, may also play a role in the 
development of depressive disorders.
Digoxin toxicity results from the paralysis of the sodium-potassium pump giving rise 
to a condition known as malignant hyperkalaemia. The most effective treatment 
requires the use of anti-digoxin antibodies for removal of the drug from the system. 
The severe adverse effects of digoxin present the necessity for reliable assays that can 
rapidly and effectively determine the serum concentrations of the drug. 
Results and discussion
We have previously described successful impedimetric based sensors for the detection 
of ciprofloxacin in PBS 7.4, 10 mM ferri/ferocyanide, and ciprofloxacin in milk as a 
real sample. The current work aims to develop biosensors for the detection of digoxin 
in PBS 7.4, 10 mM ferri/ferocyanide solution. The chosen concentration range reflects 
the range of clinical significance for digoxin. Due to anti-digoxin being supplied at 
low concentrations it was not possible to maintain the antibody concentration a 1mg 
ml-1 following the biotynilation procedure. The antibody was further purified and 
concentrated, however, the maximum concentration reached was 0.5 mg ml-1. The 
corresponding IgG loaded sensors were treated with 500 mg ml-1 IgG antibody in an 
attempt to maintain uniform sensor fabrication procedure.
Figures 6.1 and 6.2 contain the average Nyquist and Bode plots from 3 replica 
anti-digoxin loaded sensors and their responses upon antigen exposure and followed 
by AC impedance interrogation. As in earlier work the real component of impedance 
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was found to be the major contributor to total impedance. A 4.2kΩ change from 
baseline was observed following exposure to the highest concentration of digoxin at 
10 ng ml-1. As depicted in figure 6.1 the characteristic impedance semicircles were 
gradually decreasing when the sensors were exposed to higher antigen concentrations. 
This behaviour was also observed for anti-ciprofloxacin loaded sensors interrogated in 
PBS 7.4, 10 mM ferr/ferocyanide solution, supporting the assumption that specific 
binding or bare antigen results in impedance decrease rather than increase. As can be 
readily observed sensor saturation occurs at 2 ng ml-1 since impedance at this 
concentration appears to increase rather than decrease. 
It has already been discussed that upon saturation the sensors may provide erroneous 
results that are related to non-specific binding. The low concentration of anti-digoxin 
available for sensor fabrication explains early saturation. Data obtained for IgG 
control sensors support this assumption. It is apparent, that given higher 
concentrations of purified biotinylated antibody, the sensors would most likely not 
show early saturation signs.
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Figure 6.1 Z’ vs Z’’, Nyquist plot. Impedance responses of anti-digoxin loaded carbon 
based sensors upon exposure to various digoxin concentrations (in PBS, 10 mM 
ferri/ferocyanide).
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Figure 6.2 depicts the average Bode plot for the chosen concentration range of 
digoxin. In line with previous work, a drop in impedance is observed upon exposure 
to higher concentrations of antigen with the highest obtained impedance values obtain 
at 1 Hz. It can also be seen in the Bode plot that sensor saturation has occurred 
following addition of antigen at 2 ng ml-1, indicated by the fact that total impedance at 
this concentration of digoxin is slightly higher than the response obtained for 1.5 ng 
ml-1 but also very similar to the impedance obtained upon addition of digoxin at 10 ng 
ml-1.
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Figure 6.2Total impedance vs frequency, Bode plot. Impedance responses of anti-
digoxin loaded carbon based sensors upon exposure to various digoxin concentrations 
(in PBS, 10 mM ferri/ferocyanide).
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Figure 6.3 displays the calibration profile for ac impedimetric responses of 
anti-digoxin sensors at 1 Hz. A 24.16% increase is obvious at 1.5 ng ml-1 antigen with 
impedance change dropping again at the final concentration as already discussed, due 
to saturation. A near linear correlation to antigen concentrations is observed between 
1-1.5 ng ml-1 digoxin with the R2=0.96. Figure 6.4 displays the percent impedance
change upon digoxin exposure for the control sensor fabricated through the same 
procedures to specific sensors. Non-specific sensor saturation is extremely apparent. 
This can be explained by the low concentration of biotynilated antibody used to treat 
the sensor before interrogation with AC impedance. High variation is also observed 
among the IgG replicas indicating that these standard errors will dominate the 
corrected calibration curve.
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Figure 6.3: Calibration curve of per cent (%) impedance response against log10 digoxin 
concentrations (0.1 ng ml-1 to 10 ng ml-1) for anti-digoxin doped polyaniline coated 
carbon electrodes at 1Hz (in PBS, 10 mM ferri/ferrocyanide).
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Figure 6.4: Calibration curve of per cent (%) impedance response against log10 digoxin 
concentrations (0.1 ng ml-1 to 10 ng ml-1) for polyclonal IgG doped polyaniline coated 
carbon electrodes at 1Hz (in PBS, 10 mM ferri/ferrocyanide).
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Figure 6.5 contains the corrected calibration curve for digoxin over the chosen range 
of concentrations. The response as already discussed is largely affected by the high 
variation observed among IgG sensors due to immediate saturation. 
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Figure 6.5 Corrected calibration curve of per cent (%) impedance change against 
digoxin concentrations (0.1 ng ml-1 to 10 ng ml-1) for anti-ciprofloxacin doped 
polyaniline coated carbon electrodes at 1Hz (in PBS, 10 mM ferri/ferrocyanide).
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As shown in figure 6.6 the linear correlation to log10 concentration of antigen for the 
corrected calibration curve between 1-1.5 ng ml-1 is R2=0.89.
R2 = 0.8867
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Figure 6.6 Corrected calibration curve of per cent (%) impedance change against log10
digoxin concentrations (0.1 ng ml-1 to 10 ng ml-1) for anti-ciprofloxacin doped 
polyaniline coated carbon electrodes at 1Hz (in PBS, 10 mM ferri/ferrocyanide). 1-1.5 ng 
ml-1 digoxin concentrations.
Conclusions
It is clear that given a higher concentration of purified anti-digoxin, saturation would 
not be observed so early and a more extended range would be achieved. The 
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polyclonal IgG response might also display lower variability hence allowing for the 
production of a calibration curve with smaller error bars that could have been taken as 
being more reliable. The low molecular weight of digoxin indeed makes it a hard to 
detect molecule so the observed data, while, indicating early sensor saturation still 
prove that the developed immunosensors can detect even minute molecules and hence 
prove the selectivity of the proposed system.
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Chapter 7
Development of immunosensors for the 
detection of Green fluorescent
protein
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Introduction
The green fluorescent protein was isolated from the jellyfish Aequorea victoria. It is a 
large protein with a molecular weight of 26.9 kDa, comprised of 238 amino acids and 
upon exposure to blue light fluoresces green. The mechanism responsible for 
conversion from blue light to green involves the Ca2+ sensitive photoprotein, 
aequorine. According to Errampalli et al., (1999) the active chromophore is a 
tripeptide that maturates in the presence of oxygen. In 1992, molecular biology based 
techniques were used for the development of a GFP-based reporter system displaying 
visible fluorescence (Errampalli et al., 1999). Wild type GFP absorbs light at 395 nm 
and emits green light at 510 nm in both bioluminescent organisms or in a purified 
form present in solution. Cloned GFP cDNA from A. Victoria was successfully 
obtained in 1992 while the cloned gene was further introduced in oprganisms like 
Drosophila and E. coli and shown to cause fluorescence. The GFP gene can be 
introduced into intact cells or cell organells and be exploited as a reported gene for 
gene expression and protein localisation. 
As a reporter protein, GFP is harmless to the host cells or organisms and can thus be 
used for in vivo as well as in vitro monitoring. Detection is simply based on exposure 
to blue or ultraviolet light and the addition of either substrates or complex culture 
media is not required. GFP based detection and monitoring systems are characterised 
by low equipment cost. In contrast, other alternatives such as the luxAB gene, require 
aldehyde substrates for visualisation to be possible. GFP is characterised by high 
stability to temperature (65oC), pH (6-12) and a range of denaturants. 
Errampalli et al., (1999) report that molecules produced from a single copy of wild 
type GFP present in the bacterial chromosome did not fluoresce enough to allow 
detection by fluorescence microscopy. Other workers have reported that a minimum 
of 10,000 wild type GFP molecules in tissue culture cells were required for 
microscopy based detection. Fortunately, a mutant GFP strain was isolated, 
Psedomonas putida, which displayed higher solubility and cytoplasmic distribution 
alongside more fluorescence, thus allowing single cell detection in situ (Errampalli et 
al., 1999; Eberl et al., 1997).
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GFP mutants have been developed that emit blue, red and yellow light, each at 
different excitation and emission wavelengths. These mutants have made it possible to 
detect and simultaneously monitor a number of bacterial species co-existing in the 
same environment. Quantitative studies carried out by Patterson et al., (1997), showed 
that no single GFP variant is well suited for all applications, but rather, each has 
specific advantages and disadvantages over the others, and thus the appropriate 
protein can be chosen depending upon the specific application objectives.
GFP is currently used to monitor a variety of environmental and ecological processes. 
It is used for monitoring of genetically modified organisms introduced into the 
environment, plant-microbial interactions, biofilm studies and biodegradation 
monitoring. Similarly, GFP has found use in the sensing industry. Errampalli et al., 
(1999), discuss the development of bioluminescence based sensors based on the 
reduction of light emission in the presence of pollutants that are toxic to bacterial 
cells. One aspect considered by the authors, is that GFP fluorescence is not dependent 
on cellular metabolic activity, thus toxicity assessment may not be reliable. 
Nevertheless, the protein has been invaluable to science as observed by the vast 
number of scientific works employing its use.
Results and discussion
In this work, we aim to develop biosensors for the detection and quantification of 
GFP. As discussed in previous sections of this report, successful sensors for 
ciprofloxacin, digoxin and myelin basic protein have been developed by our group. 
The same approaches were used for the fabrication of anti-GFP based sensors in the 
current work. Following biotynilation, the antibody sample required concentration 
and removal of sodium azide. This was carried out as described in the materials and 
methods section. The achieved concentration was 0.3 mg ml-1. Previous works has 
shown that low antibody concentrations have detrimental effects in the detection 
range of the sensors, simply due to saturation. Sensors loaded with polyclonal IgG are 
always matched to specific sensors with regards to the concentration of immobilised 
antibodies. The problem therein is that IgG loaded sensors become saturated much 
faster than the specific sensors. This has been shown to result in high variation among 
the polyclonal IgG loaded replicas, which subsequently affects the variation observed 
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in the corrected response. For this reason, and since there is no range of clinical 
significance for GFP, it was decided to initiate measurements from an antigen 
concentration of 0.1 ng ml-1 and increase the concentration by steps of one order of 
magnitude until saturation signs were observed. The anti-GFP obtained and used for 
this work was derived from mouse myeloma cells and the murine polyclonal IgG was 
used for the control sensors. The GFP protein used for this work was of the wild type 
and produced in E. coli. The final aim of this work was to visualise the immobilised 
protein on the sensor surface using fluorescence microscopy, however, no 
fluorescence was observed upon microscopic examination. The possible reasons for 
this are discussed in the end of this chapter.
Figures 7.1 and 7.2 represent the data obtained for anti-GFP loaded sensors upon 
antigen exposure at a range of GFP concentrations and subsequent impedance 
interrogation. As can be seen in figure 7.1, a characteristic semicircle region occurs 
for each of the chosen concentrations indicating the charge transfer process. Gradual 
increases in impedance are obvious upon addition of higher antigen concentrations. 
This was not in accordance with previously obtained data for ciprofloxacin and 
digoxin, where, addition of antigen on specific sensors resulted in impedance drop 
rather than increase. As discussed earlier, each antibody/antigen pair behaves 
differently and the nature of the complex heavily affects the resulting impedance 
changes. It was shown in previous work on myelin basic protein (Tsekenis et al.,
2008) that addition of MBP on specific sensors also resulted in impedance increases. 
Similarly to MBP, GFP is a rather large protein with a molecular weight of 16.9 kDa. 
Ciprofloxacin and digoxin both have extremely lower molecular weights compared to 
MBP and GFP, and have both caused impedance decrease upon addition to specific 
antibody loaded sensors. The results from all previous work and current work suggest 
that the molecular weight of the antigen may play a role in the resulting impedance of 
the system. It can be assumed that large molecules generally cause impedance 
increases while smaller molecules cause impedance decrease upon binding to their 
respective specific antibodies. Further work would be required to support or reject this 
theory, however, the results obtained within our work and the limited knowledge of 
the impedance mechanism itself are only enough to note the occurring phenomenon, 
but cannot to date, explain it in more depth.
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It is clear in figures 7.1 and 7.2, that no saturation of the sensors occurred even at the 
highest concentration of the chosen range since a rather large change in impedance 
was observed upon addition of GFP at 100 ng ml-1. A change above 7 kΩ from 
baseline was observed upon addition of 100 ng ml-1 GFP as shown by the real 
component of impedance. Similarly to previous work, the real component was 
preferred for the production of calibration curves as it is again the major contributor 
of impedance in the observed system. The occurring changes in total impedance can 
be viewed in figure 4.40 which depicts the Bode plot for the specific antibody loaded 
sensors. An approximate 7 kΩ change from baseline was observed in total impedance 
upon addition of GFP at 100 ng ml-1. The range tested for this set of sensors was 
between 0.1-100 ng ml-1 GFP. This can be accounted for by an early saturation of the 
non-specific sensors. As discussed earlier, saturation of the polyclonal antibody 
loaded sensors results in high variation which eventually has a detrimental effect on 
the corrected calibration curve. Due to time limitations and unavailability of more 
concentrated antibodies at the time, this work was not repeated for a more extensive 
GFP concentration range, however, it is obvious from these results that the detection 
range for GFP could be extended to lower as well as higher limits.
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Figure 7.1 Z’’ vs Z’, Nyquist plot. Impedance responses of anti-GFP loaded carbon 
based sensors upon exposure to various GFP concentrations (in PBS, 10 mM 
ferri/ferocyanide).
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Total impedance is seen to reach a maximum value above 1 Hz and is then slightly 
decreased at 1 Hz. This was also obvious from the Nyquist plot (figure 7.1) above. 
We have in previous work shown that the imaginary component reaches a maximum 
value before 1 Hz and then displays a rather large decrease at 1 Hz. However, 
decreases in the real component have not been observed before. It is therefore 
assumed that the characteristic Nyquist and Bode plot curves can very in shape 
depending upon the various antigen/ antibody pairs undergoing interrogation via AC 
impedance. Careful examination of the obtained data indicated that the maximum 
values for both components for each antigen concentration occur at slightly different 
frequencies. Therefore, the use of values obtained from the Z’ component at 1 Hz 
were once more chosen for the production of calibration curves.
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Figure 7.2 Total impedance vs frequency, Bode plot. Impedance responses of anti-GFP
loaded carbon based sensors upon exposure to various GFP concentrations (in PBS, 10 
mM ferri/ferrocyanide).
Figures 7.3, 7.4 and 7.5 contain the calibration curve for anti-GFP loaded sensors, 
calibration curve for polyclonal IgG loaded sensors and the corrected calibration 
curve for anti-GFP based sensors respectively. It is readily seen by the obtained 
calibration profile in figure 7.3 that the obtained responses where very high ranging 
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from 111% to 418% change from baseline over the chosen range of GFP 
concentrations. Relatively high responses were also obtained by the polyclonal IgG 
loaded sensors but these were not as high as those obtained for the specific antibody 
interrogations (figure 7.4). It should further be noted that the variation observed 
among the three specific replicas was not as high as the variation among IgG loaded 
sensors. High standard errors are thought to occur due to sensor saturation as 
discussed earlier in this work. Since the IgG standard errors can compromise the 
corrected calibration curve it was thought best to not extend the concentration range 
of GFP in order to provide a more reliable calibration plot. Obtaining highly 
concentrated monoclonal anti-GFP would permit the use of a more extended range of 
GFP concentrations.
The reasons for these rather different responses of the fabricated anti-GFP sensors are 
thought to be related to the antibody/antigen pair used. Sensor fabrication still remains 
a non-automated procedure. The anti-GFP antibody used here was a purified 
monoclonal antibody with high affinity for GFP fusion proteins as described by the 
manufacturer. The chosen antigen was a wild type full length GFP protein with a 
histidine tag. Considering the fact that these products were chosen to provide the best 
possible results, the high impedance responses could be expected. The antigen size, 
however, seems to also have an effect in the responses in regards to magnitude. This 
was assumed due to the high percentage changes form baseline observed for non-
specific sensors. As discussed earlier, the impedance mechanism is not to date well 
understood and the current work is not focused towards collecting background 
information for the occurring reactions but rather proving that these phenomena can 
be used for the development of commercially successful sensors.
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Figure 7.3: Calibration curve of per cent (%) impedance response against GFP 
concentrations (0.1ng ml-1 to 100 ng ml-1) for anti-GFP doped polyaniline coated carbon 
electrodes at 1Hz (in PBS, 10 mM ferri/ferrocyanide).
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Figure 7.4: Calibration curve of per cent (%) impedance response against GFP 
concentrations (0.1ng ml-1 to 100 ng ml-1) for polyclonal IgG doped polyaniline coated 
carbon electrodes at 1Hz (in PBS, 10 mM ferri/ferrocyanide).
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As observed in figure 7.5 the obtained corrected calibration curve for anti-GFP based 
sensors displays high impedance responses with almost linear correlation (R2=0.99) to 
the log10 antigen concentration over the chosen concentration range (100 pg ml
-1 to 
100 ng ml-1). Even after subtraction of the non specific responses the corrected 
responses remained extremely high reaching 312% change from baseline for 100ng 
ml-1 GFP. The observed variation for the corrected responses was found to be 
relatively low, especially considering the high standard errors obtained from non-
specific sensors. 
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R2 = 0.9946
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Figure 7.5: Corrected calibration curve of per cent (%) impedance response against 
GFP concentrations (0.1ng ml-1 to 100 ng ml-1) for anti-GFP doped polyaniline coated 
carbon electrodes at 1Hz (in PBS, 10 mM ferri/ferrocyanide).
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Conclusions
Within this work, the development of a successful immunosensor for detection of 
wild type GFP is reported. The fabricated sensors displayed high responses upon 
antigen addition at various concentrations, with little variation, and an achieved 
detection limit of 100 pg ml-1. It is assumed, that given higher concentrations of 
specific antibody, this range could be extended to lower as well as higher antigen 
concentrations.
The initial experimentation plan for this work also involved the use of fluorescent 
microscopy for visualisation of the immobilised GFP on sensor surface. Upon 
microscopic examination, however, no detectable GFP was found on the sensors 
surface by means of fluorescence. It is assumed here that the sensor materials blocked 
a significant amount of the blue irradiation (light source was underneath the sensor) 
thus no green light was emitted from the top surface where the immobilised protein 
remained. The small concentration of the immobilised antibody and large size of the 
antigen have resulted in a small number of protein molecules being attached. As 
already discussed in the introduction of chapter 4.4, wild type GFP fluorescence is not 
as strong as that observed by some mutant GFP types. Errampalli et al., (1999) 
suggest that at least 10,000 GFP molecules are required for fluorescence based 
visualisation in tissue culture cells. Considering this, the layer of carbon acting as the 
sensing electrode can be understood to prohibit any irradiation from reaching the 
sensor top surface and exciting GFP for fluorescence observations. Due to time 
limitations, such an experiment was not further pursued, however, as already seen, the 
developed sensors were found to be highly efficient from the ac impedimetric 
interrogations that were carried out. A paper is in preparation for this work.
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Chapter 8
Conclusions and suggestions for future work
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Conclusions
While electrodeposition of polymers onto all types of electrodes (including the glass-
slide gold electrodes) was found to be an extremely efficient method, the project 
specific electrodes, both gold and platinum, were deemed unreliable for use in 
advanced experimentation such as ac impedance spectroscopy. Initially, an extra 
reduction peak during voltammetric scans was observed while using gold electrodes; 
this was attributed to a contaminant present within the electrode format and was 
thought to be a fabrication procedure fault. Later it was realised that the 
irreproducibility amongst all types of project specific electrodes was severe.
Sonochemical ablation was found to produce typical microelectrode arrays in some 
cases as described in section 4.2. However, the results were irreproducible amongst 
electrodes. Irreproducibility of the electrode fabrication procedure was one reason 
thought to be a cause of this. In addition, the custom made sonication tank used 
initially in this project did not provide a totally homogenous distribution of cavitation 
bubbles; this, teamed with the fact that the project specific electrodes are very small in 
size was another possible complimentary reason for irreproducibility of 
microelectrode array creation.
AC impedance spectroscopy using typical screen printed carbon electrodes for three 
different antibody/antigen pairs was met with success. It was shown that sensors 
containing the specific-monoclonal antibody show higher percent changes from 
baseline than those containing the non-specific polyclonal IgG or non-purified 
antibodies. The use of a redox couple such as ferri/ferrocyanide was found to enhance 
the analytical capabilities of impedimetric measurements and was preferred over plain 
PBS buffer for subsequent experimentation. 
Early investigations using the anti-ciprofloxacin/ciprofloxacin pair lead to two 
important conclusions regarding the development of successful sensors. It was 
realised that each antibody of choice must be both purified and concentrated to a 
minimum of 1 mg ml-1 for measurements to be highly reliable, while, lower antibody 
concentrations meant early sensor saturation. Additionally, the matching polyclonal 
IgG should be used at the same concentration to the specific antibody for any 
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comparisons between sensors to be reliable. Purification and concentration works for 
antibodies where all carried in our partner lab (Leeds University), however, due to the 
low concentrations at which antibodies are commercially available, it was not always 
possible to reach the desired concentration of 1 mg ml-1.
Sensors for the detection of ciprofloxacin have been successfully developed and 
found to detect ciprofloxacin at concentrations as low as 1 ng ml-1 in both laboratory 
PBS samples and in milk products. The maximum concentration used in these works 
was 10 μg ml-1. As discussed earlier, ciprofloxacin forms chelation complexes with 
Ca2+ from milk indicating the ability of our developed sensors to detect both the free 
and chelated antigen and differentiate between the two, shown via impedance 
decrease (free antigen in PBS) and impedance increase (chelated antigen in milk) 
upon antigen addition.
Succesful sensors for the detection of digoxin have also been developed within this 
PhD research programme. As discussed earlier, the achieved anti-digoxin 
concentration was lower than our preferred antigen concentration of 1 mg ml-1, and 
hence sensor saturation was observed upon antigen addition at low concentrations. 
The corresponding IgG used for this work was also kept at low concentration, thus 
resulting in high irreproducibility among IgG coated sensors. A detection limit of 0.1 
ng ml-1 was achieved, however, due to the extended error bars observed for the 
corresponding polyclonal IgG, the corrected calibration curve also contained large 
error bars. In line with previous investigations a decrease in impedance was observed 
upon antigen addition. It is believed that higher antibody concentrations would 
produce far more reliable measurements.
Final investigations in this work involved the detection of Green Fluorescent protein 
(GFP). A detection limit of 100 pg ml-1 was achieved with the highest measured GFP 
concentration being 100 ng ml-1. Interestingly, while the achieved antibody 
concentration was relatively low, the irreproducibility among sensors was not 
extreme, however, higher antibody concentration would allow us to measure a more 
extended range of antigen concentrations. Nevertheless, high responses were achieved 
upon antigen addition to the developed sensors and the obtained results where deemed 
reliable. 
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Three sensors have been reported within this work for the detection of ciprofloxacin, 
digoxin and GFP. The promising results indicated that the constructed devices may 
form the basis for development of a commercially viable sensor for detection of 
chosen antigens in liquid samples. The investigations within this research programme 
did not involve solid sample testing. Similar work gave rise to sensors for the 
detection of Myelin Basic Protein and Prostate Specific Antigen (PSA).
The concept of impedance increase or decrease upon exposure to antigens has been 
discussed within this work on a number of occasions. All specific binding is thought 
to give rise to decreasing impedance while non-specific binding persistently gives rise 
to impedance increases. Larger molecules, however, such as Myelin basic protein and 
the chelated form of ciprofloxacin have been shown to cause impedance increases. 
We conclude that larger or somewhat modified molecules may possess an insulating 
effect that can predominate the changes in impedance upon binding, thus increasing 
impedances are observed in the mentioned cases above.
Suggestions for future work
A number of antigen/antibody pairs have been investigated for the effects of their 
binding effects on impedance changes. While changes in impedance were obvious, 
there is not yet a definitive answer to why we observe an increase or decrease of 
impedance under different conditions. It has been shown that polyclonal IgG 
responses and those obtained for non purified antibodies displayed an increase in 
impedance upon increasing antigen concentrations. However, purified antibodies 
generally displayed impedance decreases with increasing antigen concentrations with 
the exception of ciprofloxacin in milk, which is not found as a free antigen but rather 
in chelation complexes. Future work from this research could focus on explaining the 
variations described above from a biochemist’s point of view in order to better 
understand both the variations in responses (impedance increase or decrease) and the 
effects of the binding event on the impedance of the system. 
With the range of commercially available antibodies and the overwhelming amount of 
target antigens, this research could be further extended into analysing more 
174
antigen/antibody pairs for medical, environmental and biodefence purposes. While the 
current range analysed by this work and previous works is indeed large, it is possible 
to further extend our knowledge of impedimetric sensor capabilities for more 
important target antigens.
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Labeless Immunosensor Assay for
Fluoroquinolone Antibiotics Based Upon
an AC Impedance Protocol
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Abstract: This paper describes the construction of a labeless immunosensor for the
antibiotic ciprofloxacin and its interrogation using an AC impedance protocol. Com-
mercial screen-printed carbon electrodes were used as the basis for the sensor. Polyani-
line was electrodeposited onto the sensors and then utilized to immobilize a
biotinylated antibody for ciprofloxacin using classical avidin-biotin interactions.
Electrodes containing the antibodies were exposed to solutions of antigen and inter-
rogated using an AC impedance protocol. The faradaic component of the impedance of
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the electrodes was found to increase with increasing concentration of antigen. Control
samples containing a non-specific IgG antibodywere also studied and calibration curves
obtained by subtraction of the responses for specific and non-specific antibody-based
sensors, thereby eliminating the effects of non-specific adsorption of antigen.
Keywords: Fluoroquinolone, ciprofloxacin, AC impedance, immunosensor,
polyaniline
INTRODUCTION
The principle of immunoassays was established in 1959 by Yalow and Berson
(Yalow and Berson, 1959). Their work developed the widely used radio-
immunoassay to examine the properties of insulin-binding antibodies in
human serum, using samples obtained from subjects that had been treated
with insulin.
Following the newly developed immunoassay technique, the concept of a
biosensor was pioneered by Clark and Lyons in 1962 (Clark and Lyons, 1962).
The original methodology was to immobilize enzymes on the surface of elec-
trochemical sensors-assuming that this would enhance the ability of a sensor
to detect specific analytes. This idea has remained virtually unchanged since
this original design, however, technological advances have allowed for the
expansion of this field of science.
The incorporation of antibodies into conducting polymer films was first
reported in 1991 (John et al. 1991). Anti-human serum albumin (anti-HSA)
was incorporated into a polypyrrole film, which was galvanostatically poly-
merized onto a platinum wire substrate. When grown in the absence of a coun-
terion, a poor polymeric film, both in appearance and electrochemical
properties was formed, suggesting that the presence of a counterion was
necessary for the polymerization process to be successful. Amino acid
analysis of the polymer using a leucine marker showed that approximately
0.1% w/v (0.2 mg) of the antibody was incorporated into the matrix. When
the pyrrole anti-HSA electrode was exposed to 50 mg ml21 HSA for 10 min,
a new reduction peak was observed at a potential of approximately
þ600 mV versus Ag/AgCl. This peak increased in magnitude after a further
30 min in the same solution and it was suggested this could be due to an
antibody/antigen interaction with the polymer. Further work by the same
group gave rise to reports of a reversible real-time immunosensor (John
et al. 1991). Other early work utilized a pulsed amperometric detection
technique for other analytes, including p-cresol (Barnett et al. 1994),
thaumatin (Sadik et al. 1994), and polychlorinated biphenyls (Bender and
Sadik 1994). Since this work there has been a huge increase in the development
of electrochemical immunosensors as detailed in several recent reviews
(Cosnier 2005; Diaz-Gonzalez et al. 2005; Rodriguez-Mozaz et al. 2006).
Antibody-antigen interactions are by their very nature complex and the
reproducible response characteristics of immunosensors requires that the
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affinity reaction occurring is minimally perturbed by the fabrication
procedure. We have previously shown that up to 2–3 mg antibodies for
BSA and digoxin may be successfully incorporated into conducting
polymer films by entrapment in a growing polypyrrole film with no detrimen-
tal effect to antibody activity (Grant et al. 2003). Electrochemical interrog-
ation of these films demonstrated selective interactions with the target
antigens. Further work utilized an AC impedance protocol (Grant et al.
2005) as the method of interrogation for these films and led to the development
of immunosensors for digoxin and bovine serum albumin.
The quinolones are a family of broad-spectrum antibiotics with the
majority of quinolones in clinical use being fluoroquinolones, which have a
fluoro group attached to the central ring system. They are widely used
within adult patients because of excellent tissue penetration which makes
them extremely effective against bacteria that grow intracellularly such as sal-
monella (Gendrei et al. 2003). One of these groups is ciprofloxacin (Fig. 1)
which is a broad-spectrum antibiotic active against many bacteria including
anthrax (Torriero et al. 2006). Many of these fluoroquinolones are added to
farm animal feed since they can lead to greater and more rapid weight gain.
Unfortunately the effect of this is thought to have enabled the rise of
resistant species of bacteria (Gendrei et al. 2003).
The monitoring of fluoroquinolones within both food and the environ-
ment is important since these antibiotics have potential health and environ-
mental damaging effects. Ciprofloxacin concentrations in hospital
wastewaters were monitored and correlations with DNA damaging effects
made (Hartmann et al. 1999). Levels of ciprofloxacin in hospital outflow
water between 0.7–124.5 ng ml21 were measured using high performance
liquid chromatography (HPLC) (Hartmann et al. 1999) and shown to
display genotoxicity at levels as low as 5.2 ng ml21. Similar work (Batt
et al. 2006) measured wastewater ciprofloxacin using liquid chromato-
graphy/mass spectrometry/mass spectrometry (LC/MS/MS) and found
levels between 0.031–5.6 ng ml21 (even after treatment) with a limit of
detection of 0.030 ng ml21. Levels in vivo have also been widely studied
with the therapeutic ranges typically being between 0.57–2.30 mg ml21 in
serum and 1.26–4.03 mg g21 in tissue (Licitra et al. 1987).
Figure 1. Structure of ciprofloxacin.
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A recent publication (Torriero et al. 2006) details the use of a horseradish
peroxidase based biosensor for the detection of ciprofloxacin due to its inhi-
bition of the oxidation of catechol, however other piperazine based
compounds could potentially interfere with this determination. Linear
responses were obtained between 0.02–65 mM with the limit of detection
being 0.4 nM. We have within this work developed a labeless immunosensor
for ciprofloxacin as a typical fluoroquinolone. The sensor utilizes screen-
printed carbon electrodes, modified by deposition of first, a conducting
polymer (polyaniline) which is then modified with biotinylating reagent.
Complexion of the immobilized biotin with avidin allows the further
binding of biotinylated antibodies via standard avidin-biotin interactions
(Fig. 2). The resultant electrodes are capable of detecting low levels of the
antigen-ciprofloxacin. Control electrodes containing non-specific IgG have
also been fabricated and allow the subtraction out of unspecific interactions.
EXPERIMENTAL
Sodium dihydrogen orthophosphate, disodium hydrogen orthophosphate,
sodium chloride, and hydrochloric acid, were obtained from BDH (Poole,
Dorset). Potassium chloride was obtained from Fisher Scientific UK Ltd,
(Loughborough). Aniline, polyclonal IgG from human serum, the biotinyla-
tion kit (part no. BK101), biotin 3-sulfo-N-hydroxysuccinimide, avidin,
bovine serum albumin (BSA), potassium ferrocyanide, and potassium ferri-
cyanide were obtained from Sigma-Aldrich, (Gillingham, Dorset). All water
used was obtained from a Purelab UHQ Deioniser (Elga, High Wycombe).
Commercial screen-printed carbon electrodes (Fig. 3) containing carbon
working and counter electrodes and an Ag/AgCl reference electrode were
obtained from Parlex Corp Ltd, Isle of Wight. The surface area of the
working electrode was 0.2178 cm2.
Phosphate Buffered Saline (PBS) at pH 7.4 stock solution was prepared
containing 0.14 mol l21 NaH2PO4, 0.52 mol l
21 Na2HPO4, and 0.0051 mol
l21 NaCl. Aniline buffer (pH 1–2) was prepared containing 0.5 mol l21
KCl, 0.3 mol l21 HCl, and 0.2 mol l21 aniline.
Figure 2. Schematic of antibody modified electrodes.
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Polyclonal antiserum (As 171) was raised against 1-(3mercaptopropyl)-
6-fluoro-7-(piperanicyl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid coupled
to HCH. The preparation of the immunogen and of the antibodies will be
described elsewhere (Pinacho et al. 2007).
For antibody biotinylation the procedure outlined in the BK101 kit was
followed (see manufacturer’s instructions for details). Biotinylated antibodies
were kept frozen in aliquots of 200-ml at a concentration of 1 mg ml21 until
required.
Cyclic voltammetry (Sycopel Potentiometer, Sycopel Scientific, Tyne &
Wear) was utilized to deposit polyaniline films on the carbon electrodes.
Screen-printed carbon electrodes were placed in aniline buffer and cycled
from –200 mV to þ800 mV versus Ag/AgCl for approximately 20 cycles
(occasionally this was varied slightly to ensure that the same amount of poly-
aniline was deposited on each electrode. Deposition was terminated at
þ800 mV to ensure the polyaniline remained in its conducting form. After
deposition, electrodes were rinsed in water.
Initially 30 ml of biotin-sulfo-NHS (10 mg ml21 in water) was placed on
the polymer coated working electrode surface for 24 h. The sensors were
rinsed with copious water and 30 ml of avidin (10 mg ml21 in water) placed
on the working electrode for 1 h followed by rinsing in water. Then 30 ml
biotinylated antibody (1 mg ml21 in water, 1 hour) was added followed by
rinsing. Finally, non-specific interactions were blocked by BSA (1026 M in
PBS, 1 hour); the sensors are ready to use at this point, however, if opted,
can be stored in PBS at 48C for no longer than 24 h.
AC impedance measurements were performed using an ACM Auto AC
DSP frequency response analyser. Antigen solutions for AC impedance
Figure 3. Screen-printed carbon electrodes used within this work.
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were prepared by diluting the required concentration of antigen in 30 ml of
PBS pH 7.4. A range of concentrations were utilized, since genotoxicity is
noted at levels above 5.2 ng ml21; we set our minimum level at 1 ng ml21
with an upper limit of 10 mg ml21, which covers the therapeutic/clinical
range. However other work within our group suggests detection limits of
about 10 pg ml21. The sensors were first interrogated without antigen
addition. Following this, each sensor was exposed to the required antigen con-
centration for 30 min, rinsed well with deionized water and then subjected to
impedance interrogation. Potassium ferrocyanide (10 mM) and potassium fer-
ricyanide (10 mM) in PBS buffer were utilized as a redox couple for impedi-
metric measurements. Three electrodes were used for each measurement.
A frequency range from 10 kHz to 1 Hz was measured, with peak
amplitude of 5 mV and a DC offset of þ400 mV against Ag/AgCl.
RESULTS AND DISCUSSION
Deposition of Polyaniline
The voltammograms for the deposition of polyaniline/DNA are depicted in
Fig. 4 and imply a steady in situ formation of polymer at the
electrode surface. As the number of scans increases, peaks appear between
þ350–400 mV versus Ag/AgCl corresponding to the oxidation and
reduction of surface bound polyaniline. The increase in current from scan
Figure 4. Deposition of conducting polyaniline films by cyclic voltammetry, curves
shown after 1, 10, and 20 cycles.
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10 to 20 is due to the increase in polyaniline thickness and coverage of the
electrode.
Impedance Profiles of the Electrodes
A series of Nyquist curves were obtained for the sensors after exposure to
various levels of ciprofloxacin in PBS (Fig. 5a). As can be seen, there is a
Figure 5. Nyquist plots of a typical antibody modified electrode exposed to various
concentrations of antigen.
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steady decrease in the impedance of the electrodes with increasing antigen
concentration. The relative conductivities of the system, which are
obtained by dividing the impedance for each frequency with no antigen
present—by the impedance (at the same frequency) for each antigen con-
centration, are shown in Fig. 5b. As can be seen, we see much larger
increases in conductivity at the lower frequencies. Therefore, it was
decided that changes in impedance at 1 Hz would be used as a measure-
ment of antigen binding.
The impedance spectra consists of two components, the real (Z0)
component where the impedance in phase with the AC potential
waveform is measured and the imaginary (Z00) where the impedance is
1808 out of phase. It is important to differentiate between the individual
components of the total impedance of the cell so that the capacitive and
Faradaic components of the composite impedimetric response may be ident-
ified and quantified. Previous work by our group showed that while both the
imaginary and real components increased, the increase in the real component
dominated the total increase in the impedance (Grant et al. 2005). Although
in this case, changes in both real and imaginary components are visible and
again the real component is the major component of total impedance,
perhaps more importantly it was also found that the real component
offers far greater reproducibility in comparison to the imaginary
contribution.
Figures 6a shows the percentage decrease in Z0 across a range of antigen
concentrations. As can be seen, there is a steady decrease in impedance as
antigen concentration increases up to a concentration of about 100 ng ml21,
above which concentration there is a tend towards a plateau, possibly indicat-
ing saturation of the specific binding sites. It is possible that any further
changes in impedance beyond this level could simply be due to non-specific
interactions. Between a concentration range of 1–100 ng ml21, there is a
near linear correlation of the impedance change with the log10 of concen-
tration (R2 ¼ 0.96).
Non-specific interactions could potentially interfere with
immunosensor performance. This could be addressed by utilization of a
second sensor containing either no antibodies—or alternatively a non-
specific antibody. Therefore an identical set of immunosensors were fab-
ricated utilizing a non-specific IgG antibody in place of the specific
ciprofloxacin antibody. Results for these electrodes were obtained in
exactly the same way and the calibration plot is shown (Fig. 6b). As
can be seen, there is a much lower response for the non-specific
antibody, showing that although there are non-specific interactions,
between the ranges of 1–100 ng ml21, they comprise a minor
component of the detected response. Figure 6c shows the subtracted
responses (6a–6b) and again this demonstrates linearity between the
response and the log10 of ciprofloxacin concentration between 1–100 ng
ml21 (R2 ¼ 0.96).
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Figure 6. Calibration curves for (a) anti-ciprofloxacin modified electrodes (b) IgG
modified electrodes (c) corrected calibration curves (curve a–curve b). All data points
are averages of three electrodes; error bars give a measure of the reproducibility of the
system.
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CONCLUSIONS
We have demonstrated the construction of an immunosensor for the antibiotic
ciprofloxacin using a combination of screen-printed electrodes coated with
conducting polyaniline and an immobilized polyclonal antibody. Interrogation
of the electrodes by AC impedance demonstrated the detection of the antigen.
Linear correlation of the impedance change with the log10 of concentration
(R2 ¼ 0.96) was observed between concentrations of 1–100 ng ml21.
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Detection of Fluoroquinolone Antibiotics in Milk via
a Labeless Immunoassay Based upon an
Alternating Current Impedance Protocol
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This paper describes the construction of a labeless im-
munosensor for the antibiotic ciprofloxacin in milk and
its interrogation using an ac impedance protocol. Com-
mercial screen-printed carbon electrodes were used as
the basis for the sensor. Polyaniline was electrodeposited
onto the sensors and then utilized to immobilize a bioti-
nylated antibody for ciprofloxacin using classical avidin-
biotin interactions. Antibody loaded electrodes were
exposed to solutions of antigen in milk and interrogated
using an ac impedance protocol. The faradaic component
of the impedance of the electrodes was found to increase
with increasing concentration of antigen. Control samples
containing a nonspecific IgG antibody were also studied
but were found to display large nonspecific responses,
probably due to the antibody binding some of the large
number of components found in milk. Control sensors
could, however, be fabricated using antibodies specific
for species not found in milk. Calibration curves could
be obtained by subtraction of the responses for specific
and control antibody-based sensors, thereby eliminating
the effects of nonspecific adsorption of antigen. Sensors
exposed to ciprofloxacin in milk gave increases in imped-
ance whereas ciprofloxacin in phosphate buffer led to
decreases, indicating the possibility of developing sensors
which can both detect and differentiate between free and
chelated antigen.
The principle of immunoassays was first established by Yalow
and Berson1 in 1959 and led to the development of the widely
used radioimmunoassay technique, initially to determine insulin-
binding antibodies in human serum, using samples obtained from
subjects that had been treated with insulin. Independently within
unconnected work, Clark and Lyons2 in 1962 developed the
concept of a biosensor. The original methodology involved
immobilizing enzymes on the surface of electrochemical sensors
so as to exploit the selectivity of enzymes for analytical purposes.
Although the field has undergone continual technological develop-
ments over the last 40 years, the basic idea has remained virtually
unchanged since the original design.
The incorporation of antibodies into conducting polymer films
was first reported3 in 1991. Polypyrrole films were galvanostatically
polymerized onto a platinum wire substrate. When grown in the
absence of a counterion, a poor polymeric film (both in appearance
and electrochemical properties) was formed, suggesting that the
presence of a counterion was necessary for the polymerization
process to be successful. Antihuman serum albumin (anti-HSA)
could be incorporated into the film; amino acid analysis of the
resulting polymer using a leucine marker determined that ap-
proximately 0.1% w/w (0.2 µg) of the antibody was incorporated
into the matrix. Exposure of the pyrrole anti-HSA electrode to a
50 µg mL-1 HSA solution for 10 min led to the formation of a
new reduction peak at a potential of approximately +600 mV
versus Ag/AgCl. This peak increased in magnitude after a further
30 min in the same solution, suggesting that this could be due to
an antibody/antigen interaction with the polymer. Further work
by the same group gave rise to reports of a reversible real-time
immunosensor.3 Other early work utilized a pulsed amperometric
detection technique for other analytes, including p-cresol,4 thau-
matin,5 and polychlorinated biphenyls.6 Since this early work there
has been burgeoning interest in the development of electrochemi-
cal immunosensors, as detailed in several recent reviews.7-9
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Antibody-antigen interactions are by their very nature com-
plex, and it follows that the affinity reaction must be only minimally
perturbed by the fabrication procedure to allow the immunosen-
sors to display reproducible response characteristics. Previously
within our group we have shown that up to 2-3 µg of antibodies
for BSA and digoxin may be successfully incorporated into
conducting polymer films by entrapment in a growing polypyrrole
film with no detrimental effect to antibody activity.10 Electrochemi-
cal interrogation of these films demonstrated selective interactions
with the target antigens. Further work utilized an ac impedance
protocol11 as the method of interrogation for these films, and led
to the development of immunosensors for digoxin and bovine
serum albumin. Later work by our group studied approaches for
immobilization of antibodies onto polyaniline-coated screen-printed
carbon electrodes utilizing a classical avidin-biotin chemistry.
This enabled the construction of immunosensors for the fluoro-
quinolone antibody ciprofloxacin12 in buffer solutions. We have
also demonstrated selective immunosensors for myelin basic
protein,13 prostate specific antigen,14 and the stroke marker
proteins neuron specific enolase15 and S-100 [].16
Fluoroquinolones are members of the quinolone family of
broad-spectrum antibiotics and comprise the majority of quino-
lones in clinical use, the name fluoroquinolone deriving from the
fact they have a fluoro group attached to the central ring system.
Antibiotics of this type have excellent tissue penetration which
makes them extremely effective against bacteria that grow
intracellularly such as salmonella, and this has led to their
widespread use within adult patients.17 One antibiotic within this
group is ciprofloxacin (Figure S1, Supporting Information) which
is a broad-spectrum antibiotic active against many bacteria
including anthrax.18 Many of these fluoroquinolones are added
to farm animal feed since they can lead to greater and more rapid
weight gain. Unfortunately this is also thought to have contributed
to the rise of antibiotic resistant species of bacteria.17
The monitoring of fluoroquinolones within both food and the
environment is important since these antibiotics have potential
health related and environmental damaging effects. Ciprofloxacin
concentrations in hospital wastewater were monitored and cor-
relations with DNA damaging effects made.19 HPLC techniques
have been utilized to measure levels of ciprofloxacin in hospital
outflow water19 and found levels between 0.7-124.5 ng mL-1, as
well as displaying genotoxicity at levels as low as 5.2 ng mL-1.
Similar work utilized LC/MS/MS methods20 and found wastewa-
ter ciprofloxacin levels between 0.031-5.6 ng mL-1 (even after
treatment) with a limit of detection of 0.030 ng mL-1. Levels in
vivo have also been widely studied with the therapeutic ranges
typically being between 0.57-2.30 µg mL-1 in serum and
1.26-4.03 µg g-1 in tissue.21
A horseradish peroxidase-based biosensor18 has been devel-
oped for the detection of ciprofloxacin due to its inhibition of the
oxidation of catechol. Linear responses were obtained between
0.02-65 µM with the limit of detection being 0.4 nM; however,
other piperazine-based compounds could potentially interfere with
this determination. We have within earlier work developed a
labeless immunosensor for ciprofloxacin as a typical fluoroqui-
nolone which utilizes screen-printed carbon electrodes modified
by deposition of first, a conducting polymer (polyaniline) which
is then functionalized with a biotinylating reagent.12 Complexation
of the immobilized biotin with neutravidin allows the further
binding of biotinylated antibodies via standard avidin-biotin
interactions (Figure S2, Supporting Information). The resultant
electrodes are capable of detecting low levels of the ciprofloxacinin
antigen dissolved in phosphate buffer.12 For an immunosensor
to be of practical use, however, it must be capable of the analysis
of the substrate within a wide range of matrixes. Since fluoro-
quinonolones are widely used within the animal industry, it was
decided to investigate whether ciprofloxacin could be detected
in milk. The European Union has set a maximum residue limit of
100 ng mL-1 for enrofloxacin plus ciprofloxacin in milk.22 Previous
studies have utilized techniques such as HPLC to detect various
fluoroquinolone antibodies in bovine milk22 with a detection limit
of 3 ng mL-1 for ciprofloxacin and LC with luminescence
detection23 to measure ciprofloxacin in milk with a linear range
of 8-3500 ng mL-1 and a detection limit of 3 ng mL-1. A number
of ELISA-based tests24,25 have also been developed to detect
fluoroquinolones in milk with detection limits of several nano-
grams per milliliter. Recent work has also described the construc-
tion of a DNA-based sensor which when combined with a surface
plasmon resonance method allows quantification of enrofloxacin
between 3-20 µg mL-1 in milk.26 An immunosensor for ciprof-
loxacin based on polypyrrole films combined with an ac impedance
technique27 has also been described with sensitivities as low as
10 pg mL-1.
EXPERIMENTAL SECTION
Sodium dihydrogen orthophosphate, disodium hydrogen or-
thophosphate, sodium chloride, hydrochloric acid, were obtained
from BDH (Poole, Dorset, U.K.). Potassium chloride was obtained
from Fisher Scientific UK Ltd., Loughborough, U.K.. Aniline,
(10) Grant, S.; Davis, F.; Pritchard, J. A.; Law, K. A.; Higson, S. P. J.; Gibson,
T. D. Anal. Chim. Acta 2003, 495, 21–32.
(11) Grant, S.; Davis, F.; Law, K. A.; Barton, A. C.; Collyer, S. D.; Higson, S. P. J.;
Gibson, T. D. Anal. Chim. Acta 2005, 537, 163–168.
(12) Garifallou, G.-Z.; Tsekenis, G.; Davis, F.; Millner, P. A.; Pinacho, D. G.;
Sanchez-Baeza, F.; Marco, M.-P.; Gibson, T. D.; Higson, S. P. J. Anal. Lett.
2007, 40, 1412–1442.
(13) Tsekenis, G.; Garifallou, G. Z.; Davis, F.; Millner, P. A.; Gibson, T. D.;
Higson, S. P. J. Anal. Chem. 2008, 80, 2058–2062.
(14) Barton, A. C.; Davis, F.; Higson, S. P. J. Anal. Chem. 2008, 80, 6198–
6205.
(15) Barton, A. C.; Davis, F.; Higson, S. P. J. Anal. Chem., submitted.
(16) Barton A. C., Ph.D. Thesis, Cranfield University, Silsoe, 2008.
(17) Gendrei, D.; Chalumeau, M.; Moulin, F.; Raymond, J. Lancet Inf. Dis. 2003,
3, 537–546.
(18) Torriero, A. A. J.; Ruiz-Dıaz, J. J. J.; Salinas, E.; Marchevsky, E. J.; Sanz,
M. I.; Raba, J. Talanta 2006, 69, 691–699.
(19) Hartmann, A.; Golet, E. M.; Gartiser, S.; Alder, A. C.; Koller, T.; Widmer,
R. M. Arch. Environ. Contam. Toxicol. 1999, 115–119.
(20) Batt, A. L.; Bruce, I. B.; Aga, D. S. Environ. Pollut. 2006, 142, 295–302.
(21) Licitra, C. M.; Brooks, R. G.; Sieger, B. E. Antimicrob. Agents Chemother.
1987, 31, 805–807.
(22) Hassouan, M.; Ballesteros, O.; Vilchez, J.; Zafra, A.; Navalon, A. Anal. Lett.
2007, 779–791.
(23) Rodriguez-Diaz, R. C.; Fernandez-Romero, J. M.; Aguilar-Caballos, M. P.;
Gomez-Hens, A. J. Agric. Food Chem. 2006, 9670–9676.
(24) Bucknall, S.; Silverlight, J.; Coldham, N.; Thorne, L.; Jackman, R. Food Addit.
Contam. 2006, 20, 221–228.
(25) Duan, J.; Yuan, Z. H. J. Agric. Food Chem. 2001, 49, 1087–1089.
(26) Cao, L. M.; Lin, H.; Mirsky, V. M. Anal. Chim. Acta 2007, 589, 1–5.
(27) Ionescu, R. E.; Jaffrezic-Renault, N.; Bouffier, L.; Gondran, C.; Cosnier, S.;
Pinacho, D. G.; Marco, M. P.; Sanchez-Baeza, F. J.; Healy, T.; Martelet, C.
Biosens. Bioelectron. 2007, 23, 549–555.
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polyclonal IgG (rabbit), the biotinylation kit (part no. BK101),
biotin 3-sulfo-N-hydroxysuccinimide, avidin, and bovine serum
albumin (BSA) were obtained from Sigma-Aldrich, Gillingham,
Dorset, U.K. Ciprofloxacin hydrochloride was purchased from
UQUIFA (Barcelona, Spain). All water used was obtained from a
Purelab UHQDeioniser (Elga, HighWycombe, U.K.). Commercial
screen-printed carbon electrodes identical to those used in
previous work (Figure S3, Supporting Information) containing
carbon working and counter electrodes and an Ag/AgCl reference
electrode were obtained from Microarray Ltd., Manchester, U.K.
The surface area of the working electrode was 0.2178 cm2.
Semiskimmed bovine milk was purchased from a local supermar-
ket.
Phosphate Buffered Saline (PBS) stock solution (pH 7.4) was
prepared containing 0.14 mol L-1 NaH2PO4, 0.52 mol L-1
Na2HPO4, and 0.0051 mol L-1 NaCl. Aniline buffer (pH 1-2) was
prepared containing 0.5 mol L-1 KCl, 0.3 mol L-1 HCl, and 0.2
mol L-1 aniline.
Polyclonal antiserum (As 171) was a gift from AMRg and was
raised (in rabbit) against 1-(3- mercaptopropyl)-6-fluoro-7-(pip-
eranicyl)-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid coupled to
horseshoe crab hemicyanin. The preparation of the immunogen
and of the antibodies has been described elsewhere.36 The
antibody was supplied in raw serum. Monoclonal antibody to
prostate specific antigen (PSA 30 mAb, isotype IgG1, product
number 323-01) with sodium azide preservative was supplied by
Canag Diagnostics, Ltd. (Gothenburg, Sweden).
For antibody biotinylation, the procedure outlined in the BK101
kit was followed (see manufacturer’s instructions for details).
Biotinylated antibodies were kept frozen in aliquots of 200 µL at
a concentration of 1 mg mL-1 until required.
Cyclic voltammetry (Sycopel Potentiometer, Sycopel Scientific,
Tyne and Wear, U.K.) was utilized to deposit polyaniline films on
the carbon electrodes. Screen-printed carbon electrodes were
placed in aniline buffer and cycled from -200 to +800 mV versus
Ag/AgCl for approximately 20 cycles (occasionally this was varied
Figure 1. (a) Bode and (b) Nyquist plots of a typical ciprofloxacin-specific antibody modified electrode exposed to ciprofloxacin.
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slightly to ensure the same quantity of polyaniline was deposited
on each electrode). Deposition was terminated at +800 mV to
ensure the polyaniline remained in its conducting form. After
deposition, electrodes were rinsed in water.
A volume of 30 µL of biotin-sulfo-NHS (10 mg mL-1 in water)
was placed on the polymer-coated working electrode surface for
24 h. The sensors were rinsed with copious water, and 30 µL of
avidin (10 µg mL-1 in water) was placed on the working electrode
for 1 h followed by rinsing in water. Then 30 µL of biotinylated
antibody (1 mg mL-1 in water) was added followed by rinsing.
Finally, nonspecific interactions were blocked by BSA (10-6 M
in PBS); the sensors may be used at this point, however, if opted,
can be stored in PBS at 4 °C for up to 24 h or dry at 4 °C for
several weeks.14-16
Alternating current impedance measurements were performed
using an ACM Auto AC DSP frequency response analyzer. Antigen
solutions were prepared by initially dissolving ciprofloxacin in PBS,
then diluting to the required concentration of antigen in 30 mL of
milk. A range of concentrations was utilized; we set our minimum
level at 0.1 ng mL-1 with an upper limit of 10 µg mL-1. The
sensors were first interrogated without antigen addition. Following
this, each sensor was exposed to the required antigen concentra-
tion for 30 min, rinsed well with deionized water, and then
subjected to impedance interrogation in fresh milk. Three elec-
trodes were used for each measurement. A frequency range from
10 kHz to 1 Hz was measured, with a peak amplitude of 5 mV
and a dc offset of +400 mV against Ag/AgCl.
RESULTS AND DISCUSSION
Deposition of Polyaniline. The voltammograms for the
deposition of polyaniline were as found in earlier work12,13 and
imply a steady in situ formation of polymer at the electrode
surface. As the number of scans increases, peaks appear between
+350 and 400 mV vs Ag/AgCl corresponding to the oxidation and
reduction of surface bound polyaniline, with the current passed
increasing with the number of scans due to the increase in
polyaniline thickness and coverage of the electrode.
Impedance Profiles of the Electrodes. A series of Bode
(Figure 1a) and Nyquist curves (Figure 1b) were obtained for
the sensors after exposure to various levels of ciprofloxacin in
milk. As can be seen, there is a steady increase in the impedance
of the electrodes with increasing antigen concentration. This was
unexpected since our work on ciprofloxacin in phosphate buffer
(containing 10 mM ferri/ferrocyanide) clearly demonstrates that
binding of the antigen leads to a drop in impedance. As can be
seen, we see much larger increases in impedance at the lower
frequencies. Therefore it was decided that changes in impedance
at 1 Hz would be used as a measurement of antigen binding.
The Nyquist plots display the two components of the imped-
ance spectra: the real (Z′) component where the impedance in
phase with the ac potential waveform is measured and the
imaginary (Z′′) where the measured impedance is 180° out of
phase. Both of the individual components contribute to the total
impedance of the cell. However it is important to differentiate
between these so that the individual components of the composite
impedimetric response may be identified and quantified.
In this system, the Z′ (real) component of the impedance can
be seen to steadily increase with decreasing frequency. In the
baseline plot, the Z′′ (imaginary) component increases to a
maximum value before falling as the frequency approaches 1 Hz.
Similar behavior appears to occur as antigen binding increases
except that for the higher concentrations of ciprofloxacin the
maximum value is beyond our frequency range. This type of
impedance spectrum is indicative of a surface-modified electrode
system where the electron transfer is slow and the impedance is
controlled by the interfacial electron transfer.28
In previous pieces of work within our group we have demon-
strated that although both the imaginary and real components
increase, the increase in the real component dominates the total
increase in the impedance.11-13 Although in this case and in
previous work,11-13 changes in both real and imaginary compo-
nents are visible, once again the real component is the major
component of total impedance and perhaps more importantly we
have repeatedly found that the real component offers far greater
reproducibility in comparison to the imaginary contribution.
Figure 2 shows the percentage increase in Z′ (measured at 1
Hz) across a range of antigen concentrations. As can be seen,
there is a steady increase in the real component of impedance as
antigen concentration increases up to a concentration of about
100 ng mL-1, above which concentration there is a tendency
(28) Katz, E.; Willner, I. Electroanalysis 2003, 15, 913–947.
Figure 2. Calibration curve for anticiprofloxacin modified electrodes.
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toward a plateau, possibly indicating saturation of the specific
binding sites. It is possible that any further changes in impedance
beyond this level could simply be due to nonspecific interactions.
Between a concentration range of 1-100 ng mL-1, there is a near
linear correlation of the impedance change with the log10 of
concentration (R2 ) 0.96).
Nonspecific interactions could potentially interfere with im-
munosensor performance. We have previously described the
utilization of control electrodes containing a nonspecific IgG
antibody.11-13 These permit the subtraction of unspecific interac-
tions from the specific binding response and also may help to
increase the stability and reliability of these sensors when applied
to complex mixtures such as milk, other foodstuffs, or clinical
samples. Therefore an identical set of immunosensors were
fabricated utilizing a nonspecific IgG antibody in place of the
specific ciprofloxacin antibody. The commercial IgG sample was
taken from the same species as the specific antibody was raised
(rabbit) in order to make the match as relevent as possible. Results
for these electrodes were obtained in exactly the same way, and
the calibration plot is shown (Figure 3a). As can be seen, there is
a very high decrease in impedance for the nonspecific antibody.
However further experiments showed that these results are a
function of the time of exposure rather than ciprofloxacin
concentration, i.e., a repeat of the experiment where the electrodes
were exposed just to milk without antigen gave an identical plot.
A possible explanation for this is that since milk is such a complex
mixture of components and IgG is a mixture of different antibod-
ies, some of the antibodies will specifically bind to certain species
in milk.
In order to test this theory, another set of control electrodes
were utilized, where instead of nonspecific IgG antibody, a specific
antibody for an antigen not normally found in milk was utilized.
Figure 3b shows the results upon exposure to ciprofloxacin in
milk for electrodes fabricated using a specific antibody for prostate
specific antigen (PSA), used in earlier work.14 Results for these
electrodes showed that although there are nonspecific interac-
tions, between the ranges of 0.1-100 ng mL-1, they comprise a
minor component of the detected response and in fact lead to a
drop rather than a gain in impedance, as was found within our
earlier work on ciprofloxacin in PBS.12 Although PSA has been
found in human milk,29 the median levels were well below 1 ng
mL-1 and also as all readings are referenced to electrodes after
exposure to bovine milk containing zero ciprofloxacin, any effect
to due binding of “bovine PSA” would cancel out. Also our previous
work has shown antibodies can differentiate between similar
compounds from different species, for example, they can dif-
ferentiate between bovine and human serum albumin.30
(29) Yu, H.; Diamandis, E. P. Clin. Chem. 1995, 41, 54–58.
(30) Barton, A. C.; Collyer, S. D.; Davis F.; Garifallou G.-Z.; Tsekenis G.; Tully,
E.; O’Kennedy, R.; Gibson T. D.; Millner P. A.; Higson S. P. J. Biosens.
Bioelectron., in press.
Figure 3. Control calibration curves for (a) IgG modified electrodes and (b) PSA modified electrodes.
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Figure 4a shows the subtracted responses (Figure 3a - Figure
2). As can be seen this demonstrates linearity between the
response and the log10 of ciprofloxacin concentration between
0.1-100 ng mL-1 (R2 ) 0.98). Above 100 ng mL-1, the receptors
appear to be saturated. Figure 4b displays our earlier results for
ciprofloxacin in PBS (containing 10 mM ferri/ferrocaynide)12
overlaid over those for milk. As can be seen, the results are very
similar in that they give linear ranges with very similar gradients
in the region 0-100 ng mL-1 and above 100 ng mL-1 appear to
be saturated. However they are of opposite nature; adsorption of
ciprofloxacin from milk gives an increase in Z′ whereas from PBS
a decrease is observed. One potential explanation for this is that
in milk a different ciprofloxacin species is being adsorbed. It has
been reported that in the presence of calcium ions, many
fluoroquinolone antibiotics, including ciprofloxacin, readily form
calcium chelate complexes.31,32 These complexes are usually
dimeric in nature with two ciprofloxacin units complexed to a
single calcium ion.31 Binding of ciprofloxacin in either its free or
chelated form over similar concentration ranges is occurring, as
shown by responses compared to control samples, with the great
structural differences between the free and complexed forms of
the antigen leading to different effects on the ac impedance results.
The effects of adsorption of various moieties on the ac impedance
behavior is highly complex and not well understood. For example
in previous work by our group on DNA-based sensors, adsorption
of cDNA stands has been shown to lead to drops in the ac
impedance of our electrodes whereas adsorption of noncDNA
leads to an increase.33,34 Unfortunately control experiments where
calcium ions were added to PBS were not possible since addition
of calcium to the buffer cause immediate precipitation of calcium
phosphates.
These results are of interest since they show that it may be
possible to differentiate between complexed and free ciprofloxacin.
Ongoing work is attempting to determine whether the complexed
and uncomplexed forms can be differentiated. This is of interest
since complexed form of ciprofloxacin is inactive, for example,
the FDA recommends that ciprofloxacin is not taken with dairy
products, calcium fortified juices, or calcium containing antacids35
since they may lower adsorption of the drug.
(31) Upadhyay, S. K.; Kumar, P.; Arora, V. J. Struct. Chem. 2006, 47, 1078–
1083.
(32) Toyoguchi, T.; Ebihara, M.; Ojima, F.; Hosoya, J.; Nakagawa, Y. Biol. Pharm.
Bull. 2005, 28, 841–844.
(33) Davis, F.; Nabok, A. V.; Higson, S. P. J. Biosens. Bioelectron. 2004, 20,
1531–1538.
(34) Davis, F.; Hughes, M. A.; Cossins, A. R.; Higson, S. P. J. Anal. Chem. 2007,
79, 1153–1157.
Figure 4. (a) Corrected calibration curve for anticiprofloxacin modified electrodes in milk (Figure 2 - Figure 3b) and (b) for comparison purposes
the calibration curve for ciprofloxacin in phosphate buffer previously reported.12 All data points are means of three electrodes; error bars give
a measure of the reproducibility of the system.
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CONCLUSIONS
We have demonstrated the construction of an immunosensor
for the antibiotic ciprofloxacin using a combination of screen-
printed electrodes coated with conducting polyaniline and im-
mobilized antibodies. The electrodes were then exposed to
solutions of the antigen in milk. Interrogation of the electrodes
by ac impedance demonstrated the detection of the antigen. Linear
increases of the impedance change with the log10 of concentration
(R2 ) 0.98) was observed between concentrations of 0.1-100 ng
mL-1. The sensor not only bound the antigen from PBS or milk
but the ac response was dependent on the matrix the ciprofloxacin
was adsorbed from, possibly due to formation of a dimeric calcium
chelated form of the antibiotic in milk. This is especially of interest,
since free and chelated ciprofloxacin have very different adsorption
characteristics when ingested.
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Label-less Immunosensor Assay for Myelin Basic
Protein Based upon an ac Impedance Protocol
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This paper describes the development and characteriza-
tion of a label-less immunosensor for myelin basic protein
(MBP) and its interrogation using an ac impedance
protocol. Commercial screen-printed carbon electrodes
were used as the basis for the sensor. Polyaniline was
electrodeposited onto the sensors, and this modified
surface then utilized to immobilize a biotinylated antibody
for MBP using a classical avidin-biotin approach. Elec-
trodes containing the antibodies were exposed to solutions
of MBP and interrogated using an ac impedance protocol.
The real component of the impedance of the electrodes
was found to increase with increasing concentration of
antigen. Control samples containing a nonspecific IgG
antibody were also studied, and calibration curves were
obtained by subtraction of the responses for specific and
nonspecific antibody-based sensors, thereby accounting
for and eliminating the effects of nonspecific adsorption
of MBP. A logarithmic relationship between the concen-
tration of MBP in buffer solutions and the impedimetric
response was observed.
The principle of immunoassays was first established by Yalow
and Berson1 in 1959. Their work led to the development of the
widely used radioimmunoassay to examine the properties of
insulin-binding antibodies in human serum, using samples ob-
tained from subjects that had been treated with insulin.
Independently within unconnected work, the concept of a
biosensor was pioneered by Clark and Lyons2 in 1962. The original
methodology involved immobilizing enzymes on the surface of
electrochemical sensors so as to exploit the selectivity of enzymes
for analytical purposes. This idea has remained virtually un-
changed since the original design, although the field has under-
gone continual technological developments over the last 40 years.
The incorporation of antibodies into conducting polymer films
was first reported3 in 1991. Antihuman serum albumin (anti-HSA)
was incorporated into a polypyrrole film, which was galvanostati-
cally polymerized onto a platinum wire substrate. When grown
in the absence of a counterion, a poor polymeric film (both in
appearance and electrochemical properties) was formed, suggest-
ing that the presence of a counterion was necessary for the
polymerization process to be successful. Amino acid analysis of
the polymer using a leucine marker showed that approximately
0.1% w/v (0.2 íg) of the antibody was incorporated into the matrix.
When the pyrrole anti-HSA electrode was exposed to 50 íg mL-1
HSA for 10 min, a new reduction peak was observed at a potential
of approximately +600 mV versus Ag/AgCl. This peak increased
in magnitude after a further 30 min in the same solutionsand it
was suggested this could be due to an antibody/antigen interac-
tion with the polymer. Further work by the same group gave rise
to reports of a reversible real-time immunosensor.3 Other early
work utilized a pulsed amperometric detection technique for other
analytes, including p-cresol,4 thaumatin,5 and polychlorinated
biphenyls.6 Since this early work there has been burgeoning
interest in the development of electrochemical immunosensorss
as detailed in several recent reviews.7-9
Antibody-antigen interactions are by their very nature com-
plex, and the reproducible response characteristics of immun-
osensors requires that the affinity reaction is minimally perturbed
by the fabrication procedure. We have previously shown that up
to 2-3 íg of antibodies for bovine serum albumin and digoxin
may be successfully incorporated into conducting polymer films
by entrapment in a growing polypyrrole film with no detrimental
effect to antibody activity.10 Electrochemical interrogation of these
films demonstrated selective interactions with the target antigens.
Further work utilized an ac impedance protocol11 as the method
of interrogation for these filmssand led to the development of
immunosensors for digoxin and bovine serum albumin. Later work
* Corresponding author. Fax: (+44) 01525 863433. E-mail: s.p.j.higson@
cranfield.ac.uk.
† Cranfield University.
‡ University of Leeds.
§ ELISHA Systems Ltd.
(1) Yalow, R. S.; Berson, S. A. Nature 1959, 184, 1648-1649.
(2) Clark, L.C.; Lyons, I. R. Ann. N.Y. Acad. Sci. 1962, 102, 29.
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by our group studied approaches for immobilization of antibodies
onto polyaniline-coated screen-printed carbon electrodes utilizing
a classical avidin-biotin chemistry. This enabled the construction
of immunosensors for the fluoroquinolone antibody ciprofloxacin.12
Myelin is a complex membrane which forms a sheath around
axons in vertebrate species.13 It is the most abundant membrane
structure within the vertebrate nervous system, allowing the fast
conduction of nerve impulses through the nerve fibers14 due to
its high resistance and low capacitance. Myelin basic protein
(MBP) is a cytoplasmic protein important in the process of
myelination of nerves in the central nervous system since it
comprises the bulk of the main line of compact myelin13 and up
to 30% of the protein content of myelin overall.14
A demyelinating disease is any disease of the nervous system
in which the myelin sheath of neurons becomes damaged. This
impairs the conduction of signals in the affected nerves, causing
impairment in sensation, movement, cognition, or other functions,
depending on which nerves are involved. Multiple sclerosis (MS),
which is a chronic and inflammatory disease of the central nervous
system, is an example of a demyelinating disease. Multiple
sclerosis affects neurons within the brain and spinal cord that are
involved with sensory and motor control functions. The name
multiple sclerosis is derived from the multiple scars (or scleroses)
that can be observed on the myelin sheaths. At the time of writing
MS does not have a cure, although several treatments are available
that may slow the appearance of new symptoms.
Multiple sclerosis is currently often diagnosed following
occurrence of a number of indicative symptoms. Magnetic
resonance imaging (MRI) may be used to evaluate patients who
display these symptoms. MRI is capable of imaging areas where
demyelination is occurring, with lesions caused by demyelination
showing up as bright areas on the scan. Cerebrospinal fluid can
also be utilized in the diagnosis of MS, and the presence of
immunoglobins can be detected in the majority of MS sufferers.
It should be noted, however, that other conditions can also lead
to the presence of these species.15
Other demyelinating diseases include transverse myelitis,
Guillain-Barre´ syndrome, and progressive multifocal leukoen-
cephalopathy. There are various identified potential causes of
demyelination, including autoimmune reactions,16 infectious agents,17
genetic conditions,18 and also exposure to compounds such as
carbamate pesticides.19
The presence of antibodies against myelin proteins such as
MBP can be a predictor of MS.20 Clinical studies of 103 patients
suffering from MS demonstrated that the presence of antibodies
for MBP and myelin oligodendrocyte glycoprotein within serum
could be correlated with a greatly increased level of relapse
compared to patients without these antibodies. Other demyeli-
nating conditions also lead to elevated levels of MBP in cere-
brospinal fluid,21,22 for example, in cases of closed head trauma23
or acquired immunodeficiency syndrome (AIDS) dementia com-
plex (ADC).24 A significant correlation has also been determined
between the clinical stage of the childhood-onset cerebral form
of adrenoleukodystrophy and cerebrospinal fluid MBP levels.25
MBP levels between 4 and 8 ng L-1 in cerebrospinal fluid may
indicate a chronic breakdown of myelin or recovery from an acute
episode. MBP levels greater than 9 ng mL-1 indicate that active
demyelination may be occurring. Normally there should be less
than 4 ng mL-1 of MBP in the cerebral spinal fluid.
Increased MBP levels can also occur as a result of a stroke. A
stroke, also known as cerebrovascular accident (CVA), is an acute
neurological injury in which blood supply to a part of the brain is
interrupted. Strokes involve a sudden loss of neuronal function
due to arterial or even venous disturbance in cerebral perfusion.
The part of the brain with disturbed perfusion no longer receives
an adequate supply of oxygen. This initiates the ischemic cascade
which causes brain cells to die or be seriously damaged, impairing
local brain function. An indirect result of stroke is an active
breakdown of myelin or demyelination, and therefore, the levels
of MBP in cerebral spinal fluid (CSF) can act as markers for
stroke.
Commercial ELISA tests exist for MBP; Diagnostic Systems
Laboratories (Texas), for example, manufactures an ELISA which
can measure levels of MBP in cerebrospinal fluid in 4 h.
We have within this work developed a label-less immunosensor
for MBP. The sensor utilizes screen-printed carbon electrodes and
is modified first by deposition of a conducting polymer (polya-
niline) and thence biotinylating reagent. Complexion of the
immobilized biotin with avidin allows the further binding of
biotinylated antibodies via standard avidin-biotin interactions as
described earlier12 and as shown schematically in Figure 1. The
resultant electrodes are capable of detecting the antigen within
(12) Garifallou, G.-Z.; Tsekenis, G.; Davis, F.; Millner, P. A.; Pinacho, D. G.;
Sanchez-Baeza, F.; Marco, M.-P.; Gibson, T. D.; Higson, S. P. J. Anal. Lett.
2007, 40, 1412-1442.
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Figure 1. Schematic of antibody-modified electrodes showing the
assembly of avidin and biotinylated electrodes and binding of
biotinylated antibody.
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the required physiological range. Control electrodes containing
nonspecific IgG have also been fabricated to measure the effects
of nonspecific binding and permit the subtraction of these
unspecific interactions from the response toward specific binding
of MBP. This approach helps to increase the stability and reliability
of these sensors when applied to clinical samples.
EXPERIMENTAL SECTION
Sodium dihydrogen orthophosphate, disodium hydrogen or-
thophosphate, sodium chloride, and hydrochloric acid were
obtained from BDH (Poole, Dorset, U.K.). Potassium chloride was
obtained from Fisher Scientific U.K. Ltd., Loughborough, U.K.
Aniline, MBP (from mouse, M2941), myelin basic protein antibody
(monoclonal anti-MBP from rat, M9434), polyclonal IgG (from
mouse, I5381), the biotinylation kit (part no. BK101), biotin 3-sulfo-
N-hydroxysuccinimide, neutravidin, bovine serum albumin (BSA),
potassium ferrocyanide, and potassium ferricyanide were obtained
from Sigma-Aldrich, Gillingham, Dorset, U.K. All water used was
obtained from a Purelab UHQ Deionizer (Elga, High Wycombe,
U.K.). Commercial screen-printed carbon electrodes (Figure 2)
containing carbon working and counter electrodes and a Ag/AgCl
reference electrode were obtained from Microarray Ltd., Manches-
ter, U.K. The surface area of the working electrode was 0.2178
cm2.
Phosphate-buffered saline (PBS), pH 7.4 stock solution was
prepared containing 0.14 mol L-1 NaH2PO4, 0.52 mol L-1 Na2HPO4,
and 0.0051 mol L-1 NaCl. Aniline buffer, pH 1-2, was prepared
containing 0.5 mol L-1 KCl, 0.3 mol L-1 HCl, and 0.2 mol L-1
aniline.
For antibody biotinylation, the procedure outlined in the BK101
kit was followed (see manufacturers instructions for details).
Biotinylated antibodies were kept frozen in aliquots of 200 íL at
a concentration of 1 mg mL-1 until required.
Cyclic voltammetry (Sycopel potentiometer, Sycopel Scientific,
Tyne & Wear, U.K.) was utilized to deposit polyaniline films on
the carbon electrodes. Screen-printed carbon electrodes were
placed in aniline buffer and cycled from -200 to +800 mV versus
Ag/AgCl for approximately 20 cycles, (the number of cycles could
be varied to ensure the same quantity of polyaniline was deposited
on each electrode). Deposition was terminated at +800 mV to
ensure the polyaniline remained in its conducting form. Following
deposition the polymer-coated electrodes were rinsed in water.
A volume of 30 íL of biotin-sulfo-NHS (10 mg mL-1 in water)
was placed on the polymer-coated working electrode surface for
24 h. The sensors were rinsed with copious water and 30 íL of
avidin (10 íg mL-1 in water) placed on the working electrode for
1 hsfollowed by further rinsing in water. Then 30 íL of
biotinylated antibody (1 mg mL-1 in water) was added followed
by rinsing. Finally, nonspecific interactions were blocked by BSA
(10-6 M in PBS); the sensors are ready to use at this point;
however, if opted, they can be stored in PBS at 4 °C up to 24 h.
The ac impedance measurements were performed using an
ACM auto ac DSP frequency response analyzer (ACM Instru-
ments, Grange over Sands, UK). Antigen solutions for ac imped-
ance were prepared by diluting the required concentration of
antigen in 30 mL of PBS, pH 7.4. A range of concentrations were
utilized; since levels should be less than 4 ng mL-1 for a healthy
individual, we set our minimum level at 1 ng mL-1 with an upper
limit of 1 íg mL-1, so as to cover the clinical range.
The sensors were first interrogated without antigen addition.
Following this, each sensor was exposed to the required antigen
concentration for 30 min, rinsed well with deionized water, and
then subjected to impedance interrogation. Potassium ferrocyanide
(10 mM) and potassium ferricyanide (10 mM) in PBS buffer were
utilized as a redox couple for impedimetric measurements. Three
electrodes were used for each measurement. A frequency range
from 10 kHz to 1 Hz was measured, with a peak amplitude of 5
mV and a dc offset of +400 mV against Ag/AgCl.
RESULTS AND DISCUSSION
Deposition of Polyaniline. The voltammograms for the
deposition of polyaniline onto the screen-printed carbon elec-
trodes12 are depicted in Figure 3 and imply a steady in situ
formation of polymer at the electrode surface. As the number of
scans increases, voltammetric peaks are seen between +350 and
400 mV versus Ag/AgCl, corresponding to the oxidation and
reduction of surface bound polyaniline. The increase in current
from scan 10 to 20 is due to the increase in polyaniline thickness
and coverage of the electrode.11
Impedance Profiles of the Electrodes. A series of Nyquist
curves were obtained for the sensors after exposure to various
levels of MBP in PBS (Figure 4a). As can be seen, there is a steady
decrease in the impedance of the electrodes with increasing
antigen concentration. The relative impedances of the system for
various antigen concentrations can be obtained by dividing the
impedance for each frequency when a given concentration of
antigen has been applied by the impedance (at the same
frequency) for the sensor exposed to zero antigen concentration;
these are shown in Figure 4b. This figure clearly shows that the
impedance of the electrodes steadily increases with the concentra-
tion of MBP. Myelin basic protein is a mixture of epitopes with
molecular weights of 14-21 kDa.14 However the commercial
antibody recognizes the peptide strand between amino acids 36
and 50 which is common to all the epitopes. The increases in
impedance are most probably due to binding of the protein to
the surface, since the protein molecules are likely to be insulating
in nature. As can be seen, much larger increases in impedance
are observed at the lower frequencies, which again indicates
Figure 2. Screen-printed carbon electrodes used within this work.
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deposition of insulating material. Therefore, it was decided that
changes in impedance at 1 Hz would be used as a measurement
of antigen binding.
The impedance spectra consists of two components: the real
(Z′) component, where the impedance in phase with the ac
potential waveform is measured, and the imaginary (Z′′), where
the impedance is 180° out of phase. It is important to differentiate
between the individual components of the total impedance of the
cell. Previous work by our group showed that while both the
imaginary and real components increase, the increase in the real
component dominated the total increase in the impedance.11,12
Although in this case changes in both real and imaginary
components are visible and again the real component is the major
component of the total impedance, it was also found (perhaps
more importantly) that the real component offers far greater
reproducibility in comparison to the imaginary contribution.11,12
Figure 5a shows the percentage increase in Z′ across a range
of antigen concentrations. As can be seen, there is a steady
increase in impedance as antigen concentration increases toward
a concentration of about 100 ng mL-1. Levels higher than 100 ng
mL-1 do not appear to lead to even higher impedances, but rather
tend toward a plateau, Figure 5a. This possibly indicates saturation
of the specific binding sites. Any further changes in impedance
beyond this level are likely to be due to nonspecific interactions.
Nonspecific interactions have the potential to interfere with
immunosensor performance, leading to erroneously elevated
results. This could be addressed by utilization of a second sensor
containing either no antibodies or, alternatively, by exploitation
of a nonspecific antibody. For this reason an identical set of
immunosensors were fabricated utilizing a nonspecific IgG anti-
body in place of the specific MBP antibody. The nonspecific
antibody was a commercial polyclonal IgG antibody, from the
same species (mouse) as the specific MBP antibody. This was
biotinylated using an identical protocol and then incorporated into
the sensor using identical conditions, buffers, concentrations, etc.
as utilized for the specific antibody electrodes. Whereas specific
binding of MBP will only occur when the anti-MBP antibody is
present, electrodes fabricated using a nonspecific antibody should
undergo the same nonspecific binding events as those fabricated
using specific antibodies. It therefore follows that utilization of
both types of electrodes followed by simple subtraction of
nonspecific electrode response from those of the specific elec-
trodes should allow the nonspecific responses to be cancelled out.
Results for the nonspecific IgG electrodes were obtained in
exactly the same manner as for the specific electrodes, and the
calibration plot for these measurements is shown within Figure
5b. As can clearly be seen, there is a much lower response for
Figure 3. Deposition of conducting polyaniline films by cyclic voltammetry between -0.2 and +0.8 V at 50 mV s-1; current transients are
shown for the 1st, 10th, and 20th cycles.
Figure 4. (a) Bode and (b) Nyquist plots of a typical specific anti-
MBP-modified electrode exposed to various concentrations of antigen
(MBP); for brevity not all concentrations are shown, but just for 0, 1,
2, 4, 8, 10, and 100 ng mL-1.
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the nonspecific antibody, showing that although there are non-
specific interactions, between the concentration ranges of 1-100
ng mL-1, they comprise a minor component of the detected
response.
Once the nonspecific responses have been subtracted (Figure
5a - Figure 5b), a corrected plot (Figure 5c) shows the calibration
curve for the corrected sensor response. Between a concentration
range of 1-100 ng mL-1, there is a near linear correlation of the
corrected impedance change with the log of concentration (R2 )
0.976). Between the lower range of 1-15 ng mL-1, the correlation
of the impedance change with the log of concentration is further
improved (R2 ) 0.990). The limit of detection of this system was
found to be approximately 1 ng mL-1, based on a multiple of 3
the standard deviation of the baseline samplessand combined with
the good linear response, indicates that we have developed a
sensor with good performance within the required range of
detection for MBP.
As yet we have not attempted to either reverse the antibody-
antigen binding process or remove the antibody and replace it
with fresh protein. In view of the low potential unit cost of the
electrodes it would be simpler just to use sensors as single-use
devices. However, for this to be feasible there must be both good
sensor-to-sensor and batch-to-batch reproducibility. We have found
that repeated runs on the same electrode give reproducible results
with RSDs < 2%. We have also determined the electrode-to-
electrode reproducibility of responses to have RSDs < 5%
variability in a series of trials.
CONCLUSIONS
We have demonstrated the construction of an immunosensor
for the MBP using a combination of screen-printed electrodes
coated with conducting polyaniline and an immobilized polyclonal
antibody. Interrogation of the electrodes by ac impedance dem-
onstrated the detection of the antigen. Linear correlation of the
impedance change with the log of concentration (R2 ) 0.977) was
observed between concentrations of 1-100 ng mL-1. A similar
logarithmic relationship was observed in our earlier work with
ciprofloxacin immunosensors.12
Further work utilizing samples of cerebrospinal fluid with
various levels of MBP will be undertaken, and it is expected that
the use of a dual-antibody (specific and nonspecific) electrode
system should allow subtraction of any nonspecific binding events
to allow the detection of MBP levels in “real” samples. These
studies will be reported in a future publication.
One major drawback associated with immunosensors is the
strength of the antibody/antigen binding which can render the
interaction essentially irreversible. This would lead to the sensor
rapidly becoming saturated upon multiple usage, a process which
would be very difficult to reverse by simple washing. The use of
inexpensive screen-printed electrodes as a template for these
sensors will allow for the production of simple and, more
importantly, inexpensive single-use immunosensors, thereby
eliminating the need for washing and reuse of sensors.
Commercialization of this research is proceeding through a
new spin-out company ELISHA Systems Ltd., which is in the
process of developing a range of label-less immunosensors for a
number of different antigens.
ACKNOWLEDGMENT
This work, including funding for G.T., G.-Z.G., and F.D., has
been supported by the European Community Framework VI
NMP2-CT-2003-505485, “ELISHA” contract.
Received for review October 8, 2007. Accepted December
21, 2007.
AC702070E
Figure 5. Calibration curves showing the increase in the real
component of impedance at 1 Hz for (a) specific anti-MBP-modified
electrodes exposed to varying concentrations of antigen (MBP), (b)
IgG-modified electrodes exposed to antigen under identical conditions,
and (c) corrected calibration curves where the nonspecific response
has been subtracted from the specific response (curve a - curve b).
All data points are means for the responses of three electrodes; error
bars give a measure of the reproducibility of the system.
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This paper describes the development and characterisation of labeless immunosensors for (a) the cardiac
drug digoxin and (b) bovine serum albumin (BSA). Commercial screen-printed carbon electrodes were
usedas thebasis for the sensors. Twomethodswereused to immobilise antibodies at the electrode surface.
Aniline was electropolymerised onto these electrodes to form a thin planar ﬁlm of conductive polyani-
line; the polyaniline ﬁlm was then utilised as a substrate to immobilise biotinylated anti-digoxin using a
classical avidin-biotin afﬁnity approach. As an alternative approach, poly(1,2-diaminobenzene) was elec-
trodeposited onto the carbon electrodes and this modiﬁed surface was then sonochemically ablated to
form an array of micropores. A second electropolymerisation step was then used to co-deposit conduc-
tive polyaniline along with antibodies for BSA within these pores to produce a microarray of polyaniline
protrusions with diameters of several m, containing entrapped anti-BSA.
The resulting antibody grafted electrodeswere interrogated using an AC impedance protocol before and
following exposure to digoxin or BSA solutions, along with control samples containing a non-speciﬁc IgG
antibody. The impedance characteristics of both types of electrodewere changed by increasing concentra-
tionsof antigenup toa saturation level. Calibration curveswereobtainedby subtractionof thenon-speciﬁc
response from the speciﬁc response, thereby eliminating the effects of non-speciﬁc adsorption of antigen.
Both the use of microelectrode arrays and afﬁnity binding protocols showed large enhancements in sen-
sitivity over planar electrodes containing entrapped antibodies and gave similar sensitivities to our other
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. Introduction
The principle of immunoassays was ﬁrst established in 1959
Yalow and Berson, 1959) and their work led to the development of
he widely used radioimmunoassay to determine insulin-binding
ntibodies in human serum, using samples obtained from subjects
hat had been treatedwith insulin. Later, within unconnectedwork
Clark and Lyons, 1962), the concept of a biosensor was pioneered.
hese workers exploited the selectivity of enzymes for analytical
urposes via amethodologywhich involved immobilising enzymes
n the surface of electrochemical sensors and measuring the
xygen consumption by the glucose oxidase enzymatically catal-
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oi:10.1016/j.bios.2008.06.001ased planar electrodes. Detection limits were in the order of 0.1ngml−1
SA.
© 2008 Published by Elsevier B.V.
sed oxidation of glucose. This basic idea has remained virtually
nchanged since the original design, although the ﬁeld has under-
one continual technological developments over the last 40 years.
The incorporation of antibodies into conducting polymer ﬁlms
as ﬁrst reported (John et al., 1991) in 1991. Pyrrole was gal-
anostatically polymerised onto a platinum wire substrate from a
olution which contained anti-human serum albumin (anti-HSA).
he antibody was incorporated into the polypyrrole ﬁlm and the
olypyrrole anti-HSA electrode found to give a speciﬁc electro-
hemical response to HSA. Since this is early work, there has
een burgeoning interest in the development of electrochemical
mmunosensors—as detailed in several recent reviews (Rodriguez-
ozaz et al., 2006; Diaz-Gonzalez et al., 2005; Cosnier, 2005).
Antibody–antigen interactions are complex by their very nature
nd it is thought necessary that the afﬁnity reaction be mini-
ally perturbed by the fabrication procedure to give reproducible
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fFig. 1. Formation of polyaniline microarrays: (a) deposition of insulating
esponse characteristics. We have previously shown that up to
–3g antibodies for BSA and digoxin may be successfully incor-
orated into conducting polymer ﬁlms by entrapment in a growing
olypyrrole ﬁlm with no detrimental effect to antibody activ-
ty (Grant et al., 2003). Electrochemical interrogation of these
lms demonstrated selective interactions with the target anti-
ens. Further work utilised an AC impedance protocol (Grant et
l., 2005) as the method of interrogation for these ﬁlms and led
o the development of immunosensors for digoxin and bovine
erumalbumin. Laterwork by our group utilised polyaniline coated
creen-printed planar carbon electrodes as substrates for immobil-
sation of antibodies utilising the classical avidin-biotin interaction.
his enabled the construction of immunosensors for the ﬂuo-
oquinolone antibody ciproﬂoxacin (Garifallou et al., 2007) and
yelin basic protein—a marker for conditions such as stroke and
ultiple sclerosis (Tsekenis et al., 2008).
Our group has also pioneered the development of sonochemi-
ally fabricatedmicroarrays of conductive polymers (Higson, 1996),
he schematic for the formation of which is shown within Fig. 1.
oly(1,2-diaminobenzene) can be electrodeposited on a variety of
onductive surfaces to form an insulating layer15. We have utilised
ommercial screen-printed three electrode strips as the basis for
hese sensors. The working electrodes are initially coated with a
hin ﬁlm (50–70nm thickness) of an insulating polymer formed
y the electrochemical deposition of 1,2-diaminobenzene (Myler
t al., 1997). An advantage of this process is that it is self-limiting,
aking it highly reproducible. Sonochemical ablation is then used
o ablate or “drill” holes in this insulating material with diameters
f 0.1 to several microns and a density of up to 120,000pores cm−2.
e have used these micropore arrays for the detection of aqueous
hlorine (Davis et al., 2007). The arrays may be used as substrates
or further electropolymerisation reactions, generating arrays of
onducting polyaniline protrusions, consisting of just the polymer
r alternatively containing entrapped biological species (Barton
t al., 2004). Previous work within our group has utilised these
icroarrays containing entrapped enzymes for the amperomet-
ic detection of glucose (Barton et al., 2004; Myler et al., 2004),
lcohol (Myler et al., 2005). and a range of organophosphate pesti-
ides (Pritchard et al., 2004; Law and Higson, 2005) with extreme
ensitivity (10−17 M).
One difﬁculty often encountered when using sensors for prac-
ical analytical applications is that the species being detected can
n some situations be present only at very low concentration while
eing contained within a complex biological system such as blood.
his means that any sensor must display high sensitivities and
lso low non-speciﬁc adsorption of possible foulants or interfer-
nts. As can be seen from previous work using enzymes, use of
icroelectrodes rather thanplanarelectrodescan lead toextremely
igh sensitivities (Pritchard et al., 2004; Law and Higson, 2005).
ttempts therefore were made within this study to determine
hether the use of microelectrodes rather than planar electrodes
ithin immunosensors similar to those previously reported (Grant
o
C
d
a
L, (b) sonochemical formation of pores and (c) polymerisation of aniline.
t al., 2003, 2005) would lead to sensitivity enhancements. Micro-
lectrode arrays containing entrapped anti-BSA were constructed
nd their performance comparedwith our previouswork onplanar,
ntrapped sensors.
A disadvantage associated with the entrapment method used
ithin much of our previous work for antibody immobilisation is
hat the antigen will often be too bulky to diffuse through the poly-
er matrix and so only antibodies located at the surface of the
olymer ﬁlm or microelectrode — and suitably orientated, will be
vailable for antigen binding. Otherwork comparingmonolayers of
andomly and speciﬁcally orientated antibody fragments (Bonroy
t al., 2006) showed that immunosensor responses typically double
hen the fragment is speciﬁcally orientated.
Digoxin (Supplementary data, Fig. S2) is a cardiac drug, widely
sed in the treatment of various heart conditions such as atrial
brillation and atrial ﬂutter, with a narrow therapeutic range of
.8–2.0ngml−1 (Terra et al., 1999). Previous work by our group
emonstrated the construction of an immunosensor for digoxin,
owever, these sensors were only capable of detecting the anti-
en in the mg–gml−1 ranges (Grant et al., 2003). The anti-digoxin
ntibodies used in this early study were entrapped within a pla-
ar, electropolymerised ﬁlm. We therefore within this work also
ompare results obtained using an afﬁnity method to graft anti-
odies to the surface of the ﬁlm with those obtained previously by
ntrapment (Grant et al., 2003) in an attempt to improve sensitivity.
The focus of this paper is not just to describe the development
f particular sensors — but rather to compare the behaviour of sen-
ors fabricated using a variety of methods, namely our earlier work
n entrapment in planar polymer ﬁlms with afﬁnity grafted pla-
ar ﬁlms and also entrapment of the antibodies within conductive
olymer protrusions. As will be demonstrated, both methods lead
o an enhancement in sensitivity.
. Experimental
.1. Materials and equipment
Sodium dihydrogen orthophosphate, disodium hydrogen
rthophosphate, sodium chloride and hydrochloric acid were
btained from BDH (Poole, Dorset, UK). Aniline, polyclonal
uman anti-IgG (AIgG), biotin 3-sulfo-N-hydroxysuccinimide,
he biotinylation kit (part no. BK101), neutravidin, human serum
lbumin (HSA), BSA, anti-bovine serum albumin (ABSA, devel-
ped in rabbit), digoxin, anti-digoxin (developed in rabbit-whole
ntiserum), sodium acetate, acetic acid, sodium perchlorate,
otassium ferrocyanide and potassium ferricyanide were obtained
rom Sigma–Aldrich, Gillingham, Dorset, UK. All water used was
btained from a Purelab UHQ Deioniser (Elga, High Wycombe, UK).
ommercial screen-printed carbon electrodes (Supplementary
ata, Fig. S1) containing carbon working and counter electrodes
nd an Ag/AgCl reference electrodewere obtained fromMicroarray
td., Manchester, UK. The surface area of the working electrode
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as 0.2178 cm2. AC impedance measurements were performed
sing an ACM auto AC DSP frequency response analyser (ACM
nstruments, Grange-over-Sands, UK). Cyclic voltammetry was
erformed using a Sycopel potentiometer (Sycopel Scientiﬁc, Tyne
Wear, UK) to electrodeposit polyaniline.
Aniline buffer (pH 1–2) was prepared containing 0.5mol l−1
Cl, 0.3mol l−1 HCl and 0.2mol l−1 aniline. Phosphate buffer (PBS,
H 7.4) was prepared comprising 52.8mmol l−1 disodium hydro-
en orthophosphate 12-hydrate, 13mmol l−1 sodium dihydrogen
rthophosphate 1-hydrate and 5.1mmol l−1 sodium chloride.
cetatebuffer (pH4.0)waspreparedcomprising0.4mol l−1 sodium
cetate, 0.4mol l−1 acetic acid and 0.4mol l−1 sodium perchlo-
ate.
The anti-digoxin was supplied as a solution in whole antiserum
nd was puriﬁed using a 5ml protein G-column (Pharmacia). IgG
raction was eluted using glycine buffer (pH 2.7) and dialyzed
vernight. For antibody biotinylation, the procedure outlined in the
K101kitwas followed (seemanufacturers instructions for details).
he biotinylated anti-digoxin was very dilute (0.01mgml−1) and
as concentrated using a Centriprep centrifugal ﬁlter unit (Milli-
ore, Hertfordshire, UK) ﬁtted with an ultracel YM-30 membrane
ontaining glycerol, to prevent drying. This procedure also ensured
he removal of sodium azide from the antibody solution. The pro-
edure involved three subsequent centrifugations in a cold room
4 ◦C), each for 20min at 30,000 rpm; the ﬁnal concentration was
.5mgml−1. Biotinylated antibodieswere kept frozen in aliquots of
00l until required.
.2. Formation of microarrays
Sonochemically fabricatedmicroarrayswereconstructedaspre-
iously described (Barton et al., 2004). To deposit the insulating
ayer, a 5mmol l−1 solution of 1,2-diaminobenzene in pH 7.4 phos-
hate buffer was utilised. Prior to the immersion of the carbon
lectrode, themonomer solution usedwas thoroughly purgedwith
2 for 20min in a sealed cell to provide an oxygen free atmosphere.
n initial 1 s blast of ultrasound was also applied to a submerged
lectrode to displace air bubbles trapped at the surface of the elec-
rodes. Homogenous insulation of a planar carbon electrode was
chieved by sequentially scanning the working electrode poten-
ial from 0mV to +1000mV (vs. Ag/AgCl) and back to the starting
otential at a scan rate of 50mVs−1 for 20 sweeps.
Sonication experiments were performed using a custom
uilt 2 kW, 25kHz ultrasound tank with internal dimensions of
50mm×750mm×600mm (working volume 750mm×750mm
500mm) (Ultrawave Ltd., Cardiff, UK). Ultrasound was applied at
frequency of 25kHz for 10 s duration.
.3. Incorporation of antibody within microarrays via
lectrochemical deposition
A 0.2M aniline hydrochloride solution was prepared in a pH 4.0
cetate buffer. The solution pH fell to approximately 2.6 upon addi-
ion of monomer. Monoclonal antibody receptor was incorporated
nto the buffered monomer solution prior to polymerisation at a
esultant concentration of 0.5mgml−1. The pH of the monomer
olution increases upon addition of antibody, this was monitored
o ensure the pH remained below 4.0 so that the conductive pro-
onated ‘emeraldine’ form of polyaniline was deposited at the
orking electrode. Electrochemical deposition of the polyaniline
as performed by sequentially cycling the working electrode
otential from −200mV to +800mV (vs. Ag/AgCl) and back to the
tarting potential at a scan rate of 50mVs−1. A linear sweep from
200 to +800mV (50mVs−1) was performed at the end of cyclic
oltammetry to leave the polyaniline in its protonated emeraldine
I
t
t
eig. 2. Schematic of the afﬁnity binding procedure used to immoblise anti-digoxin.
alt form. This led to formation of polyaniline protrusions contain-
ng entrapped antibodies as previously described (Barton et al.,
004; Law and Higson, 2005).
.4. Construction of planar antibody electrodes via an afﬁnity
rotocol
Anti-digoxin was immobilised at the surface of planar elec-
rodes by themethods previously described (Garifallou et al., 2007;
sekenis et al., 2008) and the immunosensor structure is shown
chematically in Fig. 2. The potentiodynamic electrodeposition of
olyaniline from aniline buffer, pH 1–2 into the microelectrode
rray was achieved electrochemically as described for the microar-
ays.
30l of biotin-sulfo-NHS (10mgml−1 in water) was placed on
he working electrode surface for 24h. The sensors were rinsed
ith copious water and 30l of neutravidin (10gml−1 in water)
laced on the working electrode for 1h followed by further rinsing
n water. 30l biotinylated anti-digoxin (0.5mgml−1 in water, 1h)
as then added followed by rinsing. Finally, non-speciﬁc interac-
ions were blocked by HSA (10−6 mol l−1 in PBS, 1h).
.5. Determination of antigen concentration
AC impedance measurements were performed using an ACM
uto AC DSP frequency response analyser. Following immobilisa-
ion of antibody, impedance analyses were performed from 1Hz
o 10,000Hz (±5mV amplitude perturbation) in pH 7.4 phosphate
uffer, i.e. containing no antigen, as a baseline trace. This buffer
olution did, however, contain a 50:50 mixture of [Fe(CN)6]3−/4−,
t a concentrationof10mmol l−1 as redoxmediator soas toperform
aradaic impedance spectroscopy. The potential of the electro-
hemical cell is offset to the formal potential of the redox probe
+0.12V vs. Ag/AgCl identiﬁed via cyclic voltammetry). Following
he recording of a baseline spectral trace (0ngml−1 antigen), the
ame sensor is used for all concentrations and exposed for 30min
ime periods to the increasing concentrations of antigen in phos-
hate buffered test solution.
After each 30min exposure to a known concentration, the
ensor was thoroughly ﬂushed with 50ml of pH 7.4 phosphate
uffer (containing [KFe(CN)6]3−/4− and no antigen) to remove any
on-speciﬁcally adsorbed matter before AC impedance spectra
ere recorded in the phosphate buffered test solution (containing
KFe(CN)6]3−/4− and no antigen). This sensor was then exposed to
n increasing antigen concentration and the process repeated for
he full range of applied antigen concentrations under investiga-
ion. Traces recorded may then be compared to the baseline trace.
mmunosensors were also tested where the electrode was exposed
o a diminishing series of antigen concentrations i.e. starting with
he highest and gave similar results (Garifallou, 2008).
The electrode assemblies were found to be very stable, for
xample a sensor placed in pH 7.4 phosphate buffer (containing
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gig. 3. (a) Bode and (b) Nyquist plots of a typical speciﬁc anti-digoxin modiﬁed elec
KFe(CN)6]3−/4− showed no change in the AC impedance curves
ven after 90min equillibration (Tsekenis, 2008).
. Results and discussion
.1. Impedance results for planar, afﬁnity immobilised
nti-digoxin electrodes
Fig. 3 shows the (a) Bode and (b) Nyquist curves obtained
or a planar polyaniline/anti-digoxin modiﬁed, carbon electrode
xposed to various concentrations in the range of 0–10ngml−1
f antigen. The Nyquist curve (Fig. 3b) demonstrates that the Z′
real) componentof the impedance increases steadilywithdecreas-
ng frequency whereas the Z′′ (imaginary) component increases
o a maximum value (at frequencies in the range 5–10Hz) before
alling as the frequency approaches 1Hz. This type of impedance
pectrum is indicative of a surface-modiﬁed electrode system
here the electron transfer is slow and the impedance is con-
rolled by the interfacial electron transfer (Katz and Willner,
003).
As can be seen, there is a steady decrease in impedance as
ntigen concentration increases towards a concentration of about
.5ngml−1. Levels of 2ngml−1 and 10ngml−1 did not lead to even
ower impedances, but rather tend towards a plateau, indicating
aturation of the speciﬁc binding sites. Any further changes in
mpedance beyond 1.5ngml−1 are likely to be due to non-speciﬁc
nteractions. The corresponding Bode plots (Fig. 3a) also show a
ecrease in the total impedance as the digoxin levels increase. This
ndicates that the binding of digoxin is facilitating electron transfer
etween the electrode and the redox probe. Since the therapeu-
ic range is 0.8–2.0ngml−1 (Terra et al., 1999) this indicates that
hese sensors will be sufﬁciently sensitive and in fact there may
e a need to undertake some dilution of the sample. However the
ange of these sensors is unfortunately rather small, which may
reclude their use in real situations. What is of interest though is
t
r
s
t
ig. 4. Calibration curves showing the decrease in the real component of impedance (i
lectrodes exposed to varying concentrations of antigen, (b) IgG modiﬁed electrodes expos
he non-speciﬁc response has been subtracted from the speciﬁc response (curve a minus
ive a measure of the reproducibility of the system.exposed to various concentrations in the range 0–10.0ngml−1 of digoxin in PBS.
hemuchhigher sensitivity compared to digoxin sensors fabricated
y entrapment, indicating that controlled immobilisation does lead
o enhanced sensitivity.
The impedance spectra consists of two components, the real
Z′) component where the impedance in phase with the AC poten-
ial waveform is measured and the imaginary (Z′′) where the
mpedance is 180◦ out of phase. Previous work by our group has
emonstrated that in these type of systems, the increase in the
eal component dominated the total increase in the impedance
nd perhaps more importantly the real component offers far
reater reproducibility in comparison to the imaginary contribu-
ion (Garifallou et al., 2007; Tsekenis et al., 2008).
Our previous work demonstrated that the sensors of this
ype gave the largest relative changes at the lower frequencies
Garifallou et al., 2007, Tsekenis et al., 2008). Calibration curves
ould be drawn (Fig. 4a) showing the percentage decrease in Z′ at
Hz across a range of antigen concentrations. Again these show a
elationship between antigen concentration and the decrease in Z′.
Non-speciﬁc interactions have thepotential to either exaggerate
r mask speciﬁc interactions. Whereas speciﬁc binding of antigens
ill only occur when their antibodies is present, electrodes fab-
icated using a non-speciﬁc antibody should undergo the same
on-speciﬁc binding events as those fabricated using speciﬁc anti-
odies. The calibration curve showing the percentage decrease
n Z′ at 1Hz is shown for sensors fabricated using an identical
rotocol except that the speciﬁc antibody is replaced by a non-
peciﬁc IgG antibody (Fig. 4b). As can clearly be seen, there is a
uch lower response for the non-speciﬁc antibody, showing that
lthough there are non-speciﬁc interactions, between the concen-
ration ranges of 0–2ngml−1, they comprise aminor component of
he detected response.
Once the non-speciﬁc responses have been subtracted, a cor-
ected plot (Fig. 4c) shows the calibration curve for the corrected
ensor response. Between a concentration range of 0–1.5ngml−1,
here is a clear correlation of the corrected impedance change with
n the range 0–2.0ngml−1 digoxin) at 1Hz for: (a) speciﬁc anti-digoxin modiﬁed
ed to antigen under identical conditions and (c) corrected calibration curves where
curve b). All data points are means for the responses of three electrodes; error bars
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wig. 5. Calibration plot showing changes in electron transfer resistance vs. BSA
oncentration: (a) entrapped ABSA (0–300ngml−1) and (b) entrapped anti-IgG
0–300ngml−1).
he concentration. The limit of detection, calculated as 3× the stan-
ard deviation of the baseline sample of this system (Analytical
ethods Committee, 1987) is approximately 0.1ngml−1. Our pre-
ious system using entrapment of digoxin within a polymer ﬁlm
ombined with pulsed waveform detection (Grant et al., 2003) was
nly capable of resolving digoxin at levels higher than 50gml−1,
o as can be seen the combination of an AC interrogation protocol
nd an afﬁnity-based immobilisation procedure leads to at least
two orders of magnitude increase in sensitivity. The responses
or 10ngml−1 digoxin (not shown in plots) were indistinguishable
rom those at 2ngml−1.
.2. Impedance results for entrapment immobilised anti-BSA
icroelectrodes
Impedance traces for polyaniline microelectrode sensors
ontaining entrapped ABSA were obtained as for the anti-digoxin-
ased electrodes. These were very similar in appearance to those
btained for previous electrodes, again indicating a electrochemi-
al system where the electron transfer is slow and the impedance
s controlled by the interfacial electron transfer (Katz and Willner,
003). Rather than just studying the change in Z′ at 1Hz, it was
ecided to undergo a more detailed investigation of the electro-
hemical system. A computer ﬁtting of the experimental data to
theoretical model, represented by a simple equivalent circuit,
ay be performed by the software accompanying the frequency
esponse analyser. In this case, the interface is modelled by an
quivalent circuit (Supplementary data, Fig. S3), also called a Ran-
les circuit (Randles, 1947), consistingof adouble-layer capacitor in
arallel with a polarization resistor (also known as a charge trans-
er resistor with certain constraints) and a Warburg impedance,
onnected in series with a resistor that measures the resistance
f the electrolyte solution. For a more thorough evaluation of the
ata obtained, the changes in the Nyquist curves may be trans-
ated into electron transfer resistance changes to provide a clear
nd consistent format.
The relative electron transfer resistance changes from the base-
ine response at each concentration of BSA for a typical electrode
odiﬁed with ABSA are plotted in Fig. 5a. The electron trans-
er resistance increases with increasing BSA concentration and
emonstrates that an entrapped ABSA immunosensor gave a linear
esponse to the analyte from 0ngml−1 to 100ngml−1 ABSA.
The insulation of the modiﬁed electrode upon formation of
table antibody–antigen immunocomplexes hinders the electron
ransfer kinetics of the redox probe resulting in the increase
f electron transfer resistance. The electron transfer resistance
ncreases with increasing antigen concentration for both types
f electrode. The limit of detection (three times the standard
eviationof thebaseline value) of the entrappedABSA immunosen-
or is 1ngml−1. There is negligible change from 100ngml−1 to
o
A
a
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00ngml−1 suggesting that the immunosensor approaches satu-
ation.
Non-speciﬁc interactions have the potential to interfere with
mmunosensor performance, leading to erroneously elevated
esults. For this reason, identical sets of immunosensors were fab-
icated by both methods utilising a non-speciﬁc IgG antibody in
lace of the speciﬁc ABSA antibody. Results for these electrodes
ere obtained in exactly the same manner as for the speciﬁc elec-
rodes. From the Nyquist plots for these systems (not shown),
t could be seen that while binding of BSA to the non-speciﬁc
mmunosensors occurs, the responses are smaller than for ABSA
odiﬁed sensors. A calibration plot for this system can also be
rawn (Fig. 5b) and shows a linear-type non-speciﬁc response is
bserved for the afﬁnity-based anti-IgG immunosensor from 1 to
00ngml−1 BSA with a plateau above this concentration. Upon
omparison of Fig. 5awith Fig. 5b, it is apparent that approximately
0% of the ABSA-afﬁnity immobilised sensor response encountered
s, in fact, non-speciﬁc. This is most likely due to the fact that BSA is
protein with a high afﬁnity for surfaces and no blocking reagents
ave been utilised for these electrodes.
To obtain a calibration proﬁle, in terms of ‘corrected’ electron
ransfer resistance change for an ABSA immunosensor, account-
ng for any non-speciﬁc responses, the non-speciﬁc response was
ubtracted fromthe speciﬁc responseover theentire analytical con-
entration range. In total 10ABSA-immobilised sensors of each type
nd 10 corresponding anti-IgG-immobilised sensors were interro-
ated over their active concentration range, to allow an assessment
f the reproducibility of the responses for this system. Results are
resented in Fig. 6. The error bars are the standard deviations
btained for the 10matched sensor pairs from themean ‘corrected’
alues.
From Fig. 6 a linear response was observed for the immunosen-
ors from 0 to 100ngml−1 BSA. Fig. 6 (inset) shows an expanded
iew from 0 to 10ngml−1 BSA and shows linear behaviour with
2 >0.99. At concentrations above 100ngml−1, the sensor becomes
aturated. From the standard deviations obtained, we can say that
iscrimination of BSA antigen analyte is possible at 5ngml−1. The
imit of detection of the ABSA immunosensor is 1.5ngml−1 BSA
nd is calculated from 3× the standard deviation of the baseline
esponse and extrapolated from the line of best-ﬁt according to
UPAC guidelines (Analytical Methods Committee, 1987). Previous
ork (Grant et al., 2003, 2005) allowed detection of BSA at levels as
ow as 10gml−1. As can be seen the use of polyaniline microelec-
rodes has greatly increased sensitivity, although in this instance
here is a problem with high non-speciﬁc responses.
.3. Stability of the BSA immunosensors and regeneration studies
Although a long-term sensor stability test was not performed,
batch of 18 sensor pairs was assessed from storage in dry state,
t 4 ◦C, for a period of 12 weeks. Again an identical experimental
rotocol was employed for electrochemical impedance interroga-
ion and the ‘corrected’ electron transfer change was the analysis
ethod for response recovery.
Every 2 weeks a set of three matched sensor pairings was
emoved from storage and interrogated over the full BSA antigen
nalyte concentration range from 1 to 300ngml−1. After 2 weeks
o loss of sensor response occurred but after 4 weeks there was
10% loss in response and further steady decreases until after 10
eeks storage only 10% of the original response was detected.
Some of our previous work demonstrated that acid washing
f some immunosensors led to their regeneration (Barton, 2007).
ttempts were made so see whether it was possible to regener-
te the sensors by acid washing. 5 ABSA-immobilised sensors and
matched non-speciﬁc AIgG-immobilised sensors are exposed to
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Rig. 6. Corrected calibration curves where the non speciﬁc response has been su
0–10ngml−1).
he full interrogationprocedureprior to reversibility investigations.
n order to split the antibody–antigen complex and to regener-
te the sensors, 0.1M HCl acidic buffer (pH 2.3) was applied for
hree separate 1min time periods. In between each acidic buffer
xposure, pH 7.4 PBS was used to rinse the sensor surface. Finally
he sensors were rinsed with 50ml PBS to produce PSA-free sen-
ors which could then be used for fresh analysis. Unfortunately
n all cases the washing removed all activity. An identical base-
ine response could be achieved which suggests that the sensor
urface integrity remains, yet the antigen recognition and binding
apabilities of the receptor antibodies are severely damaged by the
reatments.
. Conclusions
Our work veriﬁes several fabrication techniques and an AC
xperimental interrogation protocol as a viable approach towards
he labeless sensing of BSA and digoxin. Afﬁnity-based sensors
here anti-digoxin is immobilised on planar electrodes using
vidin–biotin interactions have been shown to displaymuchhigher
ensitivities (by two orders of magnitude, capable of detection of
gml−1 levels of antigen) than sensors developed in earlier work
tilising entrapment within planar conductive polymer electrodes
s themethod of immobilisation. Lownon-speciﬁc binding of these
lectrodes was also observed. However the range of these elec-
rodes was very limited which could preclude their use in real
nalyses.
Similarly sensors developed where ABSA is entrapped in con-
uctive polymer microelectrodes rather than planar polymer ﬁlms
ave been studied. The microelectrode array sensors were three
rders of magnitude more sensitive, again allowing detection of
gml−1 levels of antigen. These types of sensors however displayed
igher non-speciﬁc binding. However BSA is a protein noted for
ts high binding ability to surfaces and future sensors for other
nalytes will include a BSA blocking step to reduce non-speciﬁc
nteractions.
The next step involved combining these two methods in an
ttempt to enhance the sensitivity levels even further. Sensors have
een developed involving a multi-step procedure. Initially conduc-
ive polyaniline microarrays were constructed. The polyaniline was
hen modiﬁed with biotinylating reagents and biotinylated anti-
odies immoblised by the afﬁnity procedures described above.
inally the sensors areblockedwithHSA.Ongoingworkhasdemon-
trated the construction of sensors for prostate speciﬁc antigen,
euron speciﬁc enolase and the stroke marker protein S-100[].
hese immunosensors have been shown capable of quantifying
ntigens at levels as low as 1pgml−1, these will be the subject
T
T
T
Yted from the speciﬁc response (0–300ngml−1) (inset) corrected calibration plot
f a further series of publications to be submitted for publication
hortly and will be described in detail at the 10th World Congress
n Biosensors, Shanghai, May 14th–18th 2008.
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